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                                                         Abstract:  
Novel role for human beta defensin-2 as a protease inhibitor in 
protecting keratinocytes against Staphylococcus aureus secreted 
proteases.  
Atopic dermatitis (AD) patients’ exhibit increased susceptibility to viral and microbial 
infections, especially Staphylococcus aureus (S. aureus). Evidence suggests that S. aureus 
secreted proteases are responsible for increased breakdown of junctional and desmosomal 
adhesions, that help to maintain skin barrier function. I therefore examined the effect of S. 
aureus secreted exotoxins (proteases), on an intact monolayer of HaCaT cells, a 
keratinocyte cell line. Damage to the HaCaT monolayer was observed as a loss in tight 
junction and desmosomal contacts, which were visualized throughout the monolayer when 
I stained them (after staining) with specific antibodies. I quantitated those effects by 
Western blotting and by measuring transepidermal electrical resistance (TEER).  
S. aureus secreted serine protease (V8) was the key agent responsible for the gross 
effects on HaCaT monolayers.  I also discovered that pre-treatment of HaCaTs cells with 
both IL-1β and LTA protected monolayer from S. aureus protease and this could be 
attributed to increase secretion of a novel peptide. I further demonstrate that  hBD2 a novel 
peptide act as an ant-protease that inhibit both V8 & staphopain B. Importantly, novel 
peptide could reduce the deleterious effect of S. aureus conditioned media, which contain 
higher concentration of bothV8 and staphopain B proteases. For further specification I 
compared S.aureus parent strain 8325-4 and their mutant strains L17 (SspB), L22 (SspA) 
and (L27) Scpa and SH1000. S. aureus proteases effects were observed in the presence or 
absence of recombinant, synthetic and linear scrambled novel peptides. The protective role 
played by skin commensal was tested by heat killing S. Epidermidis. I found HaCaT 
monolayer was protected from S. aureus secreted proteases when pretreated with heat 
killed S. Epidermidis. Thus, I concluded that V8 protease may be the most important factor 
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Structural and functional importance of skin barrier affected by 
S.aureus proteases in AD 
1 Introduction  1.1 Human skin 
Human skin is the outer covering of the body (Pereira et al., 2013). The average 
adult human skin has a surface area of 1.5 to 2 m2. There are two main kinds of human 
skin, Glabrous (non-hairy) and non-Glabrous (hair bearing).  Glabrous skin is found on 
the palms and soles. Non-Glabrous skin has both hair follicles and sebaceous glands with 
wide variation between different body sites (Howard et al., 2010).  
1.1.1 Anatomical structures of the skin 
  Epidermis, dermis and hypodermis are three layers of the skin. Each layer differs 
in thickness, function and mechanical strength.  Skin appendages include sweat glands, 
hair follicles, sebaceous gland and nails (Fig 1.1) (In RoB et al., 2005).  
 The hypodermis is the innermost layer of the skin, and consists of a network of 
adipocytes (fatty tissue) and fibroblast  (collagen secreting cells). The hypodermis is also 
known as the subcutaneous layer, and functions as both an insulator, conserving the 
body’s heat, and as a shock absorber, protecting the inner organs. It also stores fat as an 
energy reserve for the body. The blood vessels, nerves, lymph vessels, and hair follicles 









Fig- 1.1 the structure of human skin   
Skin is composed of three layers: the epidermis, dermis and hypodermis. Adnexal 
structures of the skin include, hair follicles, glands associated with muscles, nerves and 










Dermis is made up of two sub layers; the papillary and reticular layers. The papillary 
dermis comprised of mostly areolar tissue and 20 % of the dermis, and the reticular 
dermis contains thick connective tissue and constitute 80% of the dermis.  Dermis also 
contains most of the skin’s specialized cells (fibroblast, macrophages, and adipocytes) 
and structures, which includes blood vessels (Brown and Burn, 1996).   The “collagen” 
and “elastin” are fiber protein produced by dermal fibroblasts which provide strength and 
elasticity to the skin. The dermis contains appendages such as sweat glands, and hair 
follicles which are linked to the epidermis but project deep into the dermis. (Naylor et 
al., 2011). 
The epidermis  
Epidermis is the outermost layer of the skin; it protects the body by acting as a frontline 
barrier against the environment (Elias PM et al., 2008).  The epidermal barrier is 
continuously renewed by terminally differentiating keratinocytes (Candi E et al., 2005). 
Epidermal thickness varies in different types of skin, being thinnest on the eyelids and 
thickest on the palms and the soles of the feet. In addition to its main cellular components 
keratinocytes, the epidermis contains the following cell types; melanocytes (pigment 
producing cells), the Langerhans cells (antigen presenting cells involved in the immune 
system of the skin), Merkel cells and sensory nerves (Naylor et al., 2011). The skin 
epidermis and dermis contains an easily accessible, immune privileged reservoir of adult 






leads to the production of multilayers, stratified epithelium. The epidermis is made up of 
five sub-layers which are as follows, stratum basale (SB), stratum spinosum (SS), stratum 
granulosum (SG), stratum lucidum (SL), stratum corneum (SC). Epidermal layers works 
together continually to rebuild the surface of the skin (Marks and James G, 2006). 
Epidermal sub-layers 
 The stratum basale (SB) also known as stratum germinatum is the innermost layer 
of the epidermis, containing large columnar cells attached to the epidermal basement 
membrane at the dermo-epidermal junctions. The basal cell layer also contains 
melanocytes which produce coloring pigment (melanin). Basal cells proliferate and 
provide daughter cells which undergo terminal differentiation to produce other layers of 
the epidermis.  The basal cells constantly migrate upward and differentiate into different 
cells in the spinous layer, which is the thickest layer of the epidermis and is involved in 
the synthesis of structural proteins. The structural proteins keratin five and fourteen 
which are present in the basal cell layer are replaced with keratin one and ten in the 
spinous layer. The spinous layer cells show spiny projections and are held together by 
desmosomal interaction. Upper spinous layer has lamellar bodies (LB), which contain 
ceramides cholesterol and free fatty acids. This layer also contains Langerhans cells. The 
cells of the spinous layer constantly move up to the stratum granulosum which is called 
the granular layer.  Keratinocytes of the granular layer has keratohyline granules (KHG) 
which contains precursors of the cornified envelope (C.E) such as profilaggrin and 
loricrin (Candi, E., et al. 2005). As the cells move further towards the surface of the skin 






die  (Figure 1.2) (Brown and Burns, 1996) (Marks  and James G, 2006).  The dead 
skin cells make a thin and clear layer called stratum lucidum (SL), which appears 
translucent under a microscope. The stratum lucidum is located between the stratum 
granulosum and stratum corneum layers and is composed of three to five layers of dead 
flattened keratinocytes. The keratinocytes of the stratum lucidum do not have distinct 
boundaries and are filled with eleidin, an intermediate form of keratin. 
 The Lamellar bodies (LB) release their content into the intercellular space of the 
stratum corneum (SC).  The content of the KHG and LB content covalently cross-linked 
with transglytaminase-1 form C.E (Cabral. A et al, 2001). 
  This arrangement of terminally differentiated cells with lipid matrix provides 
skin its permeability barrier which is constantly renewing throughout the life. In a healthy 
skin this process of terminal differentiation is highly regulated and make a constant 
balance between desquamation (sloughing off the dead cells) of the terminal layer and 












Figure 1.2 Schematic representations of epidermal sub-layers 
The epidermis consists of five layers stratum basale which has melanocytes; the stratum 
spinosum which has Langerhans cell; the stratum granulosum; the stratum lucidum and 








1.2 Skin Barrier 
          Normal skin barrier is formed by the contribution of cornified envelop, lipid 
matrix, corneodesmosomes, which are the desmosomal adhesions between corneocytes 
and tight junctions (Ishida-Yamamato et al., 2005) (Elias, P. M et al., 2008).  
1.2.1 Cornified envelope (CE) The CE is formed when flattened keratinocytes break 
down their plasma membrane and replace it with the insoluble proteins loricrin, 
involucrin, filaggrin, and small proline-rich proteins. These proteins are cross-linked 
together by the action of transglutaminases (Eckert RL et al., 2005). The CE gives 
strength to the corneocytes and provides a scaffold for the binding of lipids, including 
ceramides which are present in the lamellae of the stratum corneum. Cells of the stratum 
granulosum secrete their contents into the extracellular space to make a lamellar matrix, 
composed of ceramides, cholesterol, cholesterol esters and fatty acids which retain and 
entrap water (Feingold et al.,  2014). Corneocytes of the cornified envelope (CE) are the 
“bricks” while lipid matrix is the “mortar” in the brick and mortar model of skin barrier 
integrity (Nemes Z et al., 1999). If any component of this complex is damaged it can 
result in a disturbed barrier function (Ohnemus U et al., 2008).  Filaggrin (FLG) is 
expressed in the SG layer as a precursor protein called profilaggrin, which is 
dephosphorylated and cleaved by proteases into FLG monomers. The FLG monomers are 
further degraded to make natural moisturizing factors which maintain hydration of the 
upper SC (Sandilands et al., 2009). The strong association of FLG mutation with AD is 
one of the most important genotype and phenotype linkage observed in human complex 






also demonstrated a strong association between FLG mutation and early AD onset, 
disease severity, eczema herpeticum, AD related asthma, and allergen sensitization 
(Schuttelaar et al., 2009). 
1.2.2 Adherent junctions (AJ) 
 Desmosome are known as macula adherens, which is a cell structure specialized 
for cell-to-cell adhesion. They belong to the cadherin family of extracellular 
transmembrane glycoproteins and provide structural integrity to the CE. Desmoglein 
(DSG) and desmocollin (DSC) are desmosomal proteins both linked to the keratin 
filaments through corneodesmosomal plaque proteins (Fig 1.3). DSG and DSC play an 
important role in maintaining a functional skin barrier, and can be affected by S. aureus 
proteases with a particular susceptibility demonstrated in atopic dermatitis (AD) (Amagai 
et al., 2000).  If the connecting adherent junction of the epidermal cells is not functioning 
correctly, epidermal cells can pull apart and allow abnormal movements of fluid within 
the skin, resulting in blisters and other tissue damage. Blistering diseases such as 
pemphigus vulgaris and pemphigus foliaceus are autoimmune diseases in which 












Figure 1.3 Schematic representations of epidermal Adherent junction 
Desmosome are the cellular structure of adherent junction consists of two protein 
Desmoglein (DSG) and desmocollin (DSC). DSG and DSC are linked to the epidermal 












1.2.3 Tight junctions (TJ)  
 The tight junctions (TJ) can play a central role in cell-cell adhesion in simple 
epithelia and are responsible for connecting neighboring cells in a controlled manner. 
They establish and maintain tissue barriers for the transport of particles and molecules 
between different compartments of the cell. Tight junctions maintain normal cell surface 
polarity by separating the molecular compartment of the apical and basolateral portions 
of the plasma membrane (“fence function”) as well as their role as barrier (Brandner  J 
et al., 2002).  Claudin family, Occludin and zona occludin (ZO) protein which belongs to 
the membrane-associated-guanylate kinase homologs (MAGUKs) are the main proteins 
for the tight junction’s structure and functions (Figure 1.4). There are two other lesser 
important proteins including junctional adhesion molecule (JAM) and tricellulin (Tsukita 
et al., 2008).   
1.2.4 Claudin proteins 
 Claudin proteins are the integral component of tight junctions, forms paracellular 
barrier and controls the flow of molecules in the intercellular space between cells of the 
epithelium.  They have four transmembrane domains with the N-terminal and the C-
terminal in the cytoplasm. Claudin-1 was the first member of the claudin family to be 
identified as a tight junction component (Swisshelm et al., 2005). Claudin proteins have 
molecular mass (20-27 KDa) and  contain four short  membrane spanning region a short  
N terminal cytoplasmic domain, two extracellular loops, one intracellular loop and C 






microscopy, TJs appears as a network of continuous anastomosing intramembranous 
strands. These strands consist mainly of claudins and occludin (Tsukita et al., 2001). 
Tissue distribution patterns for the Claudin family members are distinct. Claudin-1 and 3 
were expressed in human neonatal and adult keratinocytes as well as in HaCaT 
keratinocytes, all other tested Claudins were negative (Brandner J et al., 2010).  Adult 
skin was positive for claudin-1 in the intercellular space of the spinosum layer and the 
basal layer but negative for claudin-2 in all skin layers. Claudin-1 and 3 are involved in 
cell to cell contact between keratinocytes in human epidermis. (Tebbe B et al, 2002).  
The Claudin protein family members are predicted to possess four transmembrane 
domains with intracellular N and C termini. It is suggested that all Claudins share a 
common transmembrane topology.  The MAGUKs family proteins ZO-1 ZO-2 and ZO-3 
binds to the COOH-terminal YV sequence of Claudin-1-8 through their PDZ1 domain in 
vitro (Itoh M et al., 1999).  
1.2.5 Zona Occludens  
 The MAGUK-like family of proteins ZO-1 (a 220 kDa protein), ZO-2 and ZO-3 
are associated with transmembrane proteins localizing at TJ (Occludin, Claudin)   JAM 
(junctional adhesion molecule) and with adhesion Junction (AJ) through α Catenin 
(Muller, S.L et al., 2005).  ZO family proteins are the cross–linker proteins which anchor 
TJ proteins to the actin cytoskeleton.  ZO-1 is structurally different from the other family 
members by having a ZU5 domain at the C-terminal, although the function of this 
domain is unknown (Utepbergenov, D. I et al., 2006).   An Actin-binding motif appears 






caused co-localization of ZO-1 and 2 with actin fibers (Umeda K et al., 2006).  ZO-1 is a 
functional component in the cadherin-based cell adhesion system, which point towards 
ZO intercellular adhesion and communication (Umeda K et al., 2006).  As TJ exist in the 
confluent epithelial-endothelial cells that’s why ZO-1 protein is also expressed under the 
condition where the TJ are present.  
1.2.6 Occludin 
  Occludin is a 522 amino acid polypeptide with a molecular weight of 65 kDa an 
important TJs protein encoded by the OCLN gene. Occludin is the main component of 
TJs and its localization at the TJs was first time described by Shoichiro Tsukita in 1993 
together with Claudin group of proteins (Furuse M et al., 2002).  
 Occludin appears to span the plasma membrane four times, forming two 
extracellular loops and exposing its NH2 and COOH terminus to the cytosol. Interaction 
of Occludin with several cytoplasmic proteins has been found to occur via its COOH 
terminus, while the extracellular loops are thought to be involved in the regulation of 
paracellular permeability and cell adhesion (Peng, Bi-Hung et al., 2003).  
Occludins are well known to regulate junctional organization and participate in 
the restriction of the paracellular transport pathway. Loss of Occludin attenuated 
activation of phosphoinositide 3- kinase (P13K), leading to disorganization of the actin 
cytoskeleton and reduced cell protrusion. Data indicate that Occludin is required for the 






complex)  and promote cell protrusion by regulating membrane- localized activation  of  
P13K (Du, D et al., 2009). 
1.2.7 Cytosolic proteins    
 Caveolae (Cav) are 50-100nm flask-shaped invagination rich in cholesterol and 
sphingolipids  described by Palade and Yamada in 1950’s. Caveolae are a subset of lipid 
rafts found on the plasmalemmal membranes of a variety of cells including endothelial, 
smooth muscle, epithelial cells, and fibroblast. One of the major functions of caveolae is 
to serve as a platform and to compartmentalize the signaling molecules that reside in or 
are recruited to caveolae. Caveolae are also involved in transcytoses, endocytosis, and 
regulation of cell proliferation, differentiation, and apoptosis via a number of diverse 
signaling pathways (Frank PG et al., 2003). 
 Cytosolic proteins are existed as a plaque, that crosslink junctional membrane 
proteins and connect TJs to the actin cytotoskeleton. .Within this plaque are signaling 
molecules and transcription factors that signal between TJ and the nucleus, which is 
important during cellular differentiation as TJ is intimately related to cell differentiation 
(Shin at al., 2006).  
 Caveolin-1 (Cav-1)  22 KDa is the major constitutive protein of the caveolae that 
interact  with and regulates several proteins including  Src family of kinases, G-proteins 






growth factor receptors such as vascular endothelial growth factor recptors (VEGF-R) 
and  epithelial growth factor receptors (EGF-R).  Caveolin-1 protein stabilizes these 
proteins by acting as a scaffolding protein, links Integrin- subunits to the tyrosine kinase 
FYN, an initiating step in coupling, integrin’s to the Ras-ERK pathway and promoting 
cell cycle progression (Frank PG et al., 2003). Transforming growth factor- beta (TGF-
beta) signaling proceed from the cell membrane to the nucleus through the cooperation of 
the type I and II serine/Threonine kinase receptors and their  SMAD effectors (Razani, B 
et al., 2001). The TGF-beta cascade is associated with Cav-1 in caveolae and interacts 
with the type I TGF-beta receptor. Cav-1 is able to suppress TGF-beta mediated 
phosphorylation of Smad-2 (Razani, B et al., 2001). 
1.2.7 Functional importance of tight junction  
 The structure and function of the TJ proteins are very important and dysfunction 
of these proteins can result in impaired skin barrier integrity. The gate and a fence are the 
two important functions of tight junctions. The gate function refers to the capacity of 
tight junctions to regulate the passage of ions, molecules and water through the 
paracellular pathway. The gate function can be detected by measuring the transepithelial 
electrical resistance (TEER) of the tissue. The fence function refers to the ability of TJs to 
restrict the movement of lipids and proteins within the membrane from the apical to the 
basolateral domains. This function maintains the polarity of the plasma membrane and 
thus allows the transport of molecules across the epithelia (Hartsock A et al., 2008). The 






inserting a fluorescent liquid into the apical membrane and detecting if any fluorescent 
label reaches the bottom part of the transwell. 
  Claudin-1(CLDN-1) is the most important protein of the TJ, which involved in 
epidermal barrier function of the skin (Furuse et al., 2002).  Furuse et al., developed a 
CLDN-1 knock down mouse, which died within 24 hours of birth due to severe defect in 
the epidermal barrier  even though  histologically stratum corneum was normal (Furuse 
et al., 2002).  The CLDN-1 gene polymorphism was reported as a possible candidate 
mutation in AD by De Benedetto (De Benedetto A et al., 2011).   They used haplotype 
tagging to show a genetic link between AD and CLDN-1, it was found that CLDN-
1protein expression was reduced in the non-lesional skin of patients with AD.   
 One study clarifies the role of TJs function as a barrier during bacterial cell 
infection.  The expression of TJs protein was investigated during infection with S.aureus, 
where delocalization of epidermal TJs proteins was determined. The relocalization of TJs 
protein in response to S.aureus infection may suggest, TJs probably contribute to both 
inside-out and outside-in barrier function of the skin (Ohnemus U et al., 2008).  Using 
HaCaT and porcine ex vivo infection models, CLDN-1- CLDN-4, Occludin and ZO-1 
were shown to be down regulated after S.aureus infection. This was studied by measuring 
TEER indicating the functional importance of CLDN-1. In addition almost complete loss 
of atypical Protein kinase C was demonstrated which plays a key role in TJ formation 
(Ohnemus U et al., 2008).   Formation of tight junction strands, which are crucial for this 
barrier, involves the polymerization of claudins and TJ adhesion molecules, in temporal 






adherent site ( Umeda.K at al., 2006).  Epithelial cells deficient in both ZO-1 and ZO-2 
were well polarized but did not form TJs due to the lack of Claudin polymerization 
(Umeda.K et al., 2006). Ohnemus found that S.aureus secreted proteases down regulated 
TJ/AJ and desmosomal proteins, including atypical protein kinase (aPKC) at the cell-cell 
border. It was observed that reduction of the proteins at the TJ/ AJ cause decrease in the 
trans- epidermal resistance of keratinocytes monolayer in a time and concentration 
dependent manner. (Ohnemus U et al., 2008).  Nina Kirschner and Brandner described 
that barrier for diverse ions and molecules of different size are formed in keratinocytes by 
TJs and TJs proteins CLDN 1, CLDN 4, Ocln and ZO-1 contribute to this barrier. TJs 
also form a barrier for water but CLDN 1 and CLDN 4 are dispensable for this barrier, 












Figure 1.4 structural components of skin tight junction and adherent 
junction  
Tight junction protein Claudin, Occludin and adhesional junction desmosomal proteins 
desmoglein and desmocollin interact within intercellular space and intracellular 










1.3 Skin classification scales 
The skin can be classified into different types according to the responses it shows 
to various factors.  
1.3.1 The Fitzpatrick scale 
This is a numerical classification which classifies the response of different types of skin 
to UV (Ultraviolet) light. This scale provides basic tool for dermatological research, 
measures genetic disposition and reaction to sun exposure relating to the color of skin. 
The Fitzpatrick classification range separates skin type on a scale of 1- 6 as detailed 
below. The Fitzpatrick skin phenotype classification remains the gold standard for the 
response of different types of skin to UV light.  It is simple and user friendly, however, 
the system fails to accurately predict skin reactions to insult, injury and inflammation for 













Table 1.1 Fitzpatrick skin phenotype classifications (Fitzpatrick TB et al., 
1988).     
Skin type  Description  characteristics  Score  
1  Always burns in  sunlight, never tans      Pale, Fair, 
Freckles             
0-6 
2  Usually burns, sometime tans                   Fair      7-13  
3  May burn, usually tans                             Light Brown      14-20  
4  Rarely burns, always tans                        Olive Brown      21-27  















1.3.2 The Roberts skin type classification 
This classification identifies patient skin type characteristics, and provides a 
mechanism to predict specific skin type likely response to insult, injury and 
inflammation (Table 1.1) (Roberts et al., 2008). Roberts’s skin classification system 
can uniquely help to predict- Response to the treatment, Clarify post procedure 
expectation, Optimize outcomes. 
It can be a predictor of impending complications such as hyperpigmentation, and 
scarring. Roberts hyperpigmentation Scale is a 7-points system, measures the natural 
history of post inflammatory pigmentation in an individual and likelihood to incur a 
pigmentation problem. This value is based on past medical history, clinical exam, and 
ancestral background. 
Roberts hyperpigmentation (H) Scale: propensity for pigmentation 
[H.sub.0]                                                                      hypopigmentation 
[H.sub.1]           Minimal and transient    (< 1 year)     hyperpigmentation 
[H.sub.2]           Minimal and permanent (> 1 year)     hyperpigmentation 
[H.sub.3]           Moderate and transient   (< 1 year)     hyperpigmentation 
[H.sub.4]           Moderate and permanent (> 1 year)    hyperpigmentation 
[H.sub.5]           Severe and transient         (< 1 year)    hyperpigmentation 







The Roberts Scarring Scale is a patient’s pattern of scarring is classified in this 6-
point Scale. Individual scores on the scarring scale help to determine short-term and 
long-term effects of numerous medical treatments and procedures. 
Roberts Scarring (S) Scale describes scar morphology 
[S.sub.0]                      Atrophy 
[S.sub.1]                      None            
[S.sub.2]                      Macule                    
[S.sub.3]                      Plaque within scar boundaries                    
[S.sub.4]                      Keloid            
[S.sub.5]                      Keloid nodule                    
To determine a patients profile using the Roberts skin type classification system, 















1.3 Skin functions 
1.3.1 Important functions of the skin 
 Protection  
Skin provides Protection against micro-organism, UV, toxic agents and mechanical 
insults. 
Barrier function 
The primary role of the skin is to provide a barrier function.  The skin is the first barrier 
against environmental stresses and pathogens. Protection is provided by the epidermis, 
which is the outer layer of skin.  The epidermis has a broad set of protective barrier 
functions, which prohibits permeabilization of the environmental allergens (Groschwitz 
et al., 2009). Skin barrier prevents body loss of water and electrolytes and entry of 
environmental toxin and allergen (Kalinin AE et al., 2002). When this barrier is 
impaired the person is at risk of dehydration and infection. The skin protects the body 
from environmental injuries and insults. The skin developed a unique immune response 
and fundamental ability to repair the barrier quickly (Elias, PM et al., 2007).  Along with 
the barrier function skin has other important functions which are the following. 
Sensation 
An important function of the skin is to detect the different sensations of heat, cold, 
pressure, contact and pain. Sensation is detected through the nerve endings in the dermis 
which are easily affected by wounds. This sensation in the skin plays a role in helping to 
protect us from burn wound. 
Thermoregulation When the body’s heat production is stable, the blood flowing into the 






regulation is to ensure that the difference in temperature between the skin’s surface and 
the environment remains constant, thus regulating heat loss and maintaining an almost 
constant body temperature. When heat production increases, blood flow to the dermis 
also increases, which in turn, increase the heat lost from the skin to the same rate as the 
excess heat production. 
Endocrine function the skin 
Skin is one of our main source of Vitamin- D 
Synthesis of Vitamin D 
By the action of ultra violet light Vitamin-D synthesis on certain parts of the skin (Webb 
et al., 1989) (Bikle DD et al., 2010). The traditional pathway of Vitamin-D synthesis and 
processing involves pre-Vitamin D3 formation in the skin (Figure 1.5) (Chen et al., 
2000). Where it binds with the DBP (Vitamin D binding protein) and is transported to the 
liver, where it is enzymatically hydroxylated to generate 25OH D3. DBP bound 25OH 
D3, is then transported to the kidney and is finally hydroxylated by CYP27B1 to 
hormonally active Calcitriol 1, 25 dihydroxyvitamin D3 (1, 25 (OH) 2 D3)) transported 
in the circulation after binding with DBP (Lehman et al., 2001). However, more recently 
both hydroxylation steps were found to be able to occur within other cells, including the 
keratinocytes. The keratinocyte represents the only cell type where the complete 
enzymatic machinery for the synthesis of 1, 25 (OH) 2D3 from 7-dehydrocholestrol 
(7DHC) is present and where the synthesis of 1, 25 OH D3 from 7DHC has been shown 













Figure 1.5 Photochemical synthesis of vitamin D3 in the skin 
Vitamin D synthesis occurs cutaneously where pro-vitamin D3 (7- dehydrocholesterol) 
received from the circulation is converted to pre-vitamin D3 in response to UVB 
exposure. Vitamin D3 obtained from the isomerization of pre-vitamin D3 in the 
epidermal basal layers or  intestinal absorption of natural and fortified foods and 
supplements, binds to vitamin D-binding protein (DBP) in the blood stream, and is 











Antimicrobial peptide expression (AMP) 
Normal human keratinocytes revealed a dose-dependent increase of human beta defensins 
2 & 3 hBD2, hBD3 and cathelicidin mRNA after UV radiation (Glaser et al., 2009).  
UV-B radiation induces the expression of antimicrobial peptide (AMP) in human 
keratinocytes in vitro and in vivo (Harder et al., 2009).  Thus UV-B induced Vitamin-D 
can cause increase expression of hBD2 and cathelicidin by stimulating VDR (Figure 1.6) 
(vitamin D receptors). Oral vitamin D supplementation induces cathelicidin production in 




















Fig 1.6 UVB triggered vitamin D3 expressed hBD2 and Cathelicidin  
 In keratinocyte, hydroxylation steps by CYP27A1 and CYP27B1 result in active 
25 Vitamin-D3 into 1, 25 OH D3 which activate VDR (Vitamin D receptors).  VDR 
binds to VDRE in the antimicrobial peptide promotor region and cause activation of 











1.4 Atopic dermatitis (AD)  
Atopic Dermatitis (AD) is a chronic inflammatory disease, with both genetic and 
environmental factors implicated in its pathogenesis.  Individuals with AD have a 
defective skin barrier which makes them more susceptible to S. aureus colonization and 
to having pathogenic responses to allergens from dust mites (Breuer, K et al., 2002).  In 
addition, S. aureus secreted proteases can further aggravate barrier dysfunction, rendering 
individuals with AD more susceptible to the epidermal penetration of allergens (Cork et 
al., 2009).  Atopic dermatitis most often begins in childhood before age 5 and may persist 
into adulthood.  It is estimated that 75 % of the cases of AD improve by the time children 
reach adolescence, whereas 25 % continue to have difficulties with the condition through 
adulthood.  AD is known as infantile eczema when it occurs in infants.  Infantile eczema 
may continue into childhood and adolescence presenting with an oozing, crusting rash.  
This occurs mainly on the scalp and face but can occur anywhere on the body.  
Individuals with AD are considered “sensitive”; reacting abnormally and easily to 
irritants, food, and environmental allergens.  The most common food hypersensitivity 
being to eggs, peanuts and milk, ingestion of these can cause a flare in eczema which 
occurs in about 10% of AD patients less than 2 years old. (Kim et al., 2013). 
1.4.1 Clinical manifestation 
Symptoms of atopic dermatitis may vary from person to person, but most individuals 







1.4.1. A  Atopy 
Atopy is a syndrome characterized by a tendency to be hyper-allergic.  A person with 
atopy presents with a triad of the following, AD eczema, allergic rhinitis (hay fever) 
allergic conjunctivitis and allergic asthma. The individual component of atopy is caused 
by a type I hypersensitivity reaction.  Atopic responses appear after the body is exposed 
to various allergens, pollen, dander, food, dust mites, chemicals or irritants (Burk W et 
al., 1998).  The presence of an elevated level of total and allergen specific IgE in the 
serum leading to positive skin prick test to common allergies. Th1 cells secrete IL-2 and 
IFN-Ɣ and promote cellular immunity and the production of IgG1. Th2 cells secrete IL-4, 
IL-5, IL-10 and IL-13 and thereby induce the production of IgE and promote eosinophil-
mediated inflammation (Burk W et al., 2008). These results suggest that atopy refers to 
the potential for producing inflammatory reactions in various organ systems, primarily 
initiated by Th2 cytokines and that Th1/Th2 and non-Th proinflammatory cytokines are 
all involved in the disease process due to Th1/Th2-cell reversal (Chen, L et al., 2004). 
The Th2 predominance in atopic individuals results in production of IgE antibodies and 
attracts eosinophils with specific high affinity IgE receptors. This Th2 cell activity leads 
to release of IL-4, IL-5, IL-13 and IL-3. (Akdis et al., 1999; Dworzak et al., 1999).  
1.4.1. B Pruritus 
Pruritus (or itching) in individuals with AD is considered to be the most disturbing 
symptom.  Once their itch begins, it increases sensitivity of the surrounding skin which 






dry skin, heat and perspiration, irritants (wool or synthetic fibers, soap and detergents, 
some perfume and cosmetics, cigarette smoke), allergens such as (pollen, pet dander, 
dust, certain vasodilator foods), emotional stress, alcohol, upper respiratory tract 
infections and house dust mite allergens (Bieber T et al., 2008).  Proteases, kinins, 
prostaglandins, neuropeptide, and acetylcholine can all cause itch or potentiate the release 
of histamine (Ui H et al., 2006) and may be significant in this condition.  
  Various central and peripheral mediators have been suggested to play a role in 
the pathophysiology of itch of AD patients. The sensitization of Peripheral and central 
nerve fibers  contribute significantly to triggers itch in AD. Several mediators have been 
described as associated with itch in AD, including serine proteases, interleukin 31 and 
nerve growth factor (Yosipovitch G et al., 2008). Itch fibers are sensitized peripherally 
due to increased concentration of nerve growth factor (NGF) in the inflamed area that 
could lead to sensitization of the central itch process.  Sensation provoked by scratching 
can be perceived as an itch by the patient and thus excerebrate pruritus (Groene et al., 
2001).   
1.5 Pathophysiology of atopic dermatitis 
  1.5.1 Epidermal Barrier Dysfunction Epidermal barrier dysfunction is 
fundamental to the pathogenesis of AD, but remains incompletely understood (Cork et 
al., 2009). The epidermal barriers comprised of three components, stratum corneum (SC), 
tight junctions (TJS), and Langerham cell system (LCS) as an immune barrier. As SC is 






by creating both a physical and chemical shields mainly comprising lipid and 
antimicrobial peptides (AMPs) respectively (Aberg et al., 2008).  The strong association 
between both genetic barrier defects and environmental insults to the barrier with atopic 
dermatitis suggests that epidermal barrier dysfunction is a primary event in the 
development of this disease.   
1.5.2 Environmental allergens 
AD is an atopic disorder often found to be associated with hay fever and asthma, and 
associated with generally high IgE levels. Irritants readily have an excitatory effect on the 
impaired barrier of the skin of an individual with AD. Daily washing with soap and 
noxious agents can elicit an irritant contact reaction in AD (Hogan et al., 1994), but other 
specific agents have also been implicated, as described below. 
1.5.3 Foods  
  Food hypersensitivity affects about 6-8% of children under 4 years of age and 2% of the 
general population beyond the first decade of life (Sampson et al., 1999).  AD and 
asthmatic patients can have anaphylaxis resulting from exposure to specific foods.  For 
these reasons, the role of food as a trigger in all infants with moderately to severe AD 
should be considered (Sicherer et al., 2011). Histamine containing foods such as 
cheeses, vegetables (tomatoes, eggplant, and spinach), fish, shellfish, red wine and 
grapes can cause skin dryness and flushing leading to pruritus (Spencer et al., 1994).  
1.5.4 House dust mites   House dust mite species, Dermatophagoides pteronyssinus 






mite (HDM) allergens, detected on the surface of human skin, and have been proposed 
to play a role in the development of AD (Friedman et al., 1999). Der p1 and Der f 1 are 
cysteine proteases that elicit IgE responses in 80% of mite-allergic subjects and have 
proinflammatory properties. Der p1 protease weakened not only the barrier function of 
the skin but impaired the epidermal barrier recovery in both human and murine skin 
(Nakamura et al., 2006). Repeated topical application of HDM extracts in a sensitive 
mouse model for AD triggered strong skin inflammatory responses, through 
inflammatory cell infiltrate in the upper dermis and elevated IgE concentration (Oshio et 
al., 2009).   
1.5.5 Climate- effect  
 Individuals with AD have an abnormal pattern of thermoregulation, which is 
believed to reflect an intrinsic disturbance of the parasympathetic system, which 
influence the pathogenesis of AD. Epidemiological studies suggest that climate 
influences the prevalence of atopic eczema. Atopic eczema has been reported worldwide 
to be positively associated with latitude and negatively with temperature (Weiland SK et 
al., 2004). Consequently, seasonal variation can impact the disease and most individuals 
with AD are improved in summer but worsen in winter. However climatotherapy can 
play significance role in the treatment of atopic dermatitis, which is cost-effective 
(Harari M et al., 2000).  
1.5.6 Infectious agents -The altered skin barrier of atopic patients provides a portal of 






1.5.6 A Bacteria  
S. aureus colonization can be demonstrated in over 90% of lesions in individuals with 
AD. The density of S. aureus on inflamed AD lesions without superinfection can reach up 
to 10^7 colony forming unit (CFU) per  cm² on lesional skin. One study suggests that a 
strategy by which S. aureus exacerbates or maintains skin inflammation in AD is by 
secreting a group of toxins known to act as superantigens, which stimulate marked 
activation of T-cells and macrophages. (Leung et al., 2001).   S.aureus secretes,  cysteine 
(metallo) and serine proteases, these extracellular proteases are also proposed to have role 
in the virulence of this disease.  
1.5.6-B Viruses  
   Individuals with AD appear to have reduced immunity to herpes virus; eczema 
herpeticum (EH) is more commonly seen in infants and children with AD. Most cases of 
EH are due to Herpes simplex virus type 1 or 2, other viruses may be responsible, such as 
coxsackie virus however varicellar form eruption ‘eczema herpaticum’ caused by spread 
of herpes is recognized as a potentially dangerous complication of AD (Wollenberg, A et 
al., 2003).  Eczema herpaticum also occurs when there are other reasons for the 
breakdown of skin barrier including, burn, pemphigus vulgaris, Darier disease, Cutaneous 








1.6 Diagnostic criteria 
 Atopic dermatitis has a wide spectrum of dermatological manifestations and there 
is disagreement about its definition. Nevertheless, results and reproducibility of genetic, 
etiological, epidemiological, diagnostic and therapeutic studies depend on establishing 
reliable and valid diagnostic criteria. During the past decades various lists of diagnostic 
criteria for AD have been proposed (Table 1.2) (Brenninkmeijer, E. E et al., 2008).  
1.6.1 Hanifin and Rajka diagnostic criteria for Atopic Dermatitis 
  Hanifin and Rajka developed guidelines for the diagnosis of atopic dermatitis in 
1980, to define a disease for which an objective diagnostic laboratory test was lacking 
and for which nomenclature was inconsistent. According to Hanifin and Rajka, the 
diagnosis of atopic dermatitis requires the presence of at least three of four major criteria 
and three of 23 minor criteria. 
 Major criteria: must have three of four 
1-Puritis 2- Dermatitis affecting flexural surfaces in adults. Facial and extensors 
surfaces involvement  in infants and children   3- Chronic relapsing dermatitis  4-Personal 
and family history of Atopy (asthma, allergic rhinitis, atopic dermatitis). 
Minor criteria: should have three out of 23-1-Xerosis,2-Ichthyosis, palmar 
hyperlinearity or keratosis pilaris,3-Immediate type -1 skin test reactivity,4-Raised serum 
IgE,5-Early age of onset,6-Tendency toward cutaneous infection,7-Nipple eczema,8-






conus,12 -Facial erythema,13-Pityriasis alba,14-Itch when sweat,15-Food intolerance,16-
Delayed blanch or white dermographism,17-Course influenced by environmental or 
emotional factors 18 Intolerance to wool and lipid solvents 19 Anterior neck fold 20 
intolerance to wool and lipid solvents 21 perifollicular accentuation 22 Orbital darkening 
23 Anterior subcapsular cataract. 
D. Exclusions: Firm diagnosis of AD depends on excluding conditions such as scabies, 
allergic contact dermatitis, seborrheic dermatitis, cutaneous lymphoma, ichthyoses, 
psoriasis, and other primary disease entities. 
1.6.2 The UK diagnostic criteria of atopic dermatitis 
A UK working party set about the task of developing a minimum list of reliable 
discriminators for AD, using the Hanifin and Rajka list of clinical features as the building 
blocks.  In addition to validity, repeatability and simplicity, a further requirement of the 
definition was that it should correspond well to the clinical concept of disease, be 
applicable to different ages and ethnic groups and be acceptable to subjects under study 
(Williams et al., 1995).  According to UK diagnostic criteria, in order to be diagnosed a 
case of AD, the child must have an itchy skin condition for the last 12 months.   Including 
itch, the child may have three or more of the following: 
1- Onset below age two 
2- History of flexural involvement  
3- Personal history of asthma or hay fever  
4- History of generally dry skin 






In children aged less than 4 years a history of atopic disease in a first degree relative may 
be included.  The UK criteria have performed well in hospital and community validation 
studies (Williams et al., 1996).  In an independent validation study of children attending 
hospital dermatology outpatients, the criteria were shown to have a sensitivity and 
specificity of 85 % and 96 % respectively, when compared with a dermatologist’s 
diagnosis (Williams HC et al., 1999).  
Positive and negative predictive values in this survey were 80 % and 97 % respectively.  
The criteria appear to be equally applicable to children of different ethnic and 
socioeconomic groups.  They have worked well in children down to the age of 3 years, 
but further evaluation in younger children and adults is awaited.  The criteria is easy to 
ascertain, and they have proven to be highly acceptable to children and adults because of 
their relatively simple and non-invasive nature.   
1.6.3 Epidemiological uses for the diagnostic criteria:  
The commonest epidemiological uses for the diagnostic criteria will be to compare 
prevalence rates between countries or in the same population at different points in time. 
As Williams stated that, “Even though the sensitivity and specificity of the UK criteria 
for atopic eczema appear quite high, the underlying prevalence of atopic eczema has a 
critical influence on the positive predictive value of the criteria” (Williams et al., 1995).  
Thus, for one disease, there may be range of definition with slightly different validity 
indices, each of which may be better suited to specific study design or requirements. 
They all define the same disease, but with different precision and practical suitability for 
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Individuals with AD need to keep their skin hydrated through proper bathing and use of 
moisturizers to avoid it to becoming dry.  This can best be achieved by applying a 
moisturizer right away after bathing, even while the skin is wet.  However irritants such 
as soap, perfumes, noxious agents and wool, which are common triggers, should be 
avoided (Hogan et al., 1994), in addition to avoiding certain food (e.g. eggs, peanuts, and 
milk and soy products) that can cause a rash or make a rash worse.  
1.7.1Tolerance against foreign antigens 
The immunological phases of food allergy in AD include a sensitization phase and an 
effector phase. Response to that allergen or tolerance occurs in the effector phase (Noh et 
al., 2011). Tolerance can be classified into central and peripheral (Schwartz et al., 1993).  
Central tolerance is a process of negative selection of the developing T cells in the 
thymus, whereby T cells with high affinity for self-antigen are eliminated in the early 
stages of differentiation (J Sprent et al., 2002).  Whereas, peripheral tolerance requires 
then development of regulatory T-cells, which play essential roles in the maintenance of 
peripheral tolerance by continuous suppression of auto reactive T-cells that escape central 
tolerance mechanism (Seddon et al., 1999; Suri et al., 1998).  Peripheral tolerance has 
been divided into high dose and low dose responses (Rocha et al., 1991).  High dose 
responses occur via anergy of T-cells and T-cell deletion by apoptosis (William et al., 
2005), whereas low- dose tolerance to antigens administered repeatedly, is achieved by 






 The route of exposure to antigen may play an important role in the development 
of tolerance.  Tolerance induced by high-dose allergen-exposure via skin was associated 
with rapid switch and expansion of IL-10 producing regulatory T-cells (Meiler. F et al., 
2008).  Oral immune therapy appears to be effective in inducing desensitization in most 
patients, as well as oral tolerance in a subset of patients with food allergy (Beyer K et 
al.,2008) (Weiner HL et al., 1997; Chehade M et al., 2005). T-cells and IL-10/TGF-
beta appear to be the major players in natural and acquired tolerance to food antigen 
(Aneta et al., 2011).   
1.7.2 Avoiding contact with house dust mite (HDM) 
HDM is a very common allergen and contact with HDM can cause exacerbation of the 
disease; especially on face, head, neck and hands, areas which are direct in contact with 
mites (Darsow et al., 1996).  HDM proteases Der P 1 and Der f 1 not only weakened the 
skin barrier but also impaired the epidermal barrier function repair.  HDM allergen plays 
a role in the development of AD.  Repeated topical application of HDM extract in mice, a 
sensitive animal model for AD exacerbates the disease.  In 1932 Rost was the first to 
report that patients with AD improved when they were placed in a dust-free environment 
(Kumei et al., 1995).  Consequently, this contact should be avoided. The hands are 
frequently involved in individuals with AD and present unique physical, social and 
therapeutic challenges for patients. The involvement of dorsal hand surface and the volar 







1.7.3 Avoiding stress; Stress has been recognized as an important factor in the 
pathogenesis of AD. The responses to stress are variable and dependent on the existing 
psychological condition of the patient and the family. The stressful events often have 
been observed to occur before an AD exacerbation (Bender, B. G et al., 2002).  
1.8 Treatment -1.8.1 Skin barrier protection 
The primary treatment for AD involves skin barrier protection, in conjunction with 
preventative measures, such as avoiding or minimizing contact with known allergens.  To 
combat the severe dryness associated with AD, moisturizer should be used daily. 
Moisturizers should not have any ingredients that may further aggravate the condition.  
Creams are thicker moisturizer than Lotions, which has low viscosity and are thinner 
moisturizer.  Creams retained moisture better and typically work well on dry skin, 
prevented transepidermal water loss (Elmariah SB et al., 2011). AD is also linked to a 
deficiency in ceramide, which is the lipid that comprises the skin barrier. The stratum 
corneum ceramide deficiency is possibly the cause of abnormal barrier function.  One of 
the most promising barrier repair methods has been ceramide-dominant physiological 
lipid based barrier repair topical emulsions (Chamlin et al., 2002).   In contrast to the 
traditional moisturizers, these formulations focus on the physiological lipid replacement 
therapy, particularly ceramides, to restore normal balance of the epidermal barrier (Kang 
et al., 2008).  Ceramide-based moisturizers have been shown to be beneficial in reducing 
TEWL, improving barrier function, and thus, can be a useful component in AD 
management (Ishida et al., 2012). The features of occlusive, humectant and emollient 






Table 1.3 Different types of moisturizers 
Occlusive  Humectants Emollient 
-Reduces TEWL by  
 
creating a hydrophobic 
barrier over the skin and 
contributing to the matrix 
between corneocytes 
   
-Able to attract water from 
two sources: (a) they 
enhance water absorption 
from dermis into the 
epidermis (b) in humid 
conditions they also help the 
SC to absorb water from the 
external environment 
 
-Emollients provide some 
occlusivity and improve 
the appearance of the skin 




-Most occlusive agents have 
pronounced effects when 
applied to the slightly 
dampened skin 
 
-Many humectants may have 
emollient properties 
 
-Many different types of 




-Their main limitations 
include odor and potential 
allergenicity 
 
-Enhance desquamation by 
digesting desmosomes 
 
-Emollients are generally 
grouped by their ability to 
spread on the skin 
 
-Most occlusive agents are 
associated with a greasy feel  
 
 
-Glycerol reduces the 
scaling associated with 
xerosis 
 
-Emollient lipids similar 
to those naturally found in 
the skin may also increase 













 Topical steroids are also very important drugs used to control inflammatory skin 
diseases, particularly dermatitis (Table 1.4). Corticosteroids suppress the multiple 
inflammatory genes that are activated in chronic inflammatory diseases, by reversing 
histone acetylation of activated inflammatory genes through binding of glucocorticoid 
receptors. 
 In general, individuals should use a potent preparation for a short time (few days 
and weeks) and a weaker preparation for maintenance between flare ups.  Pulse therapy 
refers to the application of corticosteroids for 2-3 consecutive days each week or two. 
This is useful for maintaining control of chronic diseases (Thomas KS et al., 2002). 
Generally a milder topical steroid or non-steroid treatment is used on the in-between 






            
 
















Very potent (up 







More than 50 g of clobetasole 
propionate or 500 g of 
hydrocortisone each week can 
result in adrenal gland suppression 
in an adult and can cause 
Cushing’s syndrome.  (Coureau B 


















Skin thinning (atrophy) and stretch 
marks (striae).  
Easy bruising and tearing of the 
skin (fragility). Telangiectasia Peri- 
oral dermatitis (erythematous 
papules around the mouth). 
Contact allergy to the steroids 
molecule itself or another 
ingredient-The risk of these side 
effects depends on the strength of 
the steroid, the length of 
application, the site treated, and 













Class4 Mild Hydrocortisone 0.5-










Tacrolimus and pimecrolimus are immunosuppressants which can also be used as a 
topical preparation in the treatment of severe AD.  Immunosuppressants have unpleasant 
side effects in some patients. Oral immunosuppressants can be prescribed for severe 
cases that do not respond to other medication.  
1.8.3 A-Topical immunosuppressants 
The topical immunosuppressants or calcineurin inhibitors pimecrolimus cream and 
tacrolimus ointment are particularly useful for mild to moderate AD.  They are anti-
inflammatory but do not thin the skin or affect its barrier function. Topical 
immunosuppressants are particularly useful for eczema in thin-skinned areas (face, 
genitals and body folds). Topical pimecrolimus is most effective when used at the earliest 
sign of eczema redness or itching to prevent flares. Topical tacrolimus is more potent and 
may have greater immunosuppressive activity (El-Batawy MM et al., 2009). The main 
side effect is initial burning, feeling warm or itching. Other side effect includes skin 
erythema, flu like symptoms headache and skin infection. Results from several 
pharmacokinetic studies of both pediatric and adult patients with AD demonstrate that 
tacrolimus was minimally absorbed into the systemic circulation. Tacrolimus does not 
seem to accumulate, either in the skin or blood following repeated applications (Reitamo 
S et al, 2000). 
 






If an ongoing oral medication is required a non-steroidal immunosuppressant such as 
azathioprine; methotrexate, cyclosporine or mycophenolate may be used to enable the 
dose of steroids to be reduced and eventually discontinued (Meggitt SJ et al, 2001).  
However, monitoring is needed because side effects may occur. 
1.8.3 C- Side effects related to immunosuppressant    
People having certain medical conditions including shingles, high blood pressure, 
kidney problems, liver disease, pregnancy and susceptibility to infection should not use 
immunosuppressants.Azathioprine  can cause light sensitivity and severe reactions upon 
exposure to sunlight and long term uses  may increase the risk of skin cancer  (Murphy 
L A et al., 2002). 
1.8.4 Ultra Violet (UV) exposure 
  Phototherapy is a one of the therapeutic options in atopic dermatitis.  AD can be 
treated with UVB or PUVA (psoralen+UVA) UVA exposure which has been found to 
have local immune-modulatory effects on affected tissue, and may be used to decrease 
the severity and frequency of exacerbations. Phototherapy is reserved for severe eczema 
as it is expensive, time-consuming and has potential side effects.  It involves controlled 
exposure to UVB either of narrow band or broad band (NB-BB) or UVA for a few 
minutes two to three times each week.  A treatment course may continue for several 
months. There are some AD patients who do  
not get good respond to UVB, or even get worse when get phototherapy.  The risk and 






narrow band UVB could be considered as the first line phototherapeutic option for 















 Narrow band UVB  
(NB-UVB) 










1.9 Staphylococcus Aureus:  
(BB-UVB) 
Definition Is more common form 
of phototherapy with 
specific wavelength of 
UV radiation 311-312 
nm 
Traditionally broad band 
UVB has been used, it has 
wavelength of UVB 
radiation 290-320 nm 
Photo chemotherapy which 
is the use of psoralin then 
expose to UVA. 















 -Exposure times are 
shorter but higher 
intensity.  Longer 
remission -Influence on 
the expression of 
antimicrobial peptides 
-BB-UVB has a 
significant safety 
advantage over most other 
psoriasis therapies-Skin 
cancer-has not been 
clearly demonstrated. 
- PUVA is an effective 
treatment for most psoriasis 
patients, Longer remission 
-Its effectiveness even in 
severe psoriasis, allowing 
patients to restore a high  
quality of life 
 
Side effects 
-The most common 
side effect of NB-UVB 
therapy is erythema 
Long term exposure 




-BB-UVB can cause burn 
-Long term exposure can 
cause skin ageing and 
cancers ( SH Silva et al., 
2006) 
 
-PUVA can cause erythema 
and nausea Patients who 
undergo PUVA therapy are 
at a higher risk of skin 
cancer, and risk increases 









S. aureus is a facultative anaerobic gram and catalase positive coccobacillus also 
known as “golden staph”.  S.aureus appears as grape like clusters when viewed through 
the microscope and has large, round golden –yellow colonies. S. aureus cell wall 
structures are presented in (Figure 1.7)  S. aureus can cause a range of illnesses from 
minor skin infections such as boils, impetigo, folliculitis furuncle, carbuncle, scalded skin 
syndrome and abscesses, to life threating diseases such as pneumonia, meningitis, 
osteomyelitis, endocarditis, toxic shock syndrome (TSS), bacteremia and sepsis (Hanifin 
et al., 1991) (McCaig LF et al., 2006).  
Each year, some 500 000 patients in American hospitals contract an S.aureus 
infection (Bowersox et al., 2007).  The major concern in the treatment of S.aureus 
infection is the ability of these bacteria to acquire resistance to antibiotics.  S.aureus 
virulence is multifactorial, because a broad range of conditions that related to virulence 
factors.  Those factors can allow S.aureus to adhere to the surface, invade cell membrane 
and avoid the immune system and can cause harmful toxic effects to the host. It is 
estimated that 20 % of the human population are long term carriers of S. aureus 
(Kluytmans et al., 1997).  Colonization primarily occurs in the anterior nares, Axila, and 









  Figure 1.7 S.aureus cell wall structures 
 An S.aureus cell wall consist of three layers: an outer polysaccharide capsule; 
peptidoglycan (murem) layer; and inner cytoplasmic membrane. Into this structure, 
proteins and teichoic acid are embedded and protrude from the cell wall on its outer side, 
forming a “fuzzy coat”. Capsule is thin and may be seen only under the electron 
microscope. Sometime more bacteria share one capsule and form a slime layer or biofilm, 











S. aureus nasal carriage is a well-defined risk factor for subsequent infection in nearly all 
categories of hospitalized patients that has been studied. However studies have been 
performed to evaluate the effect of eradication of carriage using mupirocin nasal 
ointment, which have been inconclusive so far in most subgroups (Kluytmans et al., 
2005).   
 S.aureus was isolated in 69.7% of the eczematous lesion and in 42.4% of the 
non-eczematous skin of patient with atopic dermatitis. The nasal carriage rate of S.aureus 
was higher in atopic dermatitis patients (51.5%) than in non-atopic (35%) (Goh CL et 
al., 1997).  S.aureus secrete proteins that inhibit complement activation and neutrophil 
chemotaxis or that lyse neutrophils, neutralizes antimicrobial peptides. 
 Furthermore, S.aureus expresses several types of superantigen that corrupt the 
normal humoral immune response, resulting in anergy and immunosuppression (Foster, 
T. J et al., 2005).  S.aureus virulence factors are discussed in (Table 1.6). S.aureus 
exacerbates AD by acting as a superantigen, stimulating an augmented Tcell response 
and promoting increase production of IgE. The elevated IgE levels contribute to immune 










Table 1.6 S.aureus virulence factors 





- Protein A (SPA), 
 - Fibronectin binding protein A and B  
- Collagen binding protein,  
- Clumping factor (Clf) A and  
(EAP) is an adhesion which enables 
S.aureus to adhere to host cells of 
another organism, and an invasion 
facilitating its internalization into 
these cells. 
Toxins  Superantigen . 
1-Toxic shock syndrome (TSS-1).  
2-Enterotoxins (SE-(A, B, C, D, E, G, H, I). 
Cytolytic toxins-A-hemolysins α,β,Ɣ,  
B- leukocidin- panton-valentine leukocidin 
-Disease causing toxins Exfoliative toxins (ET) 
- is associated with scalded skin syndrome 
(SSS) 
Target specificity varies.  
 
Induce apoptosis (at low 
concentration)  and lysis of various 
cell types, including  erythrocytes, 
lymphocytes, monocytes,  epithelial  
Enzymes  Lipases, hyaluronidases , 
staphylokinase,exfoliative toxin, serine, 
cysteine,aureolysin  
Degradation of hyaluronic acid, 
Plasminogen activation; inactivate 
,antimicrobial peptides-Act as serine 
,proteases; activate T cells, Inactivate 
neutrophil proteolytic activity; 





(CHIPS) is an exoprotein produced by several 
strains of S.aureus 
(CHIPS) Inhibit complement and a 
potent inhibitor of neutrophil and 
monocyte chemotaxis towards C5a 






1.9.1 S. aureus secreted proteolytic enzymes 
  S.aureus is a gram positive and catalase positive cocco bacillus secrete 
extracellular proteases which are produce in the form of pre-proenzyme require activation 
in the extracellular meilloi. S.aureus secreted lipases, hyaluronidase, collagenase and 
nucleases are proteases, which convert host tissue into nutrient for bacterial growth. 
 The major proteolytic enzymes secreted by S. aureus are metalloprotease 
(aureolysin), serine glutamyl endopeptidase (SspA; also known as V8, six Spl (serine like 
protease) and two related cysteine protease referred to as staphopain A (Scpa) and 
cysteine protease SspB (Table 1.7) (Arvidson et al., 2001). The characteristic and 
function of extracellular proteases are described in the (Table 1.7). These extracellular 
proteases are secreted in the inactive zymogen form and after activation proposed to have 
roles in the virulence of these bacteria. The activation of S. aureus extracellular proteases 
are presented schematically in (Figure 1.8) where S.aureus proteases, Aur, SspA, Ssp B 
and ScpA are secreted as a zymogen form. S.aureus six Spl proteases are secreted as an 
active proteases, analysis of the Aur reveals that it is cleaved between Glu and an Ala 
residue, which is a characteristic of endopeptidase SspA and Spl proteases. As mutation 
of SspA does not affect the activity of Aur, it is possible that Aur achieves catalytic 
maturation in a Spl-protease-dependent manner, this is because Spl proteases have no 
requirement for proteolytic maturation (Reed.S et al., 2001). Several in vitro studies 
suggested these proteases are the virulent factor (Shaw et al., 2004  Potempa J et 
al.,2009). In addition, S. aureus secreted proteases can aggravate the antimicrobial barrier 






Activation of S.aureus secreted proteases 
 
 
Figure-1.8 Activation of S.aureus extracellular proteases. 
  The cascade of activation of extracellular proteases is proceeds from aureolysin 
(Aur), serine glutamyl endopeptidase (SspA), Cysteine proteases A & B  (SspB and 
ScpA). S.aureus proteases are secreted as inactive zymogen (Pro) that must undergo 
processing for full activity. The Pro-Aur auto-activates allowing for processing of SspA 
then it proceeds from V8 (SspA) to staphopain B (Ssp B) and ScpA. ( Lindsey Shaw et 








Regulation of S. aureus virulence factors 
The accessory gene regulator (Agr) of S. aureus is the central regulatory system that 
controls the gene expression for a large set of virulence factors.  The quorum sensing 
system is the major controlling factor which controls the expression and activity of these 
virulence factors. The quorum sensing system is also referred as accessory gene regulator 
(Agr) which are presented in the (Figure 1.9). The Agr locus consists of two transcripts: 
RNA II and RNA III encode four genes (Agr, A.B.C.D) whose gene products assemble a 
quorum sensing system (Saenz, H. L. et al., 2000). This complex regulatory mechanism 
ultimately functions via the RNAIII product, generated from one of the two divergent 
promoters of the Agr operon, p3. The other promoter, p2, encodes the Agr structural 
genes, Agr BCDA. AgrB is a transmembrane transport protein with endopeptidase 
activity and facilitate AgrD cleavage, followed by secretion of the resulting octapeptide 
subsequently termed the auto-inducing peptide (AIP). AgrC forms a membrane-bound 
histidine kinase, which senses external levels of AIP. These binding events results in auto 
phosphorylation of AgrC, followed by transfer of this phosphate to the intracellular AgrA 
protein. AgrA is a DNA-binding protein which leads to activation of the p2 and p3 
promoters, as well as direct activation of specific toxin genes (Cheung AL et al., 2002). 
This process is required to diversify the composition of cell surface proteins and to 
transform the bacterial phenotype from one of adhesion, expressing a variety of cell 
surface proteins responsible for binding to host tissues, into one of invasion, producing 
factors which degrade tissues and allow for the spread of infection from initial 
















Figure 1.9 S.aureus accessory gene regulator and accessory regulator 
The accessory gene locus consists of two transcripts: RNAII and RNAIII. RNAII encodes 
four genes (Agr A.B.C.D).  Accessory gene regulator (Agr) transcription of the V8 gene 
occurs at the post-exponential phase of bacterial growth, being positively regulated by 
Agr (accessory gene regulator) and negatively regulated by Sar A (staphylococcal 







1.9.1.A Aureolysin     
Aureolysin is a S. aureus zinc metalloproteinase. The exact mechanism of aureolysin 
maturation is unknown; analysis of the Aur reveals that it is cleaved between Glu and an 
Ala residue, which is a characteristic of endopeptidase SspA and Spl proteases. Ribbon 
presentation of the overall structure of aureolysin is presented in (Figure 1.10). As 
mutations of SspA do not affect the activity of Aur, it is possible that Aur achieves 
catalytic maturation in a Spl-protease-dependent manner, this is because Spl proteases 
have no requirement for proteolytic maturation (Reed.S et al., 2001).  However it is 
common among the thermolysin enzymes to activate themselves auto -catalytically 
(Miyoshi S et al., 2000 ).    Aureolysin has been known to cleave the plasma proteinase 
inhibitors, α 1-antichymo-trypsin and α 1-proteinase inhibitor (Rapala-Kozik et al., 
1999).  The structure of the aureolysin gene is conserved among the S.aureus strains. 
This argues in favor of the likelihood that the enzyme may have an important 














 Figure 1.10 Ribbon presentation of the overall structure of aureolysin 
 The α helices are shown in Red, the β strands are in Green, and the loops are in Yellow.  
The calcium ions are represented by Brown spheres and the zinc ion is represented by a 
Blue sphere. (Taken from protein data bank with open access permission IBQB) 









1.9.1. B V8 protease (SspA) 
S. aureus sspA V8 protease (Endoproteinase-Glu-C) is a serine protease that specifically 
cleaves peptide bonds on the carboxyl side of either aspartic or glutamic acids (Prasad et 
al., 2004). This proteolytic enzyme is limited to glutamic acid in the presence of 
ammonium. V8 has a molecular weight of 27 KDa and pH between 4.0- 7.8.  V8 protease 
has structural similarity with trypsin and exfoliative toxins A & B (ETA & ETB), which 
cause staphylococcal scalded skin syndrome in newborn and in young children (Redpath 
et al., 1991). . Ribbon presentation of the overall structure of V8 protease is presented in 
(Figure 1.11).The amino terminal of the V8 protease determines its substrate specificity 
(Prasad et al., 2004).  Like other extracellular proteases V8 is involved in colonization 
and infection of human tissue.  It is required for the maturation of the cysteine protease 
staphopain B (sspB) and inactivation of sspC (an inhibitor of sspB) (Massimi et al., 
2002).  Perhaps V8 is the most abundant of S.aureus  secreted proteases which is also 
important  for transition from adhesive to non- adhesive phenotype via degradation of 
fibronectin-binding proteins, and other proteins on the surface of S.aureus cells 
(Karlsson A et al., 2001) (Mcgavin et al., 1997).  V8 may also protect bacteria from the 
host defense by cleaving the immunoglobulin classes IgG, IgA and IgM and also 
deregulate host derive proteolytic activity by cleaving α1-prtease inhibitor (Prokesova et 










  Figure 1.11 Ribbon representation of the structure of V8 protease. 
  Protein chains are colored from N-terminal to the C-terminal using a rainbow 
color gradient. The two domains, built around a six-stranded antiparallel “β” sheets 
characteristics of the trypsin like serine proteases folds which are shown in green for 
domain I and blue for domain II. The “α” helix is presented here in red color and loops 
are shown in green and yellow colors. (Picture is taken from (RCSB) protein data bank 










1.9.1-C Staphopain A (scpA) 
Staphylococcal cysteine protease staphopain A (ScpA) is secreted as a zymogen 
inactive  (define) form and is activated by Aurolysin. . Ribbon presentation of the overall 
structure of staphopain A is presented in (Figure 1.12). ScpA is able to degrade elastin, 
the extracellular cystatins C, D and E/M are hydrolyzed by both staphopain A &B. The 
normal activity of cystatins downregulated by staphopain A, B indicating that bacterial 
enzymes can cause disturbance of the host protease-inhibitor balance (Vincents et al., 
2007). These proteases appear to reside outside the cascade of activation previously 
described, as mature staphopain A was observed in the aur, sspA and sspB mutant strains 
(Kantyka et al., 2011). Several in vitro studies suggested these proteases are the 
virulence factor (Shaw et al., 2004).  In addition, S. aureus proteases disturb the 















    
Figure 1.12 Ribbon representation of the structure of staphopain A 
Staphopain A shows a typical chymotrypsin like fold. Domain I and II are shown 
respectively in red and green. A connecting linker  is depicted in grey. The catalytic triad 
residues are shown in yellow (picture is taken from (RCSB) protein data bank with open 









1.9.1-D Staphopain B (SSpB) 
Staphopain B is a cysteine protease, having a papain like fold with molecular weight of 
20 kDa  
( Figure 1.13) (Kantyka et al, 2011).   SSpB is translated from an operon (An operon is 
a functioning unit of genomic DNA containing a cluster of genes under the control of a 
single promoter) contiguous to the gene for the serine protease (sspA) (Chan et al., 
1998).   Staphopain B is secreted proteolytically processed in culture supernatants; V8 
protease is proposed to be responsible for this cleavage (Kantyka et al., 2011).  
Staphopain B is able to degrade elastin, fibrinogen, fibronectin, and kininogen and 
exhibits a strong preference for substrates where arginine is preceded by a hydrophobic 
amino acid.  This protease promotes the detachment of primary human keratinocytes 
from their substrates (Massimi et al., 2002).  Along with other extracellular proteases it 
is involved in colonization and infection of human tissue (Massimi et al., 2002).   
Prematurely activated/folded staphopain B is inhibited by staphostatin B which is 
probably required to protect staph cytoplasmic proteins from degradation by staphopain 
B.  In the cytoplasm prematurely activated/folded staphopain B forms a stable complex 














Figure 1.13 Ribbon representation of the structure of pro- staphopain B 
Staphopain B shows a chymotrypsin like fold. The two domains, built around antiparallel “β” 
sheets characteristics of the chymotrypsin like folds which are shown in green for domain I and 
blue for domain II. The “α” helix is presented here in red color and loops are shown in green and 
yellow colors. (Picture is taken from (RCSB) protein data bank with open access permission for 
















Protease Aureolysin Staphopain A&B V8 protease 
Related gene Aur scpA, SSpB sspA 
Characteristics   Low substrate specificity 
cleaving peptide toward 
the N terminal 
Staphopain A and 
B are the major 
secreted cysteine 
proteases 
Member of glutamyl  
endopeptidase family 
of enzyme.  
Synthesized as a 
proenzyme activated 
by metalloprotease 
Functions Activate proV8 into active 
form. Modification of the 
bacterial cell surface 
protein by cleavage of N-
terminal domain.  
Broad substrate 
specificity  
Unclear role in 
pathogenesis 
The degradation of  









1.9.2 S.aureus toxins  
 S. aureus depend on production of secreted and cell surface adherent virulence 
factors those are required for host colonization and disease production (Kotler DP et al., 
2007). S.aureus virulence factors perform different functions, some toxins damage  cell 
membrane and  are called invasive.  Some toxins lyse erythrocytes by causing hemolysis, 
but it is unlikely that hemolysis is a relevant determinant of virulence in vivo (Bohach et 
al., 1997).  Leukocidin causes membrane damage to leukocytes, but is not hemolytic 
(Marrack et al., 1990).  Each of these exotoxin exhibits at least three biological 
properties, superantigenicity, pyrogenicity and cytotoxicity. Following are the different 
types of S.aureus toxins. 
1.9.2.1 Superantigens toxins:  
S.aureus secrete family of non- glycosylated low-molecular-weight exoproteins called 
superantigen (Spaulding et al., 2013). Superantigens have molecular size ranging from 
19,000 to 30,000 Da and are resistant to heat, proteolysis, acids and are highly resistant to 
desiccation (remain biologically active after being dried on petri dishes for more than one 
year). S.aureus strains secrete at least 24 serologically distinct superantigens. Recent 
studies suggest that host-pathogen interactions stemming from the production of 
S.aureus- derived virulence factors, such as superantigens (entertoxin B) and alpa-toxins, 
contribute greatly to the skin inflammation seen in AD (Skov L et al., 2000).  
Superantigens contains a conserved overall structure made of two major protein domains: 






barrel and a carboxy- terminal- grasp domain made of antiparallel-strands, with  domains 
connected by a central diagonal α- helix (Mitchell DT et al., 2000).  Based on small variations 
in this common core structure, S.aureus superantigens can be categorized into} 4 major groups. 
Group I include TSST-1 and TSST-ovine, SE-1 X. , Group II SEB, SEC, Group III SEA, 
SED, and SEE. , Group IV include SE-1K to SE-1 M, SE-1 V AND SPEH 
The exoproteins produced by S.aureus contributes its ability to colonize and cause diseas 
in mammalian hosts. The superantigens interfere immune system function by eliciting 
strong primary response which distinguish them from peptide antigen. S.aureus cytotoxin 
act locally to kill immune cells and cell surface virulence factors provide defense to 
S.aureus against the immune system (Spaulding et al, 2013). There are nine toxins that 
have super antigen characteristics. A 1-Toxic shock syndrome (TSST-1) A 2-
Enterotoxins SE- (A, B, C, D, E, G, H, I).  
1.9.2.1 A-Toxic shock syndrome toxin (TSST-1).  
TSST-1 is expressed systemically and is the cause of toxic shock syndrome (TSS) 
(Patrick. M et al., 2000).  TSST-1 is weakly related to enterotoxin but does not have 
emetic activity; TSST-1 is responsible for 75% of TSS, including all menstrual cases 
(Kotler DP et al., 2007). The reason for the high association of TSST-1 with menstrual 
toxic shock syndrome is not completely clear, but it likely depends on at least three 
factors. (1) TSST-1 is produced in high concentration relative to the majority of other 
superantigens (2) TSST-1 has greater mucosal surface-penetrating ability than other 






strains produce TSST-1(Kuehnert MJ et al., 2006). In addition to these properties, these 
toxins have superantigen activity.  TSST-1 induces the production of proinflammatory 
chemokines interlukin-8 (IL-8) (CCL8) and MIP-3-(CCL20) in human vaginal epithelial 
cells (Peterson M et al., 2005). These chemokines attract neutrophils and other immune 
cells including T cells and macrophages, to infection sites. This property enables them to 
stimulate T-cells non- specifically, without normal antigen recognition, and at 1:5 ratios 
whereas only 1 in 10,000 cells are stimulated during normal antigen presentation (Davis 
CC et al., 2003).  
1.9.2.1 B- Enterotoxins (SE)  
There are eight antigenic types named SE (A, B, C, D, E, G, H, I), S.aureus superantigen 
SEs including SEA are emetic, cause episodes of retching, vomiting, and diarrhea within 
24-48-hours after ingestion of nanogram quantities and without fever (Le Loir Y et al., 
2003). S.aureus SEs are the primary cause of toxin-mediated food borne illness and 
second leading cause of food-borne illness,  their systemic effects can also cause toxic 
shock syndrome. S.aureus SEs cause prolification of T-lymphocytes and food poisoning 
(Spauldling et al 2013).   
1.9.2.2 Disease causing toxin 
 1.9.2.2 A Exfoliative toxins (ET)  
 ETS are extremely specific serine proteases cleave epidermal desmosomal protein and 
also called as epidermlytic toxins.  ETs (A, B) are associated with scalded skin syndrome (SSS) 






atypical glutamic acid-specific trypsin-like serine protease activity (Ladhani et al 1999). ETS 
causes separation within the epidermal, stratum granulosum and stratum corneum layers.  The 
separation is through the stratum granulosum of the epidermis. S.aureus ETA has been shown to 
specifically cleave desmosomal desmoglein 1 (Ladhani et al., 2003). Koji Nishifuji has 
suggested that the removal of amino-terminal extracellular domains of Dsg 1 by ETs is sufficient 
to initiate epidermal blister formation in bullous impetigo and SSSS (Nishifuji, K., et al. 
(2010).    
1.9.2.2 B-Cytolytic toxins (hemolysin)  
 S.aureus secreted cytotxins are capable of damaging the host cell plasma 
membrane. S.aureus cytotoxin which damage the erythrocyte membrane are called 
hemolysins  (α, β, Ɣ hemolysis ) and which damage the leukocyte membrane are called 
leucocidin (panton-valentine leukocidin -PVL). S.aureus cytotoxins make pores in the 
host cell plasma membrane and the pore formation initiated when toxin monomer binds 
to the cell surface and makes transmembrane channel (Verdon et al., 2009).  The α 
hemolysin is the most characterized virulence factor of S.aureus, intially forms prepore in 
the cell membrane, which  transitions to a mature β-barrel transmembrane pore. Panton-
valentine leukocidin does not make prepore instead insert itself into the host’s plasma 
membrane and forms a pore in the leukocyte  (Vandenesch et al, 2012). 
1.9.3-Adherence factors  







1.9.3.1 Surface proteins             
 S.aureus protein A (SPA), fibronectin binding protein A and B (FnbpA and Fnbp B), 
collagen binding protein, and clumping factor (Clf) A and B  
A- Protein A (SPA),  B- Fibronectin binding protein A and B (FnbpA and 
Fnbp B) C- Collagen binding protein,  D- Clumping factor (Clf) A and B   
PVL: Panton–Valentine leukocidin 
1.9.4 Toxins relevance and link to AD 
S.aureus- derived virulence factors, such as superantigen and alpha-toxin, contribute 
greatly to the skin inflammation seen in AD (Skov L et al., 2000). The enhanced allergen 
penetration through damaged epidermis accompanied by increased production of thymic 
stromal lymphopoeitin by keratinocyte (Th2-type milieu) could provide a critical link 
between barrier defects in AD patients with filaggrin gene mutation.  Loss of filaggrin 
has been linked to enhanced antigen penetration into the skin and increase S.aureus and 
viral growth in the skin as well as susceptibility to the cytotoxic effects of S.aureus alpha-
toxin (Miajlovic H et al., 2010).  
 The severity of AD correlates with the number of superantigen-secreting S.aureus 
organism colonizing the skin (Boguniewicz M et al., 2010). The superantigen also play 
role in the exacerbation of AD. A murine model of skin inflammation has shown that 
S.aureus superantigens plus allergens have an additive effect in driving cutaneous 
inflammation (Ong.P. Y et al., 2008) High levels of IgE antibodies in AD patients 






1999). The superantigen SEB applied to the skin can induce eczematoid skin changes and 
T regulatory cells lose their immunosuppressive activity. Suggesting a novel mechanism 
by which superantigens could augment T cell activation in patients with AD (Ou LS et 
al., 2004). Superantigen induces T cell expression via stimulation of IL-12 production. 
Superantigen also induces corticosteroid resistance and an increase in AD severity. 
Superantigens selectively induce T cells to secrete IL-31, a highly pruritogenic cytokine 
that regulates filaggrin expression and is produced by Th2 cells (Cornelissen C et al., 
2012). 
1.10 Antimicrobial peptides (AMP)  
Antimicrobial peptides (AMP) are also called host defense peptides; these peptides are a 
conserved component of the innate immune response and are found among all classes of life 
(Jenssen et al., 2006). The characteristics of antimicrobial peptides are presented in the (Table 
1.8). Structurally there are five different subgroups of AMP.  First subgroup contains human 
dermcidin a small anionic peptide present in the surfactant extracts, broncho-alveolar 
lavage (BAL) fluid and epithelial cells.  They require Zn as a cofactor for their 
antimicrobial activity.  Anionic AMPs are active against both gram positive and gram 
negative bacteria (Schittek, B et al., 2001). A second subgroup contains LL37 a linear α 
helical short cationic peptide having < 40 amino acids, these linear cationic peptides also lack 
cystein residues and sometime have a hinge and kink in the middle (Gennaro, R et al., 2000). 
Third subgroup contains histatins which is a cationic peptide and rich in proline, histidine and 
arginine. These peptides lack cysteine residues and are linear (Kavanagh, K et al., 2004).  A 






disulphide bonds. This subgroup includes diverse family of α, β, θ defensins, found in mammals 
and is classified according to their peptide structure (Ganz et al., 2002). A rhesus (θ) defensin is 
a18 residue peptide that forms a circular molecule that is crosslink by three disulphide bonds 
(Weiss, T. M et al., 2002). RTD (Rhesus theta defensin) θ defensins found in rhesus (Monkeys) 
has circular structure without free N or C terminus. The pattern of disulphide pairing of the θ 
defensins is different than α & β defensins (Tang et al., 1999).  Fifth subgroup contains anionic 
and cationic peptides which are fragments of larger proteins like human hemoglobin and 
lysozyme.  These fragments are similar in composition and structure to the antimicrobial peptide 
of the fourth subgroup, having antimicrobial activity. However their role in innate immunity is 
not clear yet. 














Table 1.8   the characteristics of antimicrobial peptides 
Size     AMP size Varies from 6 – 59 amino acids
Sequence AMP Contains basic amino acids residue lysine or 
arginine. Some peptides may have amino acid repeat. 
 
Charge Anionic AMPs are rich in aspartate and glutamate, 




AMP can assume a variety of secondary structures 
including α helices, relaxed coils and antiparallel β sheets 
structures. 
 
Hydrophobicity This characteristics makes AMP water-soluble and 
makes partition into the membrane lipid bilayer. 
 
Amphipathicity AMP contains hydrophilic amino acids aligned 
along one side and hydrophobic amino acid residues 
aligned along the opposite side of the helical molecule. 
 







1.10.2 Human Defensins: 
  α and β defensins are found in humans and are classified according to their 
peptide structure. Biological image assemblies for defensin have been described in 
(Figure 1.14) originally defensins were isolated from human leukocytes, and then it was 
found that defensins are also produced by epithelial and mucosal cells (Hallock et al., 
2003). Defensin genes are located in the cluster of loci on chromosomes 8p 22-23.  
Defensins are amphipathic compounds having 12-50 amino acids,  cysteine rich peptide 
with size range of 3-6 kDa and having positive charge range of +1 to +11. These peptides 
are important mediators of innate immunity and potent broad spectrum antibiotics which 
can be used as potential novel therapeutic agents (Boman, et al., 1995).  
Defensins can exist in multiple states (Monomers, dimers etc) in vivo, depend 
upon factors such as,  presence or absence of pathogen, inflammation and pH. The crystal 
structure of α defensins revealed that it has six cysteines with three disulfide briges 
located in a 1-6, 2-4, 3-5 pattern and exists as a dimer in solution, To date, six alpha-
defensins have been identified in humans. Four of these, designated human Neutrophil 
peptides (HNP) 1,2,3, and 4 the remaining two , human defensins 5 and 6 are expressed 
in intestinal paneth cells. Small intestine paneth cells secrete very high concentration of α 
defensins which contribute to innate defense of GI mucosal surface (Ganz et al., 1985). β 
defensins were isolated from the bovine tracheal epithelial cells in 1991 and are found in 
human.  Epithelial cells secrete defensins continuously and sometimes in response to 
infection, IL1-β and LPS (Mathews et al., 1999). Normally the plasma level of α 






µg/mL during sepsis (Ayabe et al., 2000). When neutrophils ingest microorganisms they 
are exposed to highly concentrated HNP in phagocytic vacuoles contributing the key non-
oxidative killing mechanism of neutrophils (Faurschou et al., 2003).  
 Beta defensins are rich with β sheet stabilized by disulfide bridges, having six 
cysteines, which are located in a 1-5, 2-4, 3-6-pattern (Lehrer et al., 2002).  β defensin 
including six cysteins with three intramolecular disulphide bonds (Schutte, B. C et al., 
2002). β defensins were isolated from the bovine tracheal epithelial cells in 1991 and are 
found in human.   β –defensins are expressed by epithelial cells of skin, gastro-intestinal 
tract, kidney, respiratory tract, eyes, mammary glands, male and female genital tracts ( 
Com et al., 2003). Epithelial cells secrete defensins continuously and sometimes in 
response to infection, IL1-β and LPS (Mathews et al., 1999).   
Beta defensins are salt sensitive except beta defensin 3 which is salt insensitive.  
Previously it was reported that shape and charge distribution of the hBD2 monomer are 
similar to those of other defensins, an additional alpha-helical region makes this protein 
topologically distinct from the mammalian alpha and beta – defensin structures (Oren et 
al., 2003).  The hBD1 and hBD2 are monomers in solution while hBD3 can exit as a 
dimer; these structures provide the first detailed description of dimerization of beta-
defensin.  The quaternary octameric arrangement of hBD2 is conserved in the crystal 
form. (Hoover et al., 2000).  α and β defensins cysteines number 5 and 6 are adjacent, 
cysteine connectivity pattern cannot alter the structure The positive charge of defensins 
attributes the important action against bacteria, fungal and parasites.  Loss of positive 






(Lichtenstein et al., 1991).     (Ganz and Weiss, 1997); Sawai et al., 2001).  The modes 
of action by which AMP kill bacteria is varied and includes disrupting membranes, 
interfering with metabolism, and targeting cytoplasmic components (Wildman et al., 
2003).  
 A fundamental difference between prokaryotic and eukaryotic cells is the higher 
proportion of anionic phosphtidylglycerol (PG) and cardiolipin (CL). Presence of higher 
proportion of PG and CL in the bacterial cytoplasmic membranes makes it more 
electronegative, while extremely low level or absent in the mammalian membranes 
(Koppleman et al., 2001)? Although at present, AMP are believed to exert electrostatic 
interaction primarily on bacterial membranes, new evidence is suggesting that AMP 
activity might be broader, including selective inhibition of intracellular targets (Cudic.M 
et al., 2003).  
1.10.3 Important of AMPs in humans  
 AMPs are widely distributed throughout nature and have been discovered in 
certain bacteria, protozoa, fungi, plants and multicellular animals. Human AMPs protects 
epithelia against invading microorganism and assisting neutrophil and platelets (Peschel 
et al., 2002). Important functions of antimicrobial peptides are described in (Table 1.9) 
AMP has been demonstrated to kill gram+ve and gram-ve bacteria’s, enveloped viruses, 
fungi and even cancerous cells (Hoskin et al., 2008).   
Defensins have antiviral activity against envelope viruses such as HSV virus and 
HIV virus (Chang et al., 2005).    AMPs are known to be multi-factorial having a role as 






the ability to modulate inflammation and immunity by functioning as immunomodulators 
(Hunter et al., 2002). These roles have impact on diverse process such as proliferation, 
immune reduction; wound healing, cytokines release, chemotaxes and redox homeostasis 
(LIU, L et al., 2003).  
AMPs are chemotactic for human monocytes, dendritic cells, PMNL and T-cells, 
and  have mitogenic effects on murine fibroblast and epithelial cells (Yang et al., 2000 )  
Defensins act to mobilize and activate various leukocytes for innate and adaptive immune 
response (Soruri et al., 2007).   
The target of AMPs that underlies their specificity for microbes is the difference 
in lipid composition between the membranes that surround microbes and cells in our 
body. Microbes have plasma membranes that contain phospholipid with negatively 
charged head groups on the outer leaflet, the side exposed to the outside. Resistanc to  
these AMPs, in general, is difficult to develop because it requires redesign of membrane 

















Table 1.9 important function of antimicrobial peptides 
Antimicrobial peptides (AMPs) Important functions 
Defensins,indolicidine and LL37 Broad-spectrum antibacterial 
Defensins NP-1 and NP-5 Synergy with other peptides 
Protegrin, indolicidine and histatins Antifungal 
LL-37 Anti-endotoxin 
Indolicidin, protegrin and defensins Anti-enveloped virus (HIV, HSV, 
VSV) 
Indolicidin and defensins Anticancer  
PR39 and defensins Wound healing 














1.10.4 Antimicrobial peptides and biotechnology 
 AMP and their synthetic derivatives defend host organism against microbes 
having antimicrobial and immunomodulator activities. The crystal structure of defensin is 
presented in (Figure 1.14). Multi drug resistant bacteria are a severe threat to public 
health. Conventional antibiotics are becoming increasingly ineffective as a result of 
resistance, and it is important to find new antibacterial strategies.. AMPs do not induce 
microbial resistance, which makes them extremely valuable in the development of new 
treatment for multi-drug resistant infection (Afacan NJ et al., 2012).   Having cell 
membrane- lytic effect AMP can kill tumor cell, and some cationic AMPs (CAPs) can 
trigger apoptosis in cancer cells via mitochondrial membrane disruption. Furthermore, 
certain CAPs are potent inhibitors of blood vessel development (angiogenesis) that is 
associated with tumor progression (Mader, J. S et al., 2006). Host defense peptides and 
their synthetic innate defense regulator (IDR) peptide derivatives are being investigated 
for their potential value in the therapy and prophylaxis of infection. Hancock RE group 
developed a synthetic cationic peptide-IDR-1002 which enhanced chemokine induction 
activity in vitro correlated with stronger protective activity in vivo in the S.aureus 
invasive infection model and also afforded protection against gram-negative bacterial 
pathogen Escherichia coli (Nijnik A et al., 2010). Defensins have immunomodulator 
effect by modulating the immune response in addition to antimicrobial action. Pro-
inflammatory role of defensins both in epithelial and immune cells are called alarmin 
molecule or damage associated molecule.   However at higher concentration cytotoxic 
effects against various eukaryotic cells and tumor cells have been described 







Figure 1.14 Biological image assemblies for Defensin  
Where protein chains are colored from N-terminal to the C-terminal using rainbow color 
gradient.  Red color potentially disordered region and Blue color probably ordered 
region.  Hydropathy has been calculated using a sliding window of 15 residues and 
summing up scores from standard hydrophobicity tables. Red is hydrophobic and Blue is 













S. aureus is considered an environmental factor in the pathogenesis of AD.  
S.aureus is not a member of the normal skin micro flora, although 90% of individuals 
with AD are carriers in their nasal and perineal areas of the skin.   S. aureus can secrete 
proteases including serine V8, cysteine staphopain A-B and aur (metallo) proteases 
(Shaw et al., 2004).  Several in vitro studies have suggested these proteases are key 
virulence factors in AD (Shaw et al., 2004) 
Protease and protease inhibitor balance plays a significant role in the maintenance 
of barrier function in AD.  Part of skin defense against S.aureus exoproteases is an 
antiproteolytic balance which can be maintained by the defensin family Elafin, SLPI and 
Cathelicidin (Wiedow et al., 1990).  Unfortunately many of these antiprotease peptides 
are substrates for an S.aureus exoproteases and therefore are readily degraded, e.g. 
human extracellular cysteine protease inhibitors are degraded by staphylococcal secreted 
cysteine proteases, staphopain A (Vincents et al., 2007).  Some atopic patients have 
decreased expression of Cystatin A at their lesional epidermis which could be associated 
with a reduced inhibition of both endogenous and exogenous cysteine proteases (Cheng 
et al., 2009).  Transgenic mice carrying a null mutation in the gene encoding either 
cystatin M or cystatin E  display severe barrier abnormalities, affecting cornification and 
desquamation, and die shortly after birth (Zeeuwen PL et al., 2002). 
 S.aureus infection and disrupted antimicrobial defense system is a common 






could be linked to impaired barrier function found in atopic dermatitis patients (Clausen 
et al., 2013).  Antiprotease action of AMP along with antimicrobial action can protect 
skin barrier from damaging effect of S.aureus secreted proteases. S. aureus proteases 
aggravate antimicrobial barrier by degrading adhesion junction (Amagai al., 2000).  
Antimicrobial barrier (AMB) and permeability barrier are linked together because both water loss 
and pathogen invasion occurs by the breakdown of intercellular junction present in the lipid 
matrix (Borkowski et al., 2011).  
1.12 Hypothesis: 
The novel antimicrobial peptide human beta defensin-2 protects the skin barrier from 
proteases secreted from opportunistic skin pathogens associated with Atopic Dermatitis 
1.12 A   Aim: To study the novel role for hBD2 in protecting skin barrier from 
damaging effect of S .aureus secreted proteases by having both antimicrobial and 
antiprotease action in relation to disease severity in AD. 
  1.12 B Objectives: 
1-To confirm S.aureus secreted V8 protease can damage the HaCaT cell monolayer. 
2- To determine the antiprotease action of hBD2 by protecting HaCaT cell monolayer 
from S.aureus secreted V8 protease   
3- Protection of the HaCaT cell monolayer from S.aureus secreted V8 protease by 






Chapter-2        2- Materials and Methods 2.1 Materials  Primary 
antibodies were purchased from Invitrogen (Paisley UK). These were Rabbit anti human 
Claudin-1, and Rabbit anti human ZO (Invitrogen), mouse anti human desmoglein (AbD 
SeroTec). Goat anti hBD2 primary antibody Pepro Tec (NJ, USA); secondary antibodies; 
anti Rabbit and anti-mouse secondary antibody (Licor Biosciences UK); Alexa Fluor 568 
Goat anti-Rabbit IgG antibody (Thermo Fisher), DEFB4 siRNA from applied biosciences 
and Lipofectamine 2000 transfection reagent from Invitrogen. DEFB4 plasmid OriGene 
(Rockville,MD) cat#C219487  (USA), S.aureus strain 8325-4 , RN6390, SH1000  
including S. Epidermidis, mutant of the parent strain 8325-4, LES17(L17) sspB pAUL-A 
ssPB; LES22 (L 22)  sspA: Paz106 sspABC, LES27 (L27) scpA: Paz106 scpA, 
Staphopain B  from Bio Centrum  (Krakow Poland); V8 and Trypsin from Worthington 
Biochemical Corporation (Lakewood, NJ USA), Leupeptin (Sigma–Aldrich), Z-Phe-Arg-
7-amido-4 methylecoumarine substrate  Calbiochem (CA, USA), Recombinant Human 
beta defensin Cayman chemical (MI, USA), SDS-12% polyacrylamide gel containing 0.1 
% β-casein (Sigma, St.Louis,MO.), LDH assay kit (Clontech,CA,USA), Bicinchoninic 
Acid assay kit (Bio-Rad, USA), Recombinant human IL-1β and human BD2 ELISA 
development kit from Peprotech (NJ, USA), ABTS enhancer (Sigma –Aldrich), 
Transwells from Corning incorporated life science (MA,USA), FITC-albumin; Lucifer 
Yellow (Sigma–Aldrich), S.aureus LTA (Sigma–Aldrich). Taq man Reverse 
Transcription Reagent kit (Applied Biosystems), Taq man probes and primers were 
purchased from Applied Biosystems(Warrington-USA). Neupage LDS sample buffer 






zymogramRenaturingBuffer(Lifetechnology), DEFB4 plasmid was from OriGene, cat. no. 
RC219487Table 2.1 primary and secondary antibodies 
Primary 
antibodies 



























































2.1 A Western blotting materials  
M-PER Lysing buffer from (Thermoscientific); BCA reagents; Novex 4-12 % gradient 
gel by Invitrogen. Precision plus Protein Standards Marker from Bio Rad (CA, USA), 
Bench Mark Pre-stained Protein Ladder from Invitrogen (UK).  
2.1 B- Cell and tissue cultures: 
The immortalized human keratinocyte cell line (HaCaT) cells was orignally (a generous 
gift of prof. Dr. N. Fusenig, Heidelberg, Germany) (Boukamp et al, 1988). The HaCaT 
was kindly provided by a colleague Siao Pei Tan as frozen cultures in cryovials at as low 
a passage number of 20. 
hBD2- hBD3 over-expressing HaCaT cell lines, constructed by Dr Brian McHugh (a 
senior post-doctoral researcher in the Davidson Group at the University of Edinburgh / 
MRC Centre for Inflammation Research) using shRNA transfection to HaCaT cells.  
2.2 Methods  
2.2.1 Recovering cells from liquid nitrogen  
To recover the cells the sample were rapidly warmed to 37°C in a water bath with 






placed into 25mL of Dulbecco's modified Eagle's medium (DMEM) supplemented with 
10% v/v fetal bovine serum and (Penicillin 100 IU/mL + Streptomycin 10 µg/mL). Cell 
cultures were kept in an incubator at 95% relative humidity with 5% CO2 at 37°C. Cells 
were passaged using 0.05% trypsin and 0.02% EDTA/100 mL (T/E) to detach and 
disperse adherent cells. Then excess trypsin was quenched with DMEM + fetal calf 
serum, and then gives a quick wash by spinning the cells at 300 x g for 5 minutes. The 
old medium was removed before adding fresh 1ml of the DMEM + serum into the pellet 
of all the samples along with gentle pipetting dispersed the cells.  The cells were counted 
by using nucleocassette from Chemometec and then seeded at a density of 4 x105 cells 
/mL of media in a 12 well plates and 2 x105 cells /350µL of DMEM medium on the 
transwell insert. After 2-3 days of culture when monolayer was approx 90% confluent, 
DMEM + serum medium was replaced with Gibco keratinocyte serum free medium (G-
SFM) before performing the experiment.   
2.2.2 Collection of supernatant from different S.aureus strains.  
S.aureus strain 8325-4, RN6390, SH1000 including S.Epidermidis kindly 
provided by Dr Fitzgerald Department of Microbiology Royal SVM Dik Vet college 
Edinburgh university, cultured in 10 mL of Tryptic Soy Broth (TSB) without antibiotic 
while mutant strains LES17(L17); LES22 (L 22) and LES27 (L27) cultured in TSB broth 
with addition of  5µg/mL Erythromycin.  All the strains cultured to late stationary phase 
in a shaker incubator at 200 rpm for 24 hours at 37°C.  The concentration of bacteria in a 
suspension was measured by calculating? OD (optical density) in a spectrophotometer.  






nm) which correlated with different growth phases. Generally cells were in their late 
stationary phase of growth and OD was in the range of 600. Bacteria free conditioned 
media was collected by centrifugation at 5000 x g before filtering through a 0.2 µm filter 
to remove any cellular material. Optical density (OD) was measured at 595 nm to 
determine cell density where an OD 595 of 1:0 corresponded to 1x109 colony forming 
units (CFU/mL).   
2.2.2 A Trypan Blue Permeability  
 Trypan blue is a viable cell exclusion dye that selectively permeates through 
compromised membrane of dying cells. It is based on the principle that live cells possess 
intact cell membranes that excluded trypan blue. Typically 0.1% Trypan blue solution 
was used at a 1:4 dilution.  
2.2.2 B LDH assay for cells cytotoxicity 
 HaCaT cells were exposed to S. aureus RN6390 CM for 30-120 min, in either the 
presence or absence of leupeptin. 100% permeability of cells was obtained by adding 0.1 
% Tween-20.  All assays were performed in triplicate. The LDH release assay was 
performed using LDH cytotoxicity detection kit in 96 well plates before measuring 
absorbance at 490 nm in an ELISA plate reader. To determine the cell-mediated 
cytotoxicity we calculated the average absorbance of triplicate samples and controls, after 
correcting for background.  






 S. Epidermidis cultured in 10 mL of TSB broth without antibiotic in a shaker 
incubator at 200 rpm for 24 h at 37°C. Centrifuge the media for 10 min at 5000 x g to 
make a cell pellet then discard the conditioned media and washed the pellet twice with 
PBS before suspended the cells in PBS. The optical density was determined at a 
particular wavelength in the range of (420-660 nm) which correlated with different 
growth phases. Generally cells were in their late stationary phase of growth and OD was 
in the range of 600nm.  Supernatant was collected and filtered through a 0.2µm filter to 







During the lag phase bacterium adapt to the new environment and the growth is very low, 
which is almost close to zero. The log phase is the period of optimal growth, and 
microbes approach the upper limit of their continued growth called carrying capacity (k). 
The stationary phase is the point at which, bacterial population level out and population 
growth is near to zero again and this stage may last for a long period of time. Ultimately, 
waste and dead cells begin to accumulate, causing the death phase. Optical density (OD) 
was measured at 595 nm to determine cell density where an OD 595 of 1:0 corresponded 






suspended in PBS and heated at 100 °C for 30 mint. The effectiveness of killing by heat 
was tested when I spread 100 µL of heat killed S.Epidermidis  CM on the Agar plate and 
leave in the incubator at 37°C over night. There was no S.Epidermidis growth seen on the 
Agar plate. 
2.2.4 Zymographic assay with supernatant from S.aureus strains   
 Zymographic analysis of the proteases present in the supernatant collected from 
all the strains. The exoproteins present in the C.M of S.aureus strain 8325-4, RN6390, 
SH1000 were concentrated by rotary evaporator for 2 hours. Protease activity associated 
with serine protease (sspA) was detected using zymographic analysis described by 
(Arvidson et al., 2000). 52.5 µL vol of each sample was mixed with 17.5 µL of 4X 
Neupage LDS sample buffer without adding β mercaptoethanol and no heating, then left 
it at room temperature for 15 minutes. Samples were loaded on an SDS-12% 
polyacrylamide gel containing 0.1 % β-casein (Sigma, St.Louis,MO.), electrophoresis 
was performed with a constant voltage of 140 V using SDS buffer precooled at 4°C. 
Proteins were electrophoresed under standard conditions. After electrophoresis, the gel 
was renatured with Novex zymogram Renaturing Buffer for 30 min then decanted the 
buffer solution. The gel was developed by placing in developing buffer overnight. Next 
day the gel was washed with deionized water, and then stained with 0.5 % coomassie 
blue for 1-2 hours with gentle agitation at 37°C. Zones of hydrolysis were visualized after 
destaining gel in Coomassie destains solution or deionized water -2-3 hours. 






HaCaT cells seeded at a density of 5 x105 cells /250 µL of plain DMEM without any 
additive in a 6 well plate.  
 
Preparation of Lipofectamine (transfection reagent) coated control siRNA 
and DEFB4 siRNA 
Before starting experiments I made two groups having twelve tubes in each group.  
Group A  
-In the first batch of 6 tubes added 5 µL of control siRNA into 250 µL of plain DMEM 
- In the second batch of 6 tubes added 5 µL of Lipofectamine (Lipofectamine 2000 is a 
common transfection reagent, produced and sold by Invitrogen, used in molecular and 
cellular biology)   into 250 µL of plain DMEM  
Mix both batches together and tubes were left at room temperature at least thirty minutes. 
During that period Lipofectamine  coated over the siRNA .  
Group B 
- In the first batch of 6 tubes added 5 µL DEFB4 siRNA into 250 µL of plain DMEM  







The tubes in both batches were mixed together and left at room temperature at least thirty 
minutes, during that period Lipofectamine particles coated over the DEFB4 siRNA 
particles. The content of the tubes in the group A and B were finally poured into the two 
six wells plates contained non-confluent HaCaT cells. Lipofectamine coated control and 
DEFB4 siRNA belong to group A and B were poured separately into six wells plates 
contained non- confluent HaCaT cells. The transfected cells in the six wells plates were 
kept in the incubator for 12 hours. Next day old medium was replaced with regular 
DMEM + Penicillin & Streptomycin + serum. After 2 days of transfection, HaCaT cells 
were ready to use in the experiments.  
2.2.6 HaCaT cell transduction with DEFB4 plasmid to overexpress hBD2 
HaCaT cells were grown in six-well plates to 30-50% confluence in plain DMEM 
without any additive. After addition of condition medium cells were infected with 
lentivirus taged with DEFB4  plasmid and incubated at 37  overnight. The next day 
medium was replaced with serum plus medium. After expansion in culture for 48-72 h 
HaCaT cells were collected and analyzed for hBD2 expression. 
2.2.7 Enzyme kinetics 
The following buffer was used for enzyme kinetics both for S.aureus V8 and Staphopain 
B, 4mM EDTA, 10mM DTT, and 400 mM sodium acetate (pH 7.8). S.aureus serine 
protease V8 (500ng in 20 µL of DH2O) was preincubated with 60 µL of buffer for 15 
min at 37°C before adding (20 nM in 20 µL of DH2O) final concentrations in the assay 
of a quenched fluorescent substrate Z-Phe-Arg-7-amido-4-methylcoumarin (1µM) stock 






concentration. Substrate hydrolysis was monitored continuously by emission of 
fluorescence using a spectrofluorometer at 360/20 nm excitation and 460/20 nm emission 
wavelength. One unit was defined as the amount of enzyme that will hydrolyze 20 nM of 
Z-Phe-Arg-7-amido-4-methyl coumarin per min at 37°C with pH 7.8. S. aureus proteases 
staphopain B and V8 interaction with recombinant hBD2- synthetic hBD2- (C-S) - 
cysteine replace with serine- (SCB) scrambled peptide and LL37 was assayed 
spectrofluorometrically.  In addition, supernatant obtained from RN6390 and 8325 
S.aureus parent strain were similarly assessed for the hydrolysis of Z- Phe-Arg. 
2.2.8 Protein extraction, electrophoresis, and Western blot analysis 
For experiments, HaCaT cells were typically seeded at a density of 4 x105 
cells/cm2 in 12 wells plate.  Confluent HaCaT cell monolayer in serum free medium 
(SFM) was exposed with V8 protease for 24 hours. Cells were lysed with M-PER Lysing 
buffer (A reagent extract cytoplasmic and nuclear protein from cultured cells, utilizes a 
proprietary detergent in 25mM bicine buffer pH 7.6). The lysates were homogenized by 
spun down at 13000g for 10 minutes. The protein concentration of both the treated and 
untreated samples were determined using a Bicinchoninic Acid (BCA) assay kit 
according to the manufacturer’s instruction. 
Purified Protein samples were mixed with loading buffer and 5 µL of each sample 
was electrophoresed on a Novex 4-12 % gradient gel. The proteins were transferred to 
Immobilon-P PVDF membranes (Millipore) or Nitrocellulose blotting membrane using a 
protean II device (Bio-Rad Laboratories, Hercules, CA). (Nitrocellulose membrane is 






blocked overnight at 4°C with 5% (w/v) dried skim milk in PBS/ 0.05 % Tween-20 
(PBST).  
Primary antibodies were diluted in 5 % milk in PBST and incubated with the 
membrane at room temperature for 2 hours. Membranes were rinsed three times in PBST 
and washed with agitation for 15 min followed by 2 washes for 5 min. Transblot 
membrane was incubated with Claudin-1, ZO-1 primary antibodies at (1:500) dilution, 
and Desmoglein at (1: 100) dilution.  Transblots were left rolling overnight in the cold 
room at 4°C.  Membranes were washed for 3x with PBS/0.1% Tween then incubated 
with Licor  Odyssy anti Rabbit and anti mouse secondary antibody at (1: 5000) dilution 
for 30 minutes at room temperature. After three more washes with PBST, 
immunoreactive protein bands were detected by using Licor Odyssy according to the 
manufacture’s instruction.  Near infrared fluorescence (Licor Odyssy) with the use of 
fluorescent, IRDye secondary antibodies, provide sensitivity better than 
chemiluminescence having low background, multiplexed detection and the sensitivity of 
any fluorescent system.  Following fluorescent dyes are appropriate for use with the 
Odyssey, Cy5-700, Alexa fluor 647-680, IRDye 700-800 
2.2.9 Immunohistochemistry, Confocal microscopy 
Immunohistochemistry assay was performed where HaCaT cells were seeded at a density 
of 2 x105 cells/cm2 in an eight wells (0.8 cm2 / well) chamber slides.  
Immunohistochemistry step1-General procedure 2-Fixation 3-Antigen retrieval 4-






When HaCaT cells become 90 % confluent they were fixed with 4% 
Formaldehyde for 20-30 minutes and subsequently washed with PBS. Cell membrane 
nonspecific Fc receptors were blocked with 1% FCS for 30 minutes at room temperature.  
Fc receptors (Fragment, crystallizable) are a protein found on the surface of certain cells 
that contribute to the protective functions of the immune system. There are several 
different types of Fc receptors, which are classified based on the type of antibody that 
they recognize) Followed by washing with PBS incubated with (Rabbit anti human 
Claudin-1 and Rabbit anti human ZO-1) primary antibodies with concentration of (1: 
200) in 0.3 % BSA then store in the dark at +4°C for overnight. Cells were washed again 
and incubated with alexa Fluor 568 Goat anti-Rabbit antibody with concentration of 
1/400 (1/300) in the FCS and leave it in the dark at +4°C for 2-3 h. Nuclei were 
counterstained using DAPI nuclear stain. Phalloidin binds specifically and with high 
affinity to the polymerized form of actin (F-actin). Actin staining is very useful in 
determining the structure and function of the cytoskeleton in living and fixed cells. 
HaCaT cells fixed monolayer was stained with Phalloidin for 20-30 minutes and then 
washed with PBS and leave the cells in 500 µL of PBS. 
2.2.10 IL1β/LTA stimulated HaCaT cells express hBD2  
HaCaT cells seeded in 6 well chamber plates were grown to confluence then 
stimulated  with IL1β/LTA (8 
-100 ng/mL and 5µg/mL) for 24 hours. Stimulated and unstimulated monolayers 






membrane Fc receptors were blocked with 1 % BSA for 30 minutes at room temperature 
to prevent background staining. It is thought that background staining occur as a result of 
either non-specific antibody (Ab) binding to endogenous Fc receptors (FcRs) or a 
combination of ionic and hydrophobic interactions. After washing with PBS fixed HaCaT 
cells monolayer was incubated with Goat anti hBD2 at a (1: 250) ratio primary antibody 
overnight in 0.3 % BSA and kept it in the fridge. Cells were washed again with PBS and 
incubated with FITC- labeled appropriate secondary antibody at a (1:500) dilution then 
leave it  for 2-3 hours in the dark at +4°C. After three hours the chamber wells were 
washed with PBS and then left them to soak in the PBS to avoid them to be dried up. 
Representative pictures were taken by confocal microscope.  
2.2.11 HaCaT cell permeability measured by FITC-albumin assay 
 For detection of macromolecular passage across the transwell culture insert, a tracer 
solution containing FITC-alb was prepared in complete medium.  HaCaT cell were 
grown on the transwell insert growth surface area of 0.33 cm2  with 0.45 µM pore size 
transwell with cell density of 2 x104 cells/cm2. Before starting the experiment standard 
curve was obtained for FITC-alb with the concentration of 1M, 500mM, 250mM at 
480/20 excitation and 590/25 emission wavelength.  
 For the permeability assay, 0.02 % FITC-alb was added to the apical side of the 
transwell and sample were collected at several time points from the lower compartment 
of the transwell. For inhibition assay test wells were incubated with inhibiting peptides 2-






kept in the incubator for an hour. The plate was kept on the steady shaker for 15 mint at 
37°C with steady speed of 300 HTZ to equalize FITC-alb on the top of the monolayer. 
Then 10 µL of the filtered media was drawn from the lower compartment of the transwell 
and transfer it to 96-well plate. For the detection of FITC-alb, 96-well plates were read on 
a plate reader at emission and excitation wavelength of 485 and 590 nm, respectively. In 
order to allow qualitative comparison, the data is presented and expressed as relative 
permeability (with respect to a control stimulus run in each individual experiment) 
intensity of the FITC-alb permeabilized media at 485/590 nm was compared with the 
intensity of empty well with no monolayer. This process was repeated  after 8 and 24 
hours where each time withdraw 10 µL of permeabilized media was drawn from the 
lower compartment of the transwell and transfer it to 96-well plate to measure increase in 
fluorescence intensity. HaCaT cell monolayer damage by V8 protease was viewed as a 
loss of cell- cell contact.  The damage to the HaCaT cell monolayer was more prominent 
when size of the gaps between the cells was increased. The increase in the gap enables 
FITC-albumin to permeabilize through these gaps rapidly to enter into the bottom part of 
the well. Ultimately fluorescence intensity of the medium present in the bottom part of 
the well was increased. 
2.2.12 Role of Vitamin D in protecting skin barrier by expressing hBD2 
Trans-epithelial electrical resistance (TEER ohms/cm2) was measured by using Millipore 
protocol provided in the Ohms meter manual. HaCaT cells were grown on Transwell 
polycarbonate microporous filters with a pore size of 0.45 µM (corning costar UK). 






24 hours. TEER measurement was repeated every day and culture medium was changed 
daily. Each insert was measured at 3 different sites and mean values were calculated. A 
control without cells was also performed. All the experiment performed in duplicate with 
n=3. Damage to HaCaT cells monolayer by V8 protease was visualized under the light 
microscope. 
 HaCaT cells monolayer resistance was obtained by subtracting resistance reading 
across the blank insert from the resistance reading of the cell culture insert. The 
resistance is inversely proportional to the area of the monolayer, the larger the membrane 
lowers the resistance. After measuring the resistance, HaCaT cell monolayer treated with 
1µM/mL 25 OH vitamin D3 and 1,25 OH vitamin D3 for  24 hours.  After 24 hours 
serum + medium was replaced with serum free medium. Vitamin D3 treated and non-
treated HaCaT cell exposed to 4µg/mL of V8 for another 24 hours. Pictures were taken 
before measured the TEER. Unit area resistance = resistance (Ω) x effective membrane 
area (cm2). The unit area resistance is obtained by multiplying the meter readings by the 
effective surface area of the filter membrane, where area is the surface area of the HaCaT 
cell monolayer. The resistance is inversely proportional to the surface area. Thus larger 
the membrane, the lower the resistance. 
2.2.13 Quantitative Reverse Transcription Polymerase Chain Reaction 
(QRT-PCR)  
Total RNA was extracted from HaCaT cells by (QIAGEN RNA extraction kit) according 






mercaptoethanol, proteinase K solution, Nuclease free water, and Dnase 1 solution). 
Following this 100ng/µL of total RNA was then reverse transcribed using the cDNA 
synthesis kit (RNA at 100ng/µL, Taqman reverse transcription reagent kit, Nuclease free 
water). The mRNA level of DEFB4 (genetic name of hBD2) was examined using pre-
developed Taqman assay (TaqMan Gene expression Assay consist of a pair of unlabled  
forward and reverse PCR primers and a TaqMan probe with a FAM dye label on the 5 
end and minor groove binder (MGB) and non fluorescent quencher on the 3 end).  
(Master Mix 12.5 make 14x=175, 18s 1.25 14x=17.5). The QRT-PCR was performed to 
find about the mRNA expression level of hBD2 in human keratinocyte cell line HaCaT 
cells by comparing it with 18S ribosomal RNA as a control. 18S rRNA is a component of 
the small eukaryotic ribosomal subumit (40S) and structural RNA for the small 
component of ribosome’s and thus one of the basic components of all eukaryotic cells. 
The genes coding for 18S rRNA are referred   to as 18S rDNA. The 18S rRNA gene is 
one of the most frequently used genes in polygenetic studies and an important marker for 
random target PCR in environmental biodiversity screening.  
2.2.14 ELISA to determine hBD2 in the CM 
hBD2 concentration present in the CM was determined by ELISA assay. The protocol 
provided by (hBD2 ELISA development kit Peprotech USA) was followed. The standard 
hBD2 peptide provided in the ELISA development kit was serially diluted in  diluent 
solution (PBS + TW-20 and BSA). The 96 well ELISA plate was coated with goat anti 
hBD2 Capture antibody provided in the ELISA development kit and keep the plate at 






v/v TW-20 and then blocked with 1% BSA in PBS for 1hour at room temperature then 
wash it 4 times with PBS+TW-20. The standard peptide (recombinant hBD2 from the kit) 
was serially diluted (1000 pg/mL to zero) with diluents 0.1% BSA+0.05% TW-20 and 
then poured into the plate. Immediately added 50 µL of each standard and sample to each 
well in triplicate and incubate at room temperature for at least 2 hours. Aspirate the wells 
and after 4 washes with PBS+TW-20 added 50 µL of biotinylated detection antibody 
diluted at 0.5µg/mL and incubate at room temperature for 2 hours. After 4 washes the 
antibody was detected with Avidin-HRP conjugate 1:2000 ratio in dilution by incubating 
30 minutest at room temperature. After 4 washes added 50 µL of ABTS Substrate in each 
well and incubate at room temperature for color development. Monitor the color 
development with plate reader at 405 nm with wavelength correction set at 650 nm.  
2.2.15 Data presentation and statistical analysis, 
  2.2.15 A Measures the size of holes in the monolayer with ImageJ  
Image J software was used to measur the size of the holes formed by inducing S.aureus 
proteases in the HaCaT cells monolayer’s. 
 In  the tool option of Image J software, ‘Freehand was selected to  draw an outline 
around the damaged area. Once the outline around all the damaged areas of the image 
was drawn, to get the measurement it need to click on ‘Analyze > Measure. In the result 
section damaged area of the image is defined as the units- pixels found in that area. Then 
the total area of the image which is define as the the total pixel area of the image can be 






used to select the whole image. The command ‘Analyze > Measure’ was used to get area 
of the entire image. The Percentage of damaged area can be calculated by using 
following formula 
  = (Outline damaged area of the image/ Total area of the image) *100 
The calculated damaged area of the monolayer can be define as ‘percentage area damage 
which is showed in the image. 
2.2.15 B Calculate W.B band intensity by using Image J software 
The intensity of the band in the W.B analysis can be calculated by using Image J 
software, which is a semi-quantitative tool.  The Rectangular tool was selected to 
highlight the band of interest. The gel was analyzed by using commands Analyze > Gel > 
Gel analyze option > uncheck the box for invert peaks but keep the default value and clik 
o.k. After getting peaks for all the bands then choose the command Analyze > Gel > Plot 
lanes which provides values to the selected peaks. In order to prevent the overlapping of 
the peaks to each other the segmented free straight line tool was selected. This command 
makes straight line and separates each peak from the other peak. By selecting Wand 
(tracing) tool and clicking the peak give values to each peak. Then go to Analyze > Gel > 
Label the peak, that will provide the percentage area. Get the percentage by dividing the 
highest value by itself and then the other values divided by the highest multiply by 100. 
2.2.15 C easuring cell Fluorescence using image J software The fluorescence 
density of the monolayer can be detected by Image J software. In the Image J software 






Mean gray value. Now select “Measure from the analyze menu. A box will pop up with a 
stack of values for that cell then select the region near the cell which has no fluorescence 
that will become the background value. It needs to take three selections from around the 
cell. Repeat these steps for the rest of the cells and figures.-Once it done then copy all the 
data into the new Excel worksheet.  Following formula can be used to calculate the 
corrected total cell fluorescence (CTCF). 
CTCF=Integrated Density-(Area of selected cell x Mean fluorescence of background 
readings) 
2.2.15 D One way ANOVA (unstacked) 
 One-way analysis of variance technique was used to compare means of my 
numerical data from three or more samples in an experiment. Graph Pad Prism  and 
Minitab 16 software were used for the statistical analysis. The ANOVA tests the null 
hypothesis that samples in two or more groups are drawn from populations with the same 
means value.  Typically, however, the one way ANOVA is used to test for differences 
among at least three groups, since the two-group can be covered by a t-test. When there 
are only two means to compare, the t-test and the F-test are equivalent; the relation 
between ANOVA and t is given by F=t2. The relation of the values within the group was 











3-Staphyloccocus.Aureus secreted proteases can damage HaCaT cell 
monolayer  
3.1 Introduction  
 S.aureus infection is very common in atopic dermatitis patients, 90% of AD patients are 
S. aureus carriers, having the bacteria present in their nasal and perineal areas.  Although S. 
aureus is not part of the normal skin microflora, it is considered an environmental factor in the 
pathogenesis of AD (Collins et al., 2013).  S. aureus disease causing ability is due to 
expressing a variety of virulence factors, those are surface proteins, enzymes, toxins, and 
antigens.  These virulence factors play a critical role such as, adherence to the surface, 
invasion of the host and avoidance of the immune system, which cause harmful toxic effects 
to the host. The major proteolytic enzymes secreted by S. aureus are aureolysin, V8 and two 
cysteine proteases - staphopain A and staphopain B (Arvidson S et al., 2000). ). S.aureus 
cysteine protease staphopain B is neutralized by staphostatin secreted by the bacteria. The 
staphopain B secreted as a zymogen, which is proteolytically processed by V8 protease, as 
outlined in chapter 1 (Chan et al., 1998; Rice et al., 2001).  Staphopain B is encoded by the 
sspB gene, which is located in the operon contiguous to the gene for the serine protease sspA 






and by damaging epidermal permeability barrier cause exacerbation of AD, which  increased 
sensitization to allergens (Shaw et al., 2004).  Specifically, one study, done in 2002 by 
Medzobrodzki et al., states that, S. aureus strains isolated from the skin lesion of 26 AD 
patients, secrete proteases. This study describes the presence of proteolytic activity in the 
lesional skin of AD which provided a link how S.aureus proteases may contribute to the 
pathogenicity of AD.  Like other extracellular proteases V8 is involved in S.aureus 
colonization and infection of human tissue (Massimi et al., 2002).  S. aureus V8 (sspA) a 
serine protease with  molecular weight of 27 KDa at pH 4.0 - 7.8  specifically cleaves peptide 
bonds on the carbonyl side of either aspartic or glutamic acids (Endoproteinase-Glu-C) 
(Prasad et al., 2004).  V8 is secreted in a pro-form, which is proteolytically cleaved to 
produce a mature and functional enzyme, possibly in an aureolysin-dependent manner (See 
page76) (Drapeau et al., 1978; Lindsay et al., 1999).  V8 is a most important protease for 
the degradation of fibronectin binding protein and surface protein “A” which are involved in 
adherence to host tissue (Mcgavin et al., 1997 & Karlsson A et al., 2001). In reference to 
disease-causing toxins, S. aureus secreted exfoliative toxin (ET) is a virulence factor. The ET 
belongs to the family of disease-causing toxins that can damage the skin barrier by protease 
activity (Amagai et al., 2000).  The Exfoliative toxins can degrade adhesional junction 
protein desmoglein-1 (DMG-1) in a dose dependent manner without any contributing factors. 
The separation of the epidermal layer at the stratum granulosum results either directly or 
indirectly from the enzymatic activity of exfoliative toxins (Bailey CJ& Redpath MB, 1992). 
The proteolytic activity of ET starts when highly charged N-terminus bind to desmoglein-1 






site ET cleaves the protein between the third and fourth extracellular domain (Dancer et al., 
1990).  
 The sequence analysis of the ET revealed homology to V8 protease, having serine-
histidine-aspartate catalytic triad which is present in all serine proteases (Figure 3.1). The 
mutation of any of these three amino acids results in loss of exfoliative activity in the newborn 
mouse model (Gemmell et al., 1997).    Exfoliative toxins (ET) homology to serine proteases 
proven by exhibiting esterase activity, an activity commonly associated with serine proteases 
(Dancer et al., 1990).  The supportive evidence that exfoliative toxins act as serine protease 
was provided when serine residue of the active site of ET-A was replaced with alanine. The 
mutated ETA toxin was able to bind, but unable to cleave desmoglein-1 (Yamaguchi et al., 
2002).  This evidence explains how both ET and V8 have capacity to damage skin barrier by 
having serine protease activity. S. aureus virulence factors (as outlined in chapter 1) are 
regulated by an accessory gene regulator (Agr): a quorum-sensing system.  Bacteria use 
quorum sensing to co-ordinate certain behaviours such as biofilm formation, virulence, and 
antibiotic resistance, based on the local density of the bacterial population (Lerat E et al., 
2004).  The Agr operon consists of two divergently transcribed promoters, P2 and P3, which 
encode a quorum-sensing system and a pleiotropic regulatory RNA molecule, respectively 
(Roux A et al., 2014). Operon is a stretch of DNA found in bacteria, operon controls gene 
regulation having three components, which are promoter, operator, and structural gene. 
Structural sequence codes for protein, RNA polymerases binds with promotor sequence, 
repressors binds to the operator sequence and inhibits RNA polymerases from binding. A 






parts of the chromosomes and have their own promoters (Blumenthal et al., 2004). Auto-
inducers are the signaling molecules produce and secrete by certain bacteria’s, which also 
have receptors that specifically detect the inducer (Novick et al., 2008). To study the role of S. 
aureus secreted proteases in the breakdown of skin barrier, S. aureus parent strain 8325-4 
which is a standard laboratory strain and their laboratory generated mutants strains were 
kindly donated by (Dr Fiztgerald department of microbiology Royal (Dick) School of 
Veterinary Sciences Edinburgh). The mutants were constructed by the insertional inactivation 
technique as described previously (Karlsson  et al., 2001) (Shaw et al., 2004).  Insertional 
inactivation is a technique, where a plasmid is use to disable expression of a gene. Shaw 
described how mutant strains were constructed by inactivation of either V8, staphopain A or 
staphopain B secreted proteases. Selectively regulating gene expression in bacteria by adding 
5mg/ml of erythromycin in the growth medium, has provided an important tool for studying 



































Figure 3.1 The structural homology of exfoliative toxin B to V8 protease 
 Schematic drawing shows S.aureus exfoliative toxin “A” having structural 
homology to V8.  In the secondary structure of ETB, α-helices are shown in red, β strands 
are in blue; loops 1, 2 and’ D’ are in magenta, cyan, and yellow, respectively. The same 
color presentation is for V8 protease. (Picture is taken from (RCSB) protein data base 











The selective modulation of gene expression levels is produced which allows the creation 
of conditional lethal phenotype, which is a powerful strategy in determining the 
contribution of phenotype when genes are essential. The following are the mutants which 
were used in the experiments; L17 (with insertional inactivation of sspB (Staphopain B) 
of S. arueus strain 8325-4-SspB), L22 (with insertional inactivation of sspA (V8) S. 
arueus strain 8325-4 sspA), L27 (insertional inactivation of scpA (Staphopain A).  
 The virulence factors, present in the supernatant of the parent and mutant strains 
were applied to the HaCaT cell monolayer.  The Proteolytic activity associated with 
recombinant V8 and serine proteases which were present in the supernatant was analyzed 
separately by using SDS page and zymographic analysis, (The zymographic method 
described by Arvidson et al., 1973 was followed) (See page106). The separation occurs 
in a polyacrylamide gel containing a specific substrate that is co-polymerized with 
acrylamide (Fernandez-Resa et al., 1995). S. epidermidis is a skin commensal and the 
role played by S. epidermidis for the protection of skin barrier against S. aureus proteases 
was also studied (See page 104).  
Aim: 
The structure of the study was designed in such a way to identify the most 






the skin barrier. The deleterious effect of S.aureus secreted serine protease is compared 
with other proteases.   
 
3.2 Results  
S. aureus parent strain 8325-4, and its derivative RN6390, SH100, and the skin 
commensal S. epidermidis, were cultured to late stationary phase in 10 mL of Tryptic 
Soya Broth (TSB) without antibiotic.  Mutant strains were similarly cultured in TSB 
broth, but in the presence of erythromycin. The concentration of bacteria in a suspension 
was measured by calculating OD (optical density) in a spectrophotometer (See page 
105).   
3.2.1- S.aureus secreted protease can damage HaCaT cell monolayer  
Confluent monolayers of HaCaT cells grown in 1 mL of serum free medium (SFM) per 
well were exposed to 40 µL of supernatant obtained from S.aureus strains 8325-4, 
RN6390 and SH100. The 40 µL of supernatant in 1 mL of SFM, 0.004 dilution factor 
(DF) is considered as minimum effective concentration of supernatant, which was 
optimized after a series of experiments.  
  Differential interface microscopy (DIC microscopy) and with phalloidin-FITC 
staining revealed: Control normal HaCaT cell monolayers revealed no damage without 
any gaps between the cells (Fig 3.2 a). Supernatant from RN 6390 caused retraction of 






hours (Fig 3.2 b). Control HaCaT cells exposed to 8325-4 revealed damage to the 
monolayer and displayed increased gaps between the cells after 12 hours (Fig 3.2 c). 
Damage to the HaCaT cell monolayers was observed with supernatant from SH100 after 
12 hours (Fig 3.2 d). HaCaT cells exposed to the supernatant derived from mutant strain 
L17 revealed normal-looking monolayers without any damage after 12 hours (Fig 3.2 e). 
HaCaT cells exposed to the supernatant derived from mutant strain L22 revealed normal-
looking monolayers without any damage (Fig 3.2 f). Percentage damage to the HaCaT 
cells by exposing supernatant of different strains compared to unexposed HaCaT cells for 
12 hours which had 0% damage. Where I observed 20% damage in the monolayer 
exposed to RN6390, 22% with 8325-4, 15% with SH100 (Fig 3.2 g) which was 














Figure-3.2 HaCaT cell monolayer exposed to S.aureus CM-DIC microscopy 
and with phalloidin-FITC staining revealed.  (a) Control normal HaCaT cell monolayers 
(b) Control-Normal HaCaT cells exposed to 0.004 DF Supernatant of RN 6390.   12 
hours (c) Control-Normal HaCaT cells exposed to 0.004 DF Supernatant of 8325-4. (d)  
Control-Normal HaCaT cells exposed to 0.004 DF Supernatant of SH100. (e) Control-
Normal HaCaT cells exposed to 0.004 DF Supernatant of mutant strain L17. (f) Control-
Normal HaCaT cells exposed to 0.004 DF Supernatant of mutant strain L22. Data is 
representative of n=4 experiments perform with replicates (one way ANOVA) 
Magnification x400. Tukey's Multiple Comparison Test  (Control-NH vs NH+ 0.004 
DF RN6390 p<0.001) (Control-NH vs NH+ 0.004 DF 8325-4 P < 0.001) (Control-NH vs 
NH+ 0.004 DF SH100 P < 0.001) (Control-NH vs NH+ 0.004 DF L17-supernat ns) 






3.2.2 S.aureus exotoxins promote cell permeabilit 
To assess the toxic effects of S.aureus CM on cell viability, we stained live cell culture 
with Trypan blue and noted that as early as 2 h, RN6390 CM caused widespread staining, 
even in cells that appeared viable and fully adherent by light microscopy (Figure 3.3 a).  
An increase in cell permeability, as assessed by Trypan blue (t=2h, Figure 3.3 a), by 
reducing the dilution factor which are as follow 0.01 0.02, 0.05, 0.1, 0.2,  which reveals 
that 0.05  dilution factor of 50 µL of added which reveals that S.aureus RN 6390 CM 
with dilution factor of 0.05  was sufficient to cause approx. 50% of all cells to stain 
positive (a consistent observation within a 10% margin of error when comparing different 
batches of RN6390 CM; data not presented). To block the activity of the proteases 
present in RN6390 CM Leupeptin is used. Leupeptin is a naturally occurring protease 
inhibitor that can inhibit cysteine, serine and threonine peptidases. Leupeptin used with 
concentration of 4 µg/mL.  Leupeptin cause decrease in Trypan, Blue permeability by 
having Protease inhibitor activity which ultimately reduced LDH (Lactate 
dehydrogenase) secretion. Where levels are compared with the total amount of LDH   
released from lysed cells following exposure to 0.1% Tween20.   LDH assays also 
confirmed our preliminary observation with Trypan blue that an incubation of at least 60 
min was required before a significant increase in permeability was observed. The ability 
of RN6390 CM to cause approx. 50% permeabilization after 120 min was assayed for the 









Figure-3.3: Quantitate the deleterious effects of RN6390 CM for HaCat 
viability. (a) HaCat cells exposed to LB media, RN6390 CM with increasing volume, 
which reveals that decreasing dilution factor of RN6390 CM was sufficient to cause 
approx. 50% of all cells to stain positive (b) RN6390 CM cause approx.50% 
permeabilization after 120 mint and LDH levels are compared with the total amount of 
LDH activity released by cells following exposure to 0.1% Tween20 serving as a positive 
control for 100% permeabilization. In addition to adding LB, some assays also contained 
Leupeptin to block the protease activity.  n=3 experiments and always performed with 
replicates. Values are mean ± SE of three independent HaCat cultures with triplets.  (Two 
way ANOVA) Magnification x200   Control =ns P > 0.05   RN6390 ** =   P<0.01   






Bonferroni post –test Compare the changes in LDH release after 30 Mins vs 60 
Mins, 30 Mins and 90 Mins, 30 Mins and 120 Mins-LDH release 30 Mins vs LDH 
release 60 Mins              
Control P > 0.05     RN6390 P > 0.05    RN+ Leup P > 0.05    Tween 20 P > 0.05    
LDH release 30 Mins vs. LDH release 90 Mins   
Control P > 0.05     RN6390 P > 0.05    RN+Leup P > 0.05    Tween 20 P > 0.05    
LDH release 30 Min vs. LDH release 120 Mins   
Control P > 0.05      RN6390   P<0.01   RN+Leup P<0.01    Tween 20 P > 0.05    
3.2.3 SDS-PAGE gel analysis for the proteases in the CM   S. aureus RN6390 
and S. epidermidis supernatant were loaded with an equal amount on to the SDS-16% 
polyacrylamide gel. Protein marker was applied to the gel in the separate lane to assess 
the molecular weight of the protein, present in the supernatant.  Electrophoresis was 
performed. Protein bands were visualized after destaining the gel in Coomassie destains 
solution -2-3 hours. There were no bands found in the supernatant derived from S. 
epidermidis, whilst multiple bands with different sizes were visible in the S. aureus 
supernatant. A 17 kDa band, suggestive of staphopain B, and another prominent band at 
27 kDa, which is the expected size of V8, was visible.  An additional prominent, 37 kDa 
band, the expected size of Aureolysin, was found in the S. aureus supernatant (Fig 3.4). I 
could say from these results that proteases are present in the CM obtained from S.aureus 








Figure 3.4 SDS-PAGE gel analyses for the proteases present in the CM.  
 To determine the presence of proteases in the supernatant and their activity, SDS 
page gel analysis was performed   (a). No bands were found in the supernatant derived 
from S. epidermidis, whilst three prominent bands were visible in the S. aureus RN6390 










3.2.4 Zymogram gel analysis for the proteases in the CM 
Zymography is defining as simple, quantifiable and functional assay to analyze proteases 
in biological samples. In zymography, the proteins are separated by electrophoresis under 
non-reducing conditions. The separation occurs in a polyacrylamide gel containing a 
specific substrate that is co-polymerized with acrylamide (Fernandez-Resa et al., 1995).   
 Zymogram gel analysis was performed to determine proteolytic activity of the 
proteases present in the supernatant of 8325-4, SH100, RN6390. And Mutant strains L27, 
L22, and L17.  The zones of hydrolysis of the substrate were visualized after staining 
with coomassie blue and then destaining gel in Coomassie destains solution. There was a 
clear, whitish area visible in the prospective lanes of samples from 8325-4; SH100 and 
RN6390. There was no visible destained area in the lanes of L17, L22, L27 and S. 
epidermidis.  (Figure 3.5). The proteases are detected as clear bands against a blue 
background of undegraded 0.1 % β-casein present in the gel. The destained band was 
visible at 27kDa, in the corresponding lane of V8, 8325-4; SH100 and RN6390. In 
another experiments I loaded recombinant V8 proteases along with supernatant from 













Figure-3.5 Zymogram gel analysis for the proteases present in the CM.  
 Proteolytic activity of the proteases presents in the supernatant derived from the wild-
type and mutant strains were quantified by zymogram gel.  Clear areas were visible only 
in the lanes of RN, SH, 8324 strains. There was no visible destained area in the lanes of 







3.2.5 S.aureus V8 protease can cause damage to the monolayer 
 So far I had found that toxic factors are present in the supernatants of RN6390, 
8325-4 and SH100 which could damage the HaCaT cell monolayers after 12 hours but 
mutant strains L17, L22 and L27 were unable to damage the HaCaT cell monolayer. 
After the zymograph analysis, it shows that proteases are present in an active form in the 
supernatant which could degraded the substrate that proteases would have cause damage 
to the HaCaT cell monolayer. In this experiment I used only recombinant V8 after 
optimising used with concentration of 4µg/mL to see the extent of damage to the HaCaT 
cell monolayer.  
 Light microscopic examination revealed, there was no visible change in the 
unexposed control HaCaT cell monolayers. HaCaT cells monolayers induced with V8 
started shrinking from their periphery and adopting rounded shapes after 12 hours, 
suggesting toxicity, and loss of cell-cell interactions. To better define the boundaries of 
individual cells, they were stained for intracellular filamentous actin, using phalloidin-
FITC to reveal the proper cell shape by staining  cortical cytoskeleton. 
Control cells displayed normal HaCaT cell monolayers, without any gaps between the 
cells (Figure 3.6 a). Prominent morphological changes were observed in the V8- induced 
cells after 24 hours, where V8 protease had disrupted the monolayer, as evidenced by a 
retraction of cells from each other and starting holes formation in the monolayer (Fig 3.6 
b). This data demonstrate that recombinant V8 protease can replicate the HaCaT 







 Figure-3.6 V8 protease can damage HaCaT cell monolayer  
  Confocal Laser microscopy and with phalloidin-FITC staining revealed: (a) 
Control normal HaCaT cell monolayers revealed cortical cytoskeleton and defined 
boundaries of individual cells, without any gaps between the cells after 24 hours (Fig a; 
Width in pixel 411, height in pixel 4, Font size 14). (b) Control HaCaT cells exposed to 4 
µg/mL of V8 for 24 hours (Fig b; Width in pixel 413, hight 4, and Font size 14). 
Experiments were always performed with replicates:  representative of n=4 at 











3.2.6 Correlating damaging effect of Trypsin with V8 and staphopain B  
   To compare proteolytic damage to the HaCaT cells monolayer which could be 
caused by serine (V8) and (trypsin) or cysteine (staphopain B) proteases, a time course 
assay was conducted. After series of experiments I found that 0.004 dilution factor (DF) 
of supernatant effectively damage the monolayer. 4 µg/mL of V8 protease i.e 4 µg of 
neat protease in 1 mL of SFM effectively damage the monolayer. In the time-course 
study, HaCaT cell monolayers were exposed to 4 µg/mL of V8, trypsin or staphopain B, 
for 4 to 24 hours and assessed the extent of damage to the monolayer (Figure 3.7). There 
were no visible changes observed in the control unexposed HaCaT cell monolayers after 
4, 8 and 24 hours (Figure 3.7; lane 1st). The HaCaT cells monolayer exposed with 4 
µg/mL of V8 show no changes after 4 and 8 hours. Whereas prominent morphological 
changes were observed (Yellow arrows) after 24 hours, which were loss in cell-cell 
contact and rounded hole formation. The image J quantification shows there was 22.16 % 
damage to the monolayer with V8 protease when compare to control which has no 
damage. (Figure 3.7; lane 2nd).  The morphological changes started in HaCaT cells after 
8 hours when exposed to trypsin. These changes included loss of cell-cell contact, voids 
and fissure formation (Yellow arrows) pointed those changes. The image J quantification 
shows there was 17.15 % damage to monolayer compare to control which had 0% 
damage. There was prominent damage to the monolayer induced by trypsin after 24 hours 
(Yellow arrows). The image J quantification provided 41.36% damage to monolayer 
compare to control. (Figure 3.7; lane 3rd). There were no such changes observed in the 






4th). This experiment shows that damage to HaCaT cell monolayer faster with trypsin 
compare to V8 protease (serine protease) while staphopain B (cysteine protease) was 




















          Lane 1st      Lane 2nd    Lane 3rd      Lane 4th 
 
Figure-3.7 Optimizing monolayers damage with V8, trypsin and staphopain 
B.   The time course, comparative study where HaCaT cells monolayers were exposed to 
4µg/mL of V8, Trypsin and staphopain B for up to 24 hours. Lane 1st Normal HaCaT 
(unexposed) cell monolayers 4- 24 hours. Lane 2nd, Normal HaCaT cell monolayers 
exposed to 4µg/mL of V8 4- 24 hours.  Lane 3rd Normal HaCaT cell monolayers exposed 
to 4µg/mL of Trypsin 4- 24 hours.  Lane 4th, Normal HaCaT cell monolayers exposed to 
4 µg/mL of staphopain B. (One way ANOVA n=3 magnification X200) 
B. Tukey's Multiple Comparison Test -After 4h-(Control-4h vs NH+V8-4-mg/mL-4h 
P > 0.05) (Control-4h vs NH+trypsin-4-mg/mL-4h P > 0.05) (Control-4h vs Staphopain 
B-4-mg/mL-4h P > 0.05). After 8 h- (Control-8h vs NH+V8-4-mg/mL-8h P > 0.05) 






P > 0.05). After 24 h (Control-24h vs NH+V8-4-mg/mL-24h P < 0.001) (Control-24h 
vs NH+trypsin-4-mg/mL-24h P < 0.001) (Control-24h vs Staphopain B-4-mg/mL-24h P 
> 0.05) 
3.2.7 V8 at higher concentrations can cause more damage  
In this experiment higher concentrations of both V8 and staphopain B protease are 
tested on the HaCaT cell monolayer. The HaCaT cell monolayer was exposed to V8 and 
staphopain B, with concentrations of 4 and 8 µg/mL, for 24 hours. There was no change 
in the HaCaT cell monolayer after 24 hours in control unexposed HaCaT cell monolayers 
(Fig 3.8 a). Whilst there was loss of cell-cell contact, increase gap between the cells and 
observed holes formation in 4µg/mL of V8-treated monolayer after 24 hours ( Image J 
quantification  calculated as a % age damage provided 24.37% damage to  monolayer 
compare to control (Fig 3.8- b). These changes were more extensive in the monolayer 
which exposed to 8µg/mL of V8. There was starting of holes formation after 12 hours in 
the monolayer exposed to 8µg/mL of V8. Whilst size of the holes was significantly 
increased after 24 hours. The percentage damage with 8µg/mL of V8 calculated with 
image J showed 43% damage to the monolayer compare to control. (Fig 3.8 c). HaCaT 
cell monolayers exposed to staphopain B 4µg/mL and 8µg/mL did not show any changes 
(Fig 3.8 d, e). Image J software calculation reveal 25 % damage to the HaCaT cell 
monolayer with 4µg/mL of V8 and 43% damage to the HaCaT cell monolayer with 
8µg/mL of V8 after 24 hours (Fig 3.8 f). The time-course study demonstrated that 4 
µg/mL of V8 could damage the HaCaT cell monolayer after 24 hours, but staphopain B 







Figure-3.8 The extent of damage increase by increasing V8 concentration  
To see how much damage to the HaCaT cell monolayer could be caused by higher 
concentration of V8 and staphopain B. Light microscope examination revealed that. (a) 
Control (Normal HaCaT), unexposed HaCaT cell monolayer. (b) Normal HaCaT cell 
monolayer exposed to 4µg/mL of V8 for 24 hours. (c) Normal HaCaT cell monolayer 
exposed to 8µg/mL of V8 24 hours. (d) Normal HaCaT cell monolayer exposed to 4 
µg/mL of staphopain B. (e) Normal HaCaT cell monolayer exposed to 8µg/mL of 
staphopain B (f) Percentage damage to the HaCaT cell monolayer was calculated by 
using image J software. (1 way ANOVA n=3 magnification X400) 
Tukey's Multiple Comparison Test; (NH- NH+ V8 4µg/mL P < 0.01) ((NH- NH+ V8 
8µg/mL P < 0.01) (NH- NH+ Staphopain B 4µg/mL ns) (NH- NH+ Staphopain B 






3.3 Discussion  
 S. aureus is the leading cause of gram-positive bacterial infection and can play a major 
role in breaking the antimicrobial barrier in atopic dermatitis (Aly et al., 1977).  
Staphylococcus commensal and pathogenic species colonize the skin, where both 
expresses proteases. The proteases, secreted by commensal contributes collaborative 
bacterial coexistence on the skin, while proteases from pathogenic bacteria are used as 
virulence factors, helping them to colonize skin. The pathogenic bacteria from these 
initial sites of colonization can disseminate into deeper layers of skin, possibly leading to 
the spread of infection. 
Additionally S. epidermidis, a skin commensal, was used as a control.  S. 
epidermidis a common bacterial colonizer of mammalian skin, also produce, cysteine and 
serine exoproteases with relatively low substrate specificity (Dubin et al., 2001).  The 
commensal lifestyle of S. epidermidis is partly achieved by the expression of extracellular 
neutral metalloprotease (Sepa ) (Lai Yet al., 2007).  S. epidermidis plays probiotic 
function by preventing colonization of more pathogenic bacteria such as S.aureus.   
 Medzobrodzki et al., states that, S. aureus strains isolated from the skin lesion of 
26 AD patients, secretes proteases. S. aureus disease causing ability is by expressing a 
variety of virulence factors, which cause harmful toxic effects to the host. S. aureus is 
known to produce prominent extracellular proteases which includes serine, cysteine and 
Aureolysin (Dubin et al., 2002).   Like other extracellular proteases V8 is involved in 






 We established a culture model of the HaCaT cell line to better understand the 
mechanism by which S. aureus secreted proteases can compromise the integrity of a skin 
cell monolayer.  S. aureus strains commonly found in the lesional skin of atopic 
dermatitis patients were used in this experiment (see page 103). 
Supernatant from S.aureus residential strains caused damage to the HaCaT cell 
monolayer, but supernatant from S. epidermidis was unable to damage the monolayer. 
Zymogen gel analysis demonstrated no proteolytic activity in the supernatant derived 
from the mutant strains. Additionally, supernatant from mutant strains had no obvious 
deleterious effects on the integrity of the HaCaT cell monolayer. Whilst 8325-4 and 
RN6390, SH100 supernatants had a profound effect and cause damage to HaCaT cell 
monolayer. These changes were more prominent when we staind HaCaT cells 
cytoskeleton with phalloidin-FITC.  
The deleterious effect of serine and cysteine proteases were analyzed when the 
monolayer was exposed to recombinant V8 and staphopain B; however staphopain B was 
unable to damage the HaCaT cell monolayer even at higher concentration.  These data 
suggest that V8 is the most active protease secreted by S. aureus into the supernatant and 
present in the conditioned media used in these studies. It would say, V8 could be the 
master protease secreted by S. aureus involved in deterioration of the skin barrier in 
individuals with AD.  This observation is consistent with another study, demonstrating 
that extracellular proteases secreted by S. aureus cause epidermal barrier dysfunction 
(Hirasawa et al., 2009).  In that study, they applied V8 to the back of nude mice for one 






(Transepidermal water loss). It is not just the bacterial proteases capable of breaking 
barrier, common allergens such as house dust mite’s secreted serine and cysteine 
proteases can damage skin barrier (Chapman et al., 2007).   
S.aureus may play a role in the chronicity and severity of AD through its release 
of super-antigenic exotoxin (Leung et al., 1993). In addition to their immunological 
effects these toxins may also directly damage the skin barrier. S.aureus produces 
proteases that break down corneodesmosomes by a mechanism similar to that of KLK- 
(Kallikrein-related epidermal serine proteases) peptidases (Miedzobrodzki et al., 2002). 
In addition S.aureus secreted sphingosine deacylase and glyceropospholipids that may 















  S. aureus proteases are environmental factors in the pathogenesis of AD and 
previous studies had demonstrated that extracellular proteases secreted by S. aureus cause 
epidermal barrier dysfunction. I tried to find out which protease has the most deleterious 
effect on the HaCaT cell monolayer. After this series of experiments, I concluded that 
S.aureus strains 8325-4, RN6390 secrete serine (V8), cysteine (staphopain B) and 
Aureolysine (Zn metalloprotease) proteases which are present in the supernatant. I found 
that V8 (S.aureus serine protease) is the most active protease when I compared it with 
staphopain B (S.aureus cysteine protease) recombinant proteases by applying them on 
HaCaT cell monolayer. I also compare V8 protease with trypsin which is human serine 
protease and found trypsin had more rapid effect that V8 protease (see page136). 
Therefore, the next aim of this study will be to find out HaCaT cell monolayer peptide 
which become substrate for this protease and endogenous inhibitors, which could block 
their proteolytic. Currently there is no topical protease inhibitor available which block the 
proteolytic effect of V8 protease. The aim of this study was to protect epidermal barrier 
of AD from S.aureus protease by having protease inhibitor action, which ultimately 








4-A secreted factor produced by stimulated HaCaT cells can 
inhibit S.aureus secreted proteases. 
 4.1 Introduction  
 S. aureus colonization is very common in individuals with AD and several 
studies confirmed isolation of multiple S. aureus strains from lesional skin of patients 
with AD (Miedzobrodzki et al., 2002). In individuals with AD, the epidermal 
permeability barrier could be damaged by S. aureus secreted proteases, which cause 
primary sensitization to allergens (Shaw.L et al., 2004).  In addition S.aureus serine 
proteases, protects bacteria against host defence mechanism, by cleaving heavy chains of 
all immunoglobulin classes, plasma protease inhibitor, and elastin. (Jusko, M., et al. 
2014, prokesova L et al., 1992). Perhaps V8 is the most abundant of S.aureus secreted 
proteases, which is also important for transition from adhesive to non- adhesive 
phenotype via degradation of fibronectin-binding proteins, and other proteins on the 
S.aureus cell surface (Karlsson A et al., 2001). 
 In order to find all about activation and secretion of endogenous inhibitors, the 
mechanism of activation pathways needs to be studied. The toll like receptors (TLRs) are 
primary, key sensors of invading pathogens, which recognize conserved pathogen-
associated molecular pattern (PAMPs) of bacteria, viruses, fungi and protozoa and induce 
host antimicrobial defense (see page Error! Bookmark not defined.) (Medzhitov et al., 
1997). The epidermal keratinocytes express TLR2 and TLR4 which are involved in 






important part of the inflammatory response of the body against infection. IL-1β is 
produced by tissue macrophages, monocytes, fibroblast, and dendritic cells, B 
Lymphocytes, NK cells and epithelial cells keratinocytes. The recognition of pathogens 
by TLR in keratinocytes leads to the production of the pro-inflammatory cytokine 
(Pivarcsi, A et al., 2003).  Keratinocyte TLR2 and TLR4 may play important role in the 
protection of the skin barrier against pathogens. 
 Part of the skin defense against S. aureus exoproteases can be maintained by S. 
epidermidis by releasing “Lipid S” a part of the cell wall LTA, into the medium during 
growth (Schroder, N.W et al., 2003).  S. epidermidis Lipid S is a short chain length form 
of LTA, which is a prominent exocellular antigen (Elliott, T.S.J et al., 2000). S. 
epidermidis Lipid S plays an important role during host bacterial infection by stimulating 
immune cells through TLR2, leading to the production of IL1-β, contributing to host 
defense against invading microbes (Lambert, P. A et al., 2000) (Morath et al., 2001). In 
vitro studies demonstrated that cell wall component of S.epidermidis, are recognized by 
TLR2. It was observed that killing of bacteria has significant qualitative and quantitative 
effects on key aspects of innate responses in vitro. Heat killed S. epidermidis (HKSE) can 
stimulate TLR2 and induce the production of NF-kB and IL1β. Heat killed preparation 
engaged the NF-kB pathway but had significantly lower capacity to activate other 
immune pathways (Strunk T et al., 2011).  
 S.aureus purified cell wall bound LTA  plays an important role during host 
bacterial infection by stimulating immune cells through TLR2, leading to production of 






Morath had shown that commercial LTA is of poor quality and purity and may not be 
biologically relevant (Morath et al., 2002). After exposure to S.aureus or LTA 
(purified), keratinocytes release IL1-β in the culture medium within 1 hour, which is the 
pre-formed IL1-β that is stored in the keratinocytes, and then newly synthesized protein is 
secreted within a time frame of 3 to 24 hours (Olaru et al., 2010).  
 Increased susceptibility to infections and S. aureus colonization in AD could be 
related to the dysfunction of host genes encoding proteins that regulate innate immune-
responses, including TLR (Howell et al, 2006). TLR2-mediated IL1-β and TNF-α 
production by CD14 monocytes was found to be selectively impaired in patients with 
AD. The most remarkable reduction in TLR2-mediated proinflammatory cytokine 
production was observed in CD14 monocytes, which are functionally defective in their 
capacity to produce proinflammtory cytokines on TLR2 stimuli (Hasannejad, H et al., 
2007). 
  The immune cells stimulation through TLR2 can be described, when a stable 
cells lines expressing TLR2 R753Q were constructed by transfecting with human 
PCDNA3.1- or TLR2-R753Q expression plasmid. In these cell lines, TLR2 coding region 
confirmed the changes from CGG to CAG at nucleotide position 2257. The TLR2-
R753Q transfected cells translating an amino acid substitution from arginine to glutamine 
at position 753 (R753Q) having a single nucleotide polymorphism (SNP). More than 
10% of patients with AD are heterozygous for TLR2-R753Q having a single nucleotide 
polymorphism (SNP). The TLR2 mutation modifies Toll-like receptor expression and 






(Mrabet-Dhabi et al., 2008).  The monocytes from AD patients with TLR-2 R753Q 
mutation produced significantly more IL-6 and IL-12 compared with that of AD patients 
with non-mutated TLR-2 upon stimulation with TLR-2 agonists (Niebuhr M et al., 
2008). The importance of TLR2 in controlling infections was observed in murine models 
where TLR2-deficient mice have a significantly higher mortality rate than wild-type 
mice, after intravenous administration of S. aureus (Osamu.Takeuchi et al., 2000). 
Atopic dermatitis patients having TLR2 mutations, and such as pathway may be needed 
to express antimicrobial factors, which could protect skin barrier.  
 Vitamin D is a well-known factor which plays a key role in the maintenance of 
skin barrier function in individuals with AD. Vitamin D3 is also essential for normal 
keratinocyte development and function (Bikll DD, et al, 2008).  The role of Vitamin D in 
inflammation was determined by Wang, when he described a strong molecular link 
between Vitamin D deficiency and the genetics of chronic inflammatory disease 
(Wang.T.T et al., 2004). The vitamin D nuclear receptor (VDR)  significantly affects 
229 human genes many of these genes have long been associated with autoimmune 
diseases, cancers and also leads to the synthesis of antimicrobial peptide.  A general 
appreciation for how 25-D and 1, 25-D competes for nuclear receptors gets to their 
opposing roles in the body. Under most circumstances, active form 1, 25- D act as the 
“on” switch and the inactive form, 25-D is the “off” switch. 25-D is not completely 
inactive, but it does not and cannot activate the VDR (Marshall, T. G et al., 2008). 
Exposure to injury and infection enhances production of 1, 25-D, which in turn leads to 






2011). The VDR activation by 1, 25 D, transcribes gene for the enzyme CYP24A1, which 
increases conversion of 1, 25-D into inactive metabolite. An activated VDR also controls 
1, 25-D concentration by limiting transcription of the gene CYP27B1, which converts 25-
D into 1, 25-D (Kato, S., and et al. 2007). The involvement of additional signalling 
pathways in the induction of AMP gene expression is especially important for the 
induction of the DEFB4 gene (hBD2). The induction of DEFB4 gene in macrophages 
requires TLR activation and the convergence of the IL-1β and vitamin D pathways 
(Adams, JS et al., 2009).  In this chapter I will study,  Vitamin D3 can protect the skin 
barrier against S. aureus secreted proteases, in fact a complete description of Vitamin D 
was presented in  chapter 1. The epidermal permeability barrier depends upon the 
transcellular and Paracellular pathways. The transcellular pathway leads across the apical 
and basolateral cell membrane, whereas the paracellular pathway is directed through the 
tight-junction (Tsukita S et al., 2001).  
 TJ’s are the main sealing site of the paracellular pathway in epithelia composes of 
four-transmembrane proteins (claudin, occluding, tricellulin and JAM). The TJ proteins 
along with barriers formation makes paracellular channels, which are in concert with 
membrane channels, regulate transport of ions both in health and disease state.  
Additional attention was drawn to the ion permeability of the paracellular pathway, as 
pathology of inflammatory or infectious diseases turned out to be caused by paracellular 
barrier defect (Mankertz, J., and J. D. Schulzke. 2007). The role played by vitamin D in 
the maintenance of skin barrier function can be detected by measuring the transepithelial 






expressions by vitamin D and permeability barrier function, I restored permeability 
barrier homeostasis artificially, by growing HaCaT cells on a transwell membrane.  
 Thus it is desirable to determine para- and transcellulr resistance separately. This 
cannot be achieved by conventional transepithelial resistance measurement. The fence 
function of the TJ is evaluated in monolayers cultured in transwell filters, by inserting a 
fluorescent label protein into the apical membrane and detecting if any fluorescent label 
reaches the bsolateral membrane .That’s why we presented FITC-alb approach which 
could optimize between these two pathways. The experiment design used most frequently 
in cell culture study of TJ protein function is either an overexpression or a knock-down of 
the TJ protein of interest. A study done by King where Claudin-1 knock-down increases 
TJ permeability to FITC dextran’s that has molecular weight in the range of  4 and 40 
kDa which is a typical size range for allergens (King TP et al., 1994). The SDS page gel 
and zymogen gel analysis of the supernatant collected from three strains of S.aureus (8325-4, 
RN6390, SH100) showed a peptide with molecular weight equal to V8 was able to damage the 
HaCaT cell monolayer.   
Aims: 
The epidermal permeability barrier can be maintained by the proper functioning 
of epidermal para- and transcellular pathways. The barrier damaged in AD caused by 
S.aureus protease interpreted as damage to the TJ (tight junction) proteins. After 
analyzing the role of S. aureus proteases as environmental factors in the pathogenesis of 
AD, now it is important to find their endogenous inhibitors to elucidate the pathogenesis 






4.2 Results  
 To test that how “S. epidermidis” a skin commensal maintained and protects the 
skin barrier, the suspension contained S.epidermidis was heated at 100°C for 30 minutes. 
It was described before; that S.epidermidis when heated at 100°C could release a cell wall 
component (Lipid S) into the liquid medium. To investigate the protective role played by 
S. epidermidis secreted lipid S, HaCaT cells monolayer was stimulated with 100 µL of 
heat killed S. epidermidis (HKSE) suspension  solution for twenty four hours (See page 
97). After twenty four hours HaCaT cells stimulated with HKSE suspenation solution 
were then exposed to supernatant of S.aureus strain 8325-4 for 12 hours. Yasuko had 
said that HaCaT cells can act as immune cells when stimulated with inducers. The 
increased production of proinflammatory mediators IL-10, TNF-α, and nitric oxide (NO) 
induced by UVB is mediated via the mitogen activated protein kinase (MAPK) signalling 
pathway in human keratinocyte (HaCaT) cells (Yasuko Mutou et al., 2010).  Morath had 
shown that commercially available S.aureus LTA is of poor quality and purity and may 
not be biologically relevant (Morath et al., 2002). I proposed that addition of pro-
inflammatory cytokine with S.aureus LTA, which may support the inducing action of 
LTA. Therefore I stimulated HaCaT cell monolayer with LTA in the presence of 
recombinant IL1β for 24 hours. HaCaT cell monolayers stimulated with IL1β/LTA were 








4.2.1 - HKSE stimulated HaCaT cells are protected from S. aureus protease.  
Normal HaCaT cells unstimulated and HaCaT cell monolayers stimulated with 
HKSE for 24 hours in SFM were exposed to supernatant of strain 8325-4 for 12 hours. It 
was observed that morphological changes started after 4 hours in HaCaT cells when 
exposed to supernatant of 8325-4. The process was on-going and voids and fissures 
appeared after 12 hours (Figure 4.1 b). Damage to the monolayer was so extensive that 
the whole monolayer was destroyed after 24 hours and remnants were floating in the 
media. In contrast, HaCaT cell monolayers first stimulated with HKSE were 
subsequently protected from the deleterious effect of the proteases present in the 
supernatant of 8325-4 after 12 hours (Figure 4.1 c).  
Percentage damage calculated by using Image J software shows where 
unstimulated, unexposed HaCaT cells had no damage. Unstimulated HaCaT cells 
monolayer exposed with 8324-5 supernatant had 30% more damage to the HaCaT cells 
monolayer compare with unstimulated, unexposed monolayer.  Whilst HaCaT cells 
stimulated with HKSE CM were 95 % protected compare with unstimulated, unexposed 











Figure- 4.1 HKSE stimulated HaCaT monolayer exposed to S. aureus CM.   
 DIC microscopy and with phalloidin-FITC staining revealed: (a) 
unstimulated HaCaT cells monolayer without exposure to proteases (b) Unstimulated 
HaCaT cell monolayers exposed to 0.004 DF supernatant of S. aureus wild type strains 
8325-4 for 12 hours. (c) HKSE (heat killed S.Epidermidis)-stimulated HaCaT cell 
monolayers exposed to 0.004 DF supernatant of S. aureus strains 8325-4 for 12 hours (d) 
percentage damage calculated by using Image J software. Data are representative of n=4 
experiments and performed with replicates. (1 way ANOVA) Magnification (100 X).  
Tukey's Multiple Comparison Test  
(Control-NH vs NH+ 0.004 DF supernatant of 8325- p **< 0.01) (Control-NH vs 
NH+HKSE- 0.004 DF supernatant ns)  (NH+ 0.004 DF supernatant of 8325 vs HKSE+ 






 4.2.2 IL1-β/LTA stimulated cells are protected from the S. aureus 
proteases.  
  I proposed that addition of recombinant IL1- β may support LTA in the 
protection against S. aureus-secreted proteases. Recombinant IL1-β-100 ng + LTA 5 µg 
(active) in 1mL of serum plus medium  was used to achieve protection against S. aureus-
secreted proteases. HaCaT cells were stimulated with IL1-β/LTA for 24 hours, discard 
the old medium and after gentle wash with PBS, added fresh SFM. Unstimulated and 
IL1-β/LTA stimulated HaCaT cell monolayers were exposed to supernatant of S.aureus 
wild type strain 8325-4 for 12 hours. 
  Control normal HhaCat cells (Fig 4.2 a).  Unstimulated HaCaT cells were unable 
to protect themselves against 4% supernatant of 8325-4, when exposed for 12 hours (Fig 
4.2 b). HaCaT cell monolayers stimulated with IL1-β/LTA were protected from the 
damaging effect of the proteases present in the 4% supernatant of 8325-4 (Fig 4.2 c). 
ImageJ statistical analysis shows Unstimulated HaCaT cells had 25 % damage caused by 
4% supernatant of 8325-4. Whilst IL1-β/LTA-stimulated HaCaT cell monolayers were 
protected and had only 4 % damaging effect of proteases from S. aureus strains 8325-4. 










Figure 4.2 IL1-β /LTA stimulated HaCaT cells exposed to S. aureus CM 
 DIC microscopy and phalloidin-FITC staining revealed: (a) unstimulated HaCaT 
cells without exposure to supernatant. (b) HaCaT cell monolayers, without IL1-β/LTA, 
exposed to 4% supernatant derived from S. aureus wild-type strains 8325-4 for 12 hours 
(c) 24 hours IL1-β/LTA-stimulated HaCaT cell monolayers exposed to 4% supernatant of 
8325-4 for 12 hours. (d) ImageJ statistical analysis Data is representative of n=4 
experiments and performed with replicates. (1 way ANOVA). 
Tukey's Multiple Comparison Test (Control-NH vs NH+8325-4 % supernat P ** < 
0.01) (Control-NH vs IL1-β/LTA +8325-4 % supernat P * < 0.05) (NH+8325-4 % 






4.2.3 Vitamin D3 can protect the skin barrier against S. aureus proteases  
Having shown that exposure to LTA and IL1β could protect the HaCaT cells 
monolayer against damage induced by S. aureus secreted virulence factors. I then aimed 
to establish whether the presence of Vitamin D3 (which is protective in atopic dermatitis) 
could also have a protective effect for HaCaT cells from S. aureus secreted proteases. In 
these studies protection was assessed both by visualization of monolayer damage caused 
by proteases and by measurement of TEER (Transepithelial electrical resistance) which is 
a very well known measure of tight junction (TJ) function. In other words, TEER of the 
monolayer is inversely proportion to the TJ permeability. Hence, as TJ becomes less 
permeable, the TEER is increased. Conversely, as permeability goes up, TEER is 
reduced. The use of HaCaT cells offers the possibility of measuring TJ function in 
response to S. aureus proteases in a simple assay. Therefore, to measure the effect of S. 
aureus proteases on TJ function, HaCaT cells were cultured on a transwell membrane.  
HaCaT cells were grown on transwells with a pore size of 0.45µm (See page 
112). Once HaCaT cells became confluent, the TEER was measured, both in 
unstimulated and stimulated monolayers, before the start of the experiment. Light 
microscopic examination revealed voids and holes formation in the unstimulated 
monolayer when exposed to 4µg/mL of V8 for 24 hour. When I measured the TEER, 
there was significant drop in the TEER reading in unstimulated monolayer when exposed 
to 4µg/mL of V8 for 24 hour (Fig 4.3 b). In contrast, 25 OH Vitamin D3 -pre-stimulated 
HaCaT monolayers, TEER was increased and there was no damage to the monolayer 






monolayer treated with 1, 25 OH Vitamin D3 and there was no damage to the monolayer 
after exposing with 4µg/mL of V8 for 24 hours (Fig 4.3 d).  Control unstimulated and 
unexposed normal HaCaT cell monolayer had resistance of 100 ± 30 ohms cm2.  
Whereas HaCaT cell monolayer exposed to 4µg/mL of V8 resistance was dropped up to 
50 ± 30 ohms cm2. HaCaT cell monolayer stimulated with 25 OH Vitamin D3 then 
exposed to 4µg/mL of V8 had resistance of 150 ± 30 ohms cm2, which was slightly more 
than the control. HaCaT cell monolayer stimulated with 1, 25 OH Vitamin D3 then 
exposed to 4µg/mL of V8, there was gain in the resistance and raised up to 200 ± 30  
ohms cm2 (Fig 4.3 e). It was observed that Vitamin D stimulated HaCaT cells monolayer 















Figure 4.3 Vitamin D stimulated HaCaT cells protected from V8  
HaCaT cells were grown on the Transwells with a mesh size of 0.45µm. (a) negative 
control, HaCaT cell monolayers not exposed to V8. (b) Positive control HaCaT cells 
exposed to 4 µg/mL of V8 for 24 hours. (c) HaCaT cell monolayers stimulated with 200 
nM 25 OH Vitamin D3 for 24 hours then exposed to 4 µg/mL of V8 for another 24 hours. 
(d) HaCaT cell monolayers stimulated with 200nM 1, 25 OH Vitamin D3 for 24 hours, 
then exposed to 4 µg/mL of V8 for another 24 hours. (e) The difference in TEER of all 
the monolayers was measured with an ohm meter before and after the experiment. Data 
are representative of n=3 experiments and performed with replicates. (1 way ANOVA) 
Tukey's Multiple Comparison Test  
(Control-NH vs NH+ V8-4mg/mL P * < 0.05) (Control-NH vs NH+25 OH D3-200nM + 






 4.2.4 Vitamin D3 and IL1-β/LTA- stimulated HaCaT cells' upregulate hBD2  
 In my previous experiments it has been shown that HaCaT cells were indirectly 
protected after stimulation with Vitamin D3 and IL1-β/LTA. It needs to find out the 
factor which is expressed after stimulation with Vitamin D3 and IL1-β/LTA. An ELISA 
was performed to examine the localization of the factor induced by HaCaT cells after 
stimulation with Vitamin D3 and IL1-β/LTA.  
 In this experiment, I used the following conditions: Wild type (Normal HaCaT 
cells) unstimulated and Wild type HaCaT cells stimulated with IL1-β/LTA and Vitamin 
D3 separately for 24 hours.  All the cells, including unstimulated and stimulated were 
lysed after 24 hours.    The concentration of hBD2 present in the lysate collected from 
unstimulated and IL1-β/LTA or Vitamin D-stimulated HaCaT cells, was analysed by 
sandwich ELISA. There was a difference between the hBD2 concentration which was 
found in the lysate collected from stimulated and unstimulated samples. The lysate 
obtained from unstimulated HaCaT cells contained 222 pg/mL of hBD2. IL1-β/LTA-
stimulated HaCaT cell lysate contained 357 pg/ mL. Vitamin D3 stimulated HaCaT cell 
contained 728 pg/mL which is the highest concentration of hBD2 compare to other (Fig 
5.1). The ELISA results give us a simple association that there is more hBD2 secretion in 









Figure 4.4: Increased hBD2 secretion by stimulating the cells detected by 
ELISA  
 Unstimulated normal HaCaT wild type (WT). Normal HaCaT cells were 
stimulated with (100ng+5µg) of IL1-β/LTA and (200 nM) of 1, 25 OH Vitamin D3 
separately for 24 hours.  ELISA was performed with the lysate from unstimulated WT 
HaCaT cells, IL1-β/LTA and 1, 25 OH Vitamin D3 stimulated cells. Data is 
representative of n=3 experiments and always performed with replicates (1 way 
ANOVA) 
Tukey's Multiple Comparison Test: (WT vs WT-stimulated with ILIβ/LTA P > ns) 







4.2.5 Restoration of permeability barrier homeostasis with FITC-albumin 
Thus to determine para- and transcellulr resistance separately, which cannot be achieved 
by conventional transepitlial resistance measurement (See page 112). We used FITC-alb 
approach to optimize the effect of S.aureus proteases on the permeability barrier in 
HaCaT cell monolayer by using trancellular pathways. Artificial permeability barrier 
homeostasis was quantified by using FITC-alb fluorescence dye.  FITC-alb dye 
transportation facilitated across the transcellular gaps produced by 4 and 8 µg/mL of V8 
protease. Untreated and  HaCaT cell monolayer treated  with hBD2 were  exposed to V8 
protease for 24 hours.The rate of FITC-albumin transference across the monolayer which 
was calculated in the sense of change in the florescence intensity  and reading are 
presented here after deducting base reading of empty wells (Fig 4.5 a).    
 To differentiate the FITC-alb cleavage by V8 protease, percentage difference in 
the fluorescence intensity was calculated. Where Empty well + FITC-alb+ V8-8mg/mL 
refered as a 100 % having maximum increase in the in the fluorescence intensity (Fig 4.5 
b). I observed there was not significant differences in the FITC-alb transference in the 










Figure- 4.5 FITC-albumin assay quantitative measure for HaCaT cell 
permeability. HaCaT cells grew on the 0.45µM pore-size transwell, with cell density of 
2x105 cells. (a) After 24 hours of exposure to monolayer with 4µg/mL and 8µg/mL was 
quantitated by the rate of FITC-albumin transference across the monolayer which was 
calculated in the sense of change in the fluorescence intensity. NH + 4µg/mL and 
8µg/mL of V8, synthetic hBD2 (s hBD2), Cysteine-replaced-with-serine linear hBD2 (C-
S), or scrambled hBD2 (SCB).  Over-expressing hBD2 stable HaCaT cell monolayers, 
Empty well + FITC- alb, Empty well + FITC-alb+ V8-8mg/mL after  24 hours A. 
(b) After 24 hours the percentage difference in the fluorescence intensity calculated 
where Empty well + FITC-alb+ V8-8mg/mL refered as a 100 % having maximum 







Tukey's Multiple Comparison Test 
    (NH vs NH+V8-4mg/mL P > 0.05)  (NH vs shBD2+V8-4mg/mL  P > 0.05) (NH 
vs C-S-hBD2+V8-4mg/mL P > 0.05) (NH vs SCB-Peptide+V8-4mg/mL P<0.05)(NHvs 
hBD2OE+V8-4mg/mL P > 0.05)  (NH vs NH+V8-8mg/mL P < 0.01)  (NH vs 
shBD2+V8-8mg/mL P > 0.05) ( NH vs C-S-hBD2+V8-8mg/mL P < 0.05) (NH vs SCB-
Peptide+V8-8mg/mL  P < 0.05) (NH vs hBD2OE+V8-8mg/mL P > 0.05) (NH vs EW-
















In addition to damaging the epidermal permeability barrier, S. aureus proteases 
aggravated the antimicrobial barrier by degrading adhesion junctions and tight junction 
proteins (Amagai and Stanley, 2000).  After a series of experiments I observed that S. 
aureus-secreted proteases present in the supernatant could be the virulence factors which 
work on their specific targets against HaCaT cell monolayers as stated before by 
Amagai.  
 S. epidermidis is a skin commensal, known to secrete Lipid S which plays an 
important role during host bacterial infection by stimulating immune cells through TLR2. 
Lipid S induces up-regulation of skin antibacterial defense mechanisms, which protect 
against S. aureus infections (Jones et al., 2005). I observed that HKSE-stimulated HaCaT 
cells were protected from the deleterious effect of the proteases present in the supernatant 
and V8 protease, while control unstimulated HaCaT cells were not protected. This 
protection of the HaCaT cell monolayer could be due to the secretory LTA (lipid S), 
which would expected to be present in the heat-killed S. epidermidis (HKSE) solution.  I 
used recombinant S.aureus LTA, in order to testify the role S.aureus LTA in the 
protection of HaCaT cells from the deleterious effect of the proteases present in the 
supernatant and V8 protease. The common molecular architecture of LTA consists of a 
diacyleglycerol- containing glycolipid anchor and a covalently coupled polymeric 
backbone structure.  However, LTA from different gram positive species have been 
found to differ in the chemical composition of the repeating units of the polymeric 






linked to a central linear 1-3 linked polyglycerolphosphate chain (Fischer W et al., 1994) 
.S.aureus LTA by itself in multiple experiments did not provide good protection against 
S. aureus proteases (data not presented). Morath had shown that commercial LTA is of 
poor quality and purity and may not be biologically relevant (Morath et al., 2002). A 
study has shown that during S.aureus infection keratinocytes respond by secreating 
cationic peptide, which can interact with LTA (Scott MG et al., 1999). I observed that 
HaCaT cells exposed to LTA in the presence of recombinant IL1-β provides better 
protection against S. aureus-secreted proteases by expressing a secreted factor. IL1-
β/LTA stimulated HaCaT cells were very well protected from deleterious effects of 
proteases present in the supernatant, and in addition this blocked the damaging effect of 
neat V8 protease (fig 4.2 page 155).  
 TLR2s are the key pathogen recognition receptors, correlated with S. 
aureus colonization, infection and increased disease severity due to modulation of the 
innate and adaptive responses (Ahmad-Nejad et al., 2004).  TLR2 is considered to be a 
critical ligand for host cell recognition of S. aureus and LTA, which alters the expression 
of pro-inflammatory mediators through activation of gene transcription factors such as 
NF-κB. 
  TLR2 single nucleotide polymorphism is found in 10% of AD patients, which 
can cause alteration of TLR2 function. Diminish, host signaling and host cell-pathogen 
interactions due to altered TLR2 surface ligands could result in the down regulation of 
antibacterial defense mechanism (Lorenz et al., 2000). Individuals with AD carrying 






vitamin D3 could play a role in this regard. Bikle had found that vitamin D3 (1, 25-D) is 
an important factor essential for normal keratinocyte development and function which 
plays a key role in the maintenance of skin barrier function in individuals with AD (Bikle 
DD, et al, 2008).   
 In addition, 1, 25-D has been suggested to increase innate immunity in skin and to 
enable efficient antimicrobial defines at epithelial surfaces (Schauber J&Gallo RL, 
2007). Here, for the first time, we present a mechanistic insight into how 25-D and 1, 25-
D can protect the skin barrier against S. aureus-secreted proteases by promoting 
expression of a protective factor.  I found that 25-D and 1, 25-D-stimulated HaCaT cells 
were protected from the deleterious effects of V8 protease, whilst unstimulated HaCaT 
cells were not protected. In this experiment TEER measurement of the unstimulated and 
unexposed normal HaCaT cell monolayer was considered as a control. The TEER 
reading was dropped in the HaCaT cell monolayer exposed to 4µg/mL of V8 protease.  
Instead HaCaT cell monolayer resistant was increased when stimulating them with 25-D 
and 1, 25-D before exposing to 4µg/mL of V8 (Fig 4.3 e). Although 25-D and 1, 25-D 
share similar binding affinity for VDR but activation of VDR receptor is achieved by a 
delicate balance between the concentration of a number of endogenous hormones 
(Marshall, T. G et al., 2008).  
 Moreover, the antimicrobial barrier (AMB) and permeability barrier are linked 
because both water loss and pathogen invasion occur by the breakdown of intercellular 
junctions, present in the lipid matrix (Borkowski et al., 2011).  As previously mentioned 






maintenance of barrier functions in AD. I tested the supportive role played by pro-
inflammatory cytokine IL1-β in the presence of LTA which by secreting unknown factor 
protect, HaCaT cell monolayer from S. aureus secreted proteases.  The factor which 
protects the HaCaT cell monolayer from S.aureus secreted protease by acting as a 
protease inhibitor could be used for the maintenance of barrier function in AD. 
  An ELISA was performed to examine the localization of factor induced by 
HaCaT cells after stimulation with Vitamin D3 and IL1-β/LTA (Fig 4.4 page160). The 
cationic nature of hBD2, possess its high affinity for charge polar head group of lipid. It 
may say, secreted hBD2 rapidly interact with extracellular lipid which cause coating of 
the plasma membrane with hBD2. I observed that by increasing stimulation time majority 
of hBD2 is cell-associated compared with its presence in the supernatant. At each time 
point supernatant and cell lysate was collected to analyse hBD2 by ELISA. 
 To assess, directly, the link between hBD2 expression and permeability barrier 
function, I restored permeability barrier homeostasis artificially, by growing HaCaT cells 
on a transwell membrane.  In order to prevent   alteration in permeability barrier I grew 
normal HaCaT cells in different wells. 90% confluent normal HaCaT cells were 
pretreated with 4 µg/mL of synthetic hBD2, C-S hBD2, SCB scrambled peptide and 
hBD2 over-expressing HaCaT cell-lines were exposed with 4 and 8 µg/mL of V8 
protease. Next, 1 tested permeability barrier homeostasis, by growing hBD2 over-






 Artificial permeability barrier homeostasis was quantified by using FITC-
alb fluorescence dye (Wischke et al., 2005).  FITC-alb dye transportation was facilitated 
across the transcellular gaps produced by 4 and 8 µg/mL of V8 protease. The rate of 
FITC-alb dye transportation across the disturbed barrier was quantitated by measuring 
OD with spectrophotometer after 24 hours (Figure- 4.5 ). Altogether, these data suggest 
that S. aureus proteases along with damaging the HaCaT cell monolayer also cause 
increased degradation of Fitc-alb. Using FITC-alb technique, it is not possible to 
accurately quantify structural damage to HaCaT cell monolayer, caused by S. aureus 
proteases. 
4.4 Conclusion  
 I assessed the effect that IL1-β has, in the context of LTA, on the susceptibility of 
HaCaT cells to damage by S.aureus secreated proteases by upregulating hBD2. 
S. epidermidis is a skin commensal that secrets lipid S a short chain length of cell 
wall LTA, thought to up regulate the expression and secretion of  a peptide after binding 
to the toll-like receptor, TLR2.  I used IL1-β has, in the context of LTA  solution to 
stimulate HaCaT to upregulating hBD2 which protect monolayer from S.aureus 
proteases. In addition, Vitamin D-stimulated cells upregulating hBD2 in the CM which 
protects the monolayer. In order to identify that hBD2 is upregulated after stimulation 







5- Identification of a factor produced by HaCaT cell having 
antiprotease action:  
5.1 Introduction  
 Atopic dermatitis patients are more prone to S. aureus infection, which could be 
due to the down-regulation of antibacterial defense (Gambichler T et al., 2008). The 
data described in chapter 4 suggested that HaCaT cells expressed a protective factor 
when being stimulated with Vitamin D3, HKSE and IL1-β/LTA. That factor expressed 
by HaCaT cells protected the monolayer from the S. aureus-secreted proteases.  
 S.aureus cell wall components Peptidoglycan (PGN) and Lipoteichoic acid (LTA) 
play an important role during host bacterial infection by stimulating immune cells 
through TLR2. The PGN and LTA lead to the production of IL1-β which contributes host 
defense against invading microbes (Morath et al., 2001). The Peptidoglycan (PGN) is a 
large polymer consisting of glycan strands of N-acetyl glucosamine and N-acetyl 
muramic acid that are cross-linked by Pentaglycine Bridge to form a 3-dimentional 
framework. The innate immune receptor stimulated specifically by PGN is still an issue 
of debate (Inohara N., Nunez G 2005). An interaction of S.aureus PGN with TLR2 has 
been suggested, but extensive purification of PGN eliminated TLR2 signaling 
(Travassos L. H., Boneca I. G 2004). Thus, it was concluded that LPP (lipopeptides) 
and other yet unidentified contaminants are responsible for PGN activity on TLR2 
(Inohara N., Nunez G 2005). However, differences in the procedure used to isolate and 






activity of PGN. CD14 may act as a TLR co-receptor by interacting with S.aureus LTA, 
PGN and enhancing TLR2 activation.  Since S.aureus LTA, PGN and Lipopeptides have 
distinctive biochemical structure; it was unclear how one receptor could recognize such a 
broad spectrum of molecules. 
   As mentioned before, defense against S. aureus can be promoted by 
antimicrobial peptides and proteins (e.g. defensins, elafin, SLPI and cathelicidin). Atopic 
dermatitis patients are more prone to S. aureus infection, which could be due to the 
down-regulation of antibacterial defense (Gambichler T et al., 2008).  In normal 
conditions, keratinocytes express very low levels of AMP, but during infection, 
inflammation, and wounding their expression is up-regulated and AMP accumulate in 
lamellar bodies of the stratum granulosum of the epidermis (Gallo RL et al., 2002). 
There are different mechanisms described for the down-regulation of antimicrobial 
peptides (AMP). One study described how abnormal extrusion of the contents of the 
lamellar body in the dried skin areas of atopic dermatitis patients may lead to a 
permeability barrier abnormality (Fartasc h M et al., 1992).  Lai and Gallo said 
keratinocytes are the main source of antibacterial defense in normal human skin, but 
when skin becomes inflamed, recruited leukocytes contribute the majority of 
antimicrobial activity (Lai Y and Gallo, 2009).  
 It was also observed that amount of hBD2 secretion is different in different 
conditions. Psoriasis is an autoimmune disease with inflammatory condition in which 
patient have dry raised, red areas covered with silver color scaly patches appear on the 






a combination of the genes that cause psoriasis and be exposed to specific external factors 
known as “triggers” such as, stress, injury, medication and infection. A previous study 
described the presence of abundant AMP in the epidermis of all patients with psoriasis; 
prevent them from skin infection however these peptides were significantly decreased in 
the lesions from patients with AD (Ong PY et al., 2002). Therefore, it is needed some 
external factor that can up-regulate skin anti-bacterial defense mechanisms, which protect 
against S. aureus infections, that external factor could be LTA (Jones KJ et al., 2005).  
 The second most important factor that can cause reduce expression of hBD2 in 
atopic dermatitis patient is TLR2 mutation. There is evidence of TLR2 mutation in atopic 
dermatitis, which can cause alterations in TLR2 surface ligands that may diminish host 
signaling and host cell-pathogen interactions, resulting in the down-regulation of 
antimicrobial defense (Lorenz E et al., 2000).  
 The importance of Vitamin D has been observed when inflammation in 
individuals with AD was reduced with UVB radiation (Bikle DD, et al, 2004). 1, 25 OH 
D3 regulates keratinocyte proliferation, differentiation and the formation of intact 
epidermal barrier.  Alteration in local vitamin D3 concentration and or activation will 
likely affect normal cutaneous immune function, barrier function and inflammation 
(Bikle DD, et al, 2004). Data presented in chapter 4 described how Vitamin D-stimulated 
HaCaT cells protected from S. aureus-secreted proteases (Figure 4.3 158). The AD 
patints having TLR2 mutation, vitamin D3 could be a fundamental external factor, 
require for hBD2 expression (cross reference). Synthesis of pre-vitamin D3 from 7-






dehydrocholestrol into calcitriol, pre-vitamin D3. To form the active hormone, calcitriol 
must be hydroxylated twice to form calcidal (25 hydroxy vitamin D3, 25 D3) and finally 
active calcitriol (1, 25 dihydroxy vitamin D3, 1, 25 D3) (Prosser DE, et al., 2004). 
Keratinocytes express two enzymes (CYP27A1) and (CYP27B1) that are capable of 
producing active 1, 25 OH D3 independent of renal and hepatic hydroxylation steps. The 
vitamin D3 is made in different layers of the epidermis, primarily in the stratum basale 
(Bikle DD et al., 2008)    
 Narrow band (NB-UVB) improves Vitamin D balance (described in the above 
paragraph) which alters antimicrobial peptide (AMP) expression in skin lesions of 
psoriasis patients and individuals with AD (Vahavihu et al., 2010). It is known that, 
Vitamin D3 upregulate antimicrobial peptide expression.  Though vitamin D3 has been 
suggested to increase innate immunity in skin and to enable efficient antimicrobial 
defense at epithelial surfaces (Schauber J&Gallo RL, 2007). Along with inducer of 
innate immunity Vitamin D3 is considered an important factor, essential for normal 
keratinocyte development and function (Bikll DD, et al, 2008).  
  After ELISA results, (Figure 4.4 page 160) we found there was significant 
increase in hBD2 secretion after stimulating with Vitamin D3. As a consequence of our 
ELISA results I planned to knock down hBD2 which expresses by HaCaT cells. The 
protective response by knocked down HaCaT cells (Figure 5.3 page 179) will be re-






 I hypothesized that the over-expression of antimicrobial peptide (AMP) may be 
an important factor which provides protection against S.aureus secreted proteases.  To 
find out how HaCaT cell can be protect from the proteases in the presence or absence of 
AMP. I will assess the responses of HaCaT cell against S.aureus secreted proteases, when 
HaCaT cell will be knocking-down by siRNA using siRNA transfection (Figure 5.3page 
179). hBD2 overexpressing HaCaT cells stable line can be made by transfecting HaCaT 
cells with DEFB4 gene plasmid.  For this purpose QRT-PCR will be performed for 
DEFB4 gene expression which was normalised to 18S ribosomal RNA (See page 114). 
The protection against S.aureus proteases was tested when hBD2 overexpressing HaCaT 
cell lines exposed to proteases.  
5.2 Results 
5.2.1 Immunohistochemistry shows IL1-β/LTA up-regulate hBD2 
expression.  
To determine whether IL1-β/LTA stimulated HaCaT cells shows an increase in the expression 
and secretion of hBD2, Immunohistochemistry experiment was conducted (See Page # 104).  
HaCaT cells were seeded with a density of 2x105 cells in chamber wells plates and grown to 
confluence, and werthen stimulated with IL1-β/LTA for 24 hours.  Unstimulated and stimulated 
monolayers were fixed and stained with Phalloidin and DAPI, afterincubation with anti- hBD2 
primary and appropriate secondary antibodies.  Photographs were taken by confocal laser 
microscope where it appears the presence of hBD2 in the cytoplasm of.The  unstimulated 






distribution of hBD2 peptide in unstimulated control cells compared with IL1-β/LTA stimulated 
HaCaT cells. The morphological appearances of hBD2 induction in IL1-β/LTA-stimulated 
HaCaT cells were different from the unstimulated cells (Fig 5.1 b).  Moreover, stimulated cells 
have punctate particles in the cytoplasm and on the outside of the membrane, but not condensed 
around the nucleus (Fig 5.1 c).  The immunostaining of perinuclearly distributed punctuate 
particles were suggestive of endoplasmic reticulum and Golgi apparatus localisation, which was 
a character of secreted, single peptide product. Realistically after viewing the photograph, it 
looks like hBD2 peptide disperses out from the stimulated cells into the cytoplasm. The 
secretory phase of hBD2 in the stimulated cells was followed by the phase where hBD2 was 
viewed as bound to the plasma membrane.  These findings showed the secretory pattern of 
hBD2 peptide in the vast majority of HaCaT cells. I would say that hBD2 induction in HaCaT 
cells can be quantified in two different ways. First, induction of hBD2 peptide in unstimulated 
and stimulated HaCaT cells, which can be differentiated by their pattern of distribution. Second, 
both unstimulated and stimulated HaCaT cells can be quantified by counting the number of cells 







Figure-5.1 Immunohistochemistry to differentiate hBD2 secretion by IL1-
β/LTA stimulation. HaCaT cells were incubated with primary antibody (1°) and 
appropriate secondary antibody (2°). Phalloidin and DAPI staining were also visible in 
that picture. (a) Unstimulated HaCaT cells were incubated with secondary antibody only. 
(b)  Unstimulated HaCaT cells incubated with primary and appropriate secondary 
antibodies. (c) IL1-β/LTA-stimulated cells incubated with primary and appropriate 
secondary antibodies. (d) ImageJ quantification of the total cell fluorescence corrected by 
taking off the background revealed a prominent increase in corrected total cell 
fluorescence (CTCF) count, in IL1-β/LTA-stimulated HaCaT cells. Data is representative 
of n= 3 experiments and always performed with replicates (one way ANOVA). 
Magnification X400.    Tukey's Multiple Comparison Test: (Control-NH vs NH-
unstimulated P > 0.05) (Control-NH vs IL1-β/LTA-stimulated P < 0.01) (NH-






5.2.2 Immunofluorescence analysis to visualize the extent of damage to 
Claudin-1 caused by S.aureus-secreted proteases-HaCaT cells were seeded 
with a density of 2x105 cells/350µL in the chamber wells plate and grown to confluence.  
HaCaT cell monolayer exposed with 4 and 8µg/mL of V8 for twenty four hours. 
Unexposed and exposed monolayer’s were fixed after 24 hours and then incubated with 
appropriate primary and secondary antibodies.  HaCaT cell monolayer in the chambers 
wells plate was stained with phalloidin-FITC and DAPI to evaluate changes in the 
epidermal cytoskeleton.  Photographs were taken by confocal laser microscope. 
Immunostaining (See page # 105)  at the cell-cell borders was reduced when HaCaT cells 
were exposed to 4 and 8 µg/mL of V8 for 24 hours. Control unexposed HaCaT cell 
monolayer’s did not show breakage of the cell cytoskeleton when looked with confocal 
laser microscope (Fig 5.2 a). HaCaT cell monolayer’s exposed to 4 µg/mL of V8, which 
causes cells to retract from each other when tight junctions were broken, ultimately it 
make holes formation in the monolayer (Fig 5.2 b). There was significant damage to the 
HaCaT cell monolayer with 8 µg/mL of V8 after 24 hours of exposure which results in 
bigger holes formation in the monolayer (Fig 5.2 c). The percentage damage to HaCaT 
cell monolayer when exposed with 4 and 8µg/mL of V8 was calculated by using Image J 
software (Fig 5.2 d).  There was no damage to unexposed normal HaCaT cell monolayer.  
The HaCaT cell monolayer exposed to 4µg/mL of V8 had 25 % damage and HaCaT cell 
monolayer exposed to 8µg/mL of V8 had 40% damage compare to control. The damage 
to the monolayer resulted in the loss of cells at that area and creates gaps in HaCaT cell 
monolayer.  Therefore due to loss of cells in the damaged area of monolayer, there will 







Figure 5.2 Immunofluorescence analysis after exposing HaCaT cell 
monolayer to V8 protease-HaCaT cell monolayer exposed with 4 and 8µg/mL of V8 
for twenty four hours. Unexposed and exposed monolayer’s were fixed after 24 hours and 
then incubated with appropriate primary and secondary antibodies.  All the chambers 
were stained with phalloidin-FITC and DAPI to evaluate changes in the HaCaT cell 
monolayer cytoskeleton.  (a) Control normal unexposed HaCaT cells stained with 
primary claudin-1 antibody and secondary antibody (Control-NH; n=4). (b) Normal 
HaCaT cells exposed to 4µg/mL of V8 (V8-4µg/mL; n=4). (c)  Normal HaCaT cells 
exposed to 8µg/mL of V8 (V8-8µg/mL; n=4). (d) Image J quantification of the 
percentage damaged caused by exposing normal HaCaT cells with 4 and 8µg/mL of V8. 
Data are shown as mean fold change (+/- SEM) over unexposed cells magnification 
X200. (One way ANOVA)  
Tukey's Multiple Comparison Test 
  (Control-NH vs NH+V8-4µg/mL P < 0.01)  (Control-NH vs NH+V8-8µg/mL P < 






5.2.3 hBD2 siRNA knockdown ablates the protective response in HaCaT 
cells  
I hypothesized that hBD2 was the key protective factor released in response to IL1-β/ 
LTA stimulation of HaCaT cells.  Sandwich ELISA (Ssee page # 100) confirmed that 
hBD2 was expressed by the HaCaT cells with IL1-β/ LTA and Vitamin D3 stimulation.  
In order to determine the protective effect of hBD2, it was knocked it down with hBD2-
siRNA (cross ref).  For the knock-down assay, HaCaT cells were transfected with control 
and hBD2 -siRNA.  After two days of transfection, HaCaT cell monolayers were exposed 
to 4µg/mL of V8 protease for twenty four hours.  In the absence of IL-1 β/ LTA 
stimulation, both control and hBD2 -siRNA transfected HaCaT cells were unable to 
protect the monolayer from the deleterious effect of V8 (Fig 5.3 a-c).  Control and hBD2 
-siRNA transfected HaCaT cells were stimulated with (IL1-β 100ng/ LTA 5µg) in 1 mL 
of culture medium for 24 hours, and then exposed with 4µg/mL of V8 for another 24 
hours. Control siRNA transfected HaCaT cells stimulated with IL1-β/LTA protect the 
monolayer from the deleterious effect of V8 (Fig 5.3 b). However, hBD2 siRNA blocked 
the protection afforded by IL1-β/LTA stimulation (Fig 5.3 d). Demonstrating that hBD2 
expression in response to these stimuli was required for the protective phenotype. 
Percentage damage caused by V8 protease calculated by image J software which is the 
(mean +/- SD) (Fig 5.3 e). Where (control siRNA +V8) has 15 % damage, (hBD2 
siRNA+V8) has 20 %, (control siRNA + IL1-β/LTA +V8) has no damage normal 








Figure 5.3: hBD2 siRNA transfected HaCaT cells exposed with V8 protease. 
Freshly seeded HaCaT cells were transfected with control and hBD2 -siRNA separately.   
90% confluent transfected HaCaT cells were exposed to 4 µg/mL of V8 for 24 hours.  
DIC microscopic images revealed (a) Control siRNA transfected HaCaT cells was 
exposed to 4µg/mL of V8 protease for 24 hours. (b) IL1-β/LTA stimulated, control 
siRNA transfected HaCaT cells was exposed to 4µg/mL of V8 protease for 24 hours. (c) 
hBD2 siRNA transfected HaCaT cells monolayer was exposed to 4µg/mL of V8 protease 
for 24 hours. (d) IL1-β/LTA stimulated hBD2 siRNA transfected HaCaT cells monolayer 
was exposed to 4µg/mL of V8 protease for 24 hours. (e) Size of the holes revealed the 
extent of damage to the HaCaT cell monolayer, percentage damage to the monolayer was 
calculated by using Image J software. Data are representative of n=3 experiments and 






Tukey's Multiple Comparison Post test; (Control-siRNA+V8vs Control-
siRNA+IL1b/LTA+V8 P<0.05) (Control-siRNA+V8 vs DEFB4-siRNA+V8 P = ns)  
(Control-siRNA+V8 vs 
DEFB4-siRNA+IL1b/LTA+V8P = ns) (Control siRNA+IL1b/LTA+V8vsDEFB4-


















5.2.4 hBD2-over-expressed HaCaT cells are protected of 8325-4 and V8 
protease - In order to further explore the role of hBD2 in protecting HaCaT cells from 
S. aureus proteases, I assessed the responses of HaCaT cell lines that over-expressed 
hBD2 (See page # 101).  The wild type normal HaCaT cells monolayers (Figure 5.5 a).  
The wild type normal HaCaT cells monolayer exposed to 0.04 DF supernatant of 8325-4 
for 12 hours (Figure 5.5 b) and HaCaT cells over-expressing hBD2 monolayers were 
exposed to 0.04 DF supernatant of 8325-4 for 12 hours (Figure 5.5 c). Despite the 
protective effects afforded by over-expression of hBD2 against the proteases in the 
supernatant, I tested the protective effect against recombinant V8. The wild type normal 
HaCaT cells monolayers and HaCaT cells over-expressing hBD2 were exposed to 4-
µg/mL of V8 for 24 hours. The wild type normal HaCaT cells monolayers were unable to 
protect from V8 and there were holes formation through the monolayer (Fig 5.5 d). 
whilst hBD2 over-expressing HaCaT cells were protected from V8 protease (Fig 5.5 e) 
percentage damage to the HaCaT cell monolayer by 0.04 DF supernatant of 8325-4 and 
recombinant V8 protease was quantitated with ImageJ software (Fig 5.5 f) (WT- Normal 
HaCaT +0.04 DF supernatant of 8325-4 for 12 hours has 25% damage) (hBD2 over-
expressing HaCaT cell monolayers + 0.04 DF supernatant of 8325-4 for12 hours has 7% 
damage) (WT-Normal HaCaT cell monolayers+ 4-µg/mL of V8 for 24 hours has 30%  
damage) (hBD2 over-expressing HaCaT cell monolayers + 4-µg/mL of V8 for 24 hours 
has 5 % damage) (Fig 5.5 f) The wild type normal HaCaT cells monolayers were not able 
to block the effect of proteases present in the 0.04 DF supernatant of 8325-4, whilst over-
expressing hBD2 monolayers almost completely blocked the effect of proteases present 







Figure 5.4 hBD2 over-expressing HaCaT cells exposed to 8325-4 CM and V8  
DIC microscopic images revealed (a) unexposed, wild type (WT) normal HaCaT cells. 
(b) WT- Normal HaCaT cell monolayers were exposed to 0.04 DF supernatant of 8325-4 
for 12 hours (c) hBD2 over-expressing HaCaT cell monolayers were exposed to 0.04 DF 
supernatant of 8325-4 for12 hours. (d) WT-Normal HaCaT cell monolayers were exposed 
to 4-µg/mL of V8 for 24 hours. (e) hBD2 over-expressing HaCaT cell monolayers were 
exposed to 4-µg/mL of V8 for 24 hours (f) percentage damage to the HaCaT cell 
monolayer by 0.04 DF supernatant of 8325-4 and V8 protease was quantitated with 
ImageJ software. Data are representative of n=3 experiments and always performed with 
replicates at Magnification X400 (One way ANOVA) Tukey's Multiple Comparison 
Test-(Control-NHvsNH+0.04DF-8325-12hP<0.001)(Control-NHvshBD2-overexpress 
HaCaT+0.04DF-8325-4 P>0.05)(Control-NH vs NH+V8-4mg/mLP<0.001)(Control-NH 






5.2.5 - DEFB4 gene expression in hBD2 or hBD3 over-expressing HaCaT 
cell lines and wild type HaCaT cells when stimulated with IL1-β 
 As mention before control and hBD2-siRNA transfected HaCaT cells were unable 
to protect the monolayer from the deleterious effect of V8 (Fig 5.3 a-b). When control 
and hBD2-siRNA transfected HaCaT cells were stimulated with (IL1-β/ LTA) and then 
exposing with V8, only control siRNA transfected HaCaT cells stimulated with IL1-
β/LTA was protective.The wild type normal HaCaT cells monolayers were unable to 
block the effect of proteases, whilst over-expressing hBD2 monolayers almost 
completely blocked the effect of proteases present in the supernatant of 8325-4. To 
further investigate this, whether hBD2 peptide encoded by DEFB4 gene expression 
varied in stimulated and unstimulated HaCaT cells as well as in hBD2 over-expressing 
HaCaT cells QRT-PCR was performed. Source, Homo sapiens defensin, (DEFB4) 
mRNA, NCBI reference sequence: NM 004942, with size of 336 bp mRNA linear PRI. 
Version NM004942.2 GI; 13124885, keyword Refseq. For this purpose DEFB4 gene 
expression was normalised to 18S ribosomal RNA. RNA was prepared from untreated 
HaCaT cells and cells stimulated with IL-1β 100 ng/ml for 48 hours. RNA was also 
prepared from HaCaT cells stable line made by transfected with DEFB4 gene plasmid to 
over express hBD2.The hBD3 over-expressing HaCaT stable cell line was made by 
transfecting with DEFB103 gene plasmid to overexpress hBD3. We observed that the 
hBD2 over-expressing cell-line expressed DEFB4 gene which was higher than the IL-1β 
stimulated HaCaT cells (Fig 5.6), these results are consistent with the changes in the 








Figure 5.5 Assessment of DEFB4 transcription in HaCaT cells  
RNA was prepared from untreated HaCaT cells (WT; n=3), HaCaT cells stimulated with 
IL-1β 100 ng/ml for 48 hours (WT IL-1 β 100 ng/ml; n=3), HaCaT cells transfected with 
a DEFB4 gene plasmid to overexpress hBD2 (hBD2 stable line; n=3) and HaCaT cells 
transfected with a DEFB103 gene plasmid to overexpress hBD3 (hBD3 stable line; n=1). 
QRT-PCR was performed for DEFB4 expression and normalised to 18S ribosomal RNA. 
Data are shown as mean fold change (+/- SEM) over untreated cells. p < 0.01,  p< 0.001. 








5.2.6 - Synthetic hBD2 treated HaCaT cells are protected from supernatant 
of 8325-4 and V8 protease 
The hBD2 knock-down assay provided me thoughts that hBD2 could be the 
protective factor of the Vitamin D3, HKSE and IL1-β/LTA stimulated cells. To further 
test the protective action of hBD2, I performed the following series of experiments with 
synthetic linear and nonlinear hBD2. HaCaT cell monolayers wild type untreated (Fig 5.4 
a). HaCaT cell monolayers (in serum free medium SFM) were treated with 4-µg/mL of 
synthetic hBD2 - two  hours prior to exposing cells to 0.04 DF supernatant (0.04 dilution 
factor) of 8325-4 for 12 hours. Positive control untreated HaCaT cell monolayers were 
unable to protect themselves from the damaging effects caused by the supernatant of 
8325-4 after 12 hours. Light microscope examination revealed the presence of voids and 
fissures in the monolayers (Fig 5.4 b). Two hours pre-treated HaCaT cell monolayers 
with synthetic hBD2 were protected from the supernatant of 8325-4 (Fig 5.4 c). Despite 
the protective effects afforded by synthetic hBD2 against the proteases in the supernatant, 
I tested the protective effect against recombinant V8. Untreated cells exposed to 4-µg/mL 
of V8 revealed formation of holes after 24 hours (Fig 5.4 d). Two hours pre-treated 
HaCaT cell monolayer with synthetic linear and non-linear hBD2 were protected from 4-
µg/mL of V8 after 24 hours of exposure (Fig 5.4 e-f). ImageJ software was used to 
calculate damage to HaCaT cell monolayer with S.aureus proteases and then Percentage 
damage was obtained by comparing reading to unexposed which had 0% damage. Where 
(NH+ 0.04 DF supernatant (0.04 dilution factor)  of 8325-4) has 25%  damage to the 






of 8325-4) has 5 % damage, (NH+ 4-µg/mL of V8 after 24 hours) has 30% damage, 
(NH+4-µg/mL of synthetic hBD2+ 4-µg/mL of V8 after 24 hours) has 2% damage, 




















Figure 5.6 Synthetic hBD2 pre-treated HaCaT cells exposed to 8325-4,V8 
protease   
DIC microscopic images revealed (a) Normal HaCaT monolayer without any 
exposure. (b) Normal HaCaT monolayer exposed to supernatant of 8325-4. (c)  4-µg/mL 
of synthetic hBD2 pre-treated normal HaCaT monolayer was exposed to supernatant of 
8325-4. (d) Normal HaCaT monolayer exposed to 4-µg/mL of V8 protease for 24 hours 
(e) 4-µg/mL of synthetic hBD2 pre-treated normal HaCaT monolayer was exposed to 4-
µg/mL of V8 protease for 24 hours. (f) 4-µg/mL linear cysteine replaced with serine (C-
S) hBD2 pre-treated normal HaCaT monolayer was exposed to 4-µg/mL of V8 protease 
for 24 hours (g) Percentage damage to HaCaT cell monolayer was calculated by using 






replicates at Magnification X400. (1 way ANOVA) Tukey's Multiple Comparison Test
 : (Control-NH vs NH+0.04DF-832-12 hours P < 0.001) (Control-NH vs ShBDd2-
4mg/mL+0.04DF-8325-12 hours P > 0.05 =ns) (Control-NH vs NH+V8-4mg/mL-24 
hours P < 0.001) (Control-NH vs Shbd2+V8-4mg/mL-24 hours P > 0.05=ns)(Control-NH 

















5.2.7 Western.Blot analysis for the cleavage of TJ protein Claudin-1 by 
S.aureus secreted proteases 
 Western. Blot analysis was performed to quantitate the cleavage of TJ protein 
Claudin-1 by proteases.   HaCaT cells are  seeded  at a density of 4x104 cells/cm2,  90% 
confluent HaCaT cells monolayer was exposed with V8-2, 4, and 8µg/mL and 0.04 DF 
supernatant of 8325-4 for 12 hours. In another experiment HaCaT cell monolayers was 
exposed with V8-2, 4, and 8µg/mL for 24 hours. The extent of damage to the monolayer 
caused by V8 was visualised by light microscope before lysing the cells. Panactin protein 
was used as a loading control antibody and anti-claudin antibody used for claudin-1 
protein. Electrophoretically transferred protein bands were visualized and photographed 
by using Liquor Odyssey (Fig 5.7 a).  
  The reduction in the band density was calculated by using Image J software. 
Where data are shown reduction in the band density compare to standardised loading 
control (Panactin protein) presented as percentage damage to the HaCaT cell monolayers 
(Fig 5.7 b).  
(Panactin -V8-2µg/mL) after 12 hours no reduction, while 4% reduction in the band 
density was seen after 24 hours. (Panactin -V8-4µg/mL) after 12 hours 12 % reduction 
and after 24 hours (50%). (Panactin-V8-8µg/mL) 48% after 12 hours, 65% after 24 
hours. (Panactin - 0.04 DF supernatant of 8325-4) 68% after 12 hours reduction in the 
band density.  Data are shown as mean fold change (+/- SD) over standardised loading 









Figure 5.7 S.aureus serine proteases effects on Claudin-1band density. 
Western Blot analysis was performed to quantitate the cleavage of TJ protein (Claudin-1) 
and extent of damage to the HaCaT cell monolayer by S.aureus proteases evaluated by 
comparing it with the loading control. (a) Unexposed normal HaCaT cells lysate 
collected after 12 hours (NH-12 hours; n=4), Normal HaCaT cells exposed to V8-
2µg/mL lysate collected after 12  hours (NH+V8-2µg/mL-12 hours; n=4), Normal 
HaCaT cells exposed to V8-4µg/mL lysate collected after 12  hours ( NH+V8-4µg/mL-
12 hours; n=4), Normal HaCaT cells exposed to V8-8µg/mL lysate collected after12  
hours ( NH+V8-8µg/mL-12hours; n=4), Normal HaCaT cells exposed to 0.04 DF 






n=4). Unexposed normal HaCaT cells lysate collected after 24hours (NH-24hours; n=4), 
Normal HaCaT cells exposed to 
V8-2µg/mL lysate collected after 24 hours (NH+V8-2µg/mL-24hours; n=4), Normal 
HaCaT cells exposed to V8-4µg/mL lysate collected after 24 hours (NH+V8-4µg/mL-24 
hours; n=4), Normal HaCaT cells exposed to V8-8µg/mL lysate collected after24 hours 
(NH+V8-8µg/mL-24 hours; n=4). (b) The reduction in the band density was calculated 
by using Image J software. Data are shown as mean fold change (± SEM) over 
standardised loading control Panactin cells (One way ANOVA). 
Tukey's Multiple Comparison Test 
  (Panactin-12 hours vs NH-12 hours P > 0.05) (Panactin-12 hour’s vs NH+V8-2mg/mL-
12 hours P > 0.05) (Panactin-12 hours vs NH+V8-4mg/mL-12 hours P > 0.05) 
(Panactin-12 hour’s vs NH+V8-8mg/mL-12 hoursP< 0.001) (Panactin-12 hour’s vs 8325-
4-12 hoursP < 0.001) (Panactin-12 hour’s vs NH+V8-8g/mL-24 hours P < 0.001) 
(Panactin-12 hour’s vs NH+V8-4mg/mL-24 hours P < 0.001) (Panactin-12 hours vs 












5.2.8 Determine the protection offered by stimulated and hBD2 stable 
HaCaT cell line against S.aureus secreted proteases by Western.Blot 
analysis    
 S. aureus-secreted proteases damaging affect to the HaCaT cells monolayer could 
be due to the cleavage of claudin-1 protein. The damage to HaCaT cells monolayer can 
be protected by stimulating HaCaT cells with IL1-β/LTA and with HaCaT stable cell-line 
which over-expressed hBD2 (hBD2OE). W.B analysis was performed to testify the 
protection offered by HaCaT cells stimulated with IL1-β/LTA and HaCaT stable cell-
line. Lysates were collected and W.B analysis was performed by using claudin-1 primary 
antibody and Panactin was used as a standardised loading control (Fig 5.8 a).   
 The reduction of band intensity compared to standardised loading control 
Panactin was calculated by using Image J software. Where data are shown reduction in 
the band density presented as percentage damage to the monolayer (Fig 5.8 b). Panactin -
V8-8µg/mL12 hours (50% reduction), Panactin - IL1-β/LTA+V8-8µg/mL after 12 hours 
(20% reduction in the band density). hBD2OE + V8-8µg/mL12 hours (12% reduction in 
the band density). Panactin – 0.04 DF supernatant of 8325-4 12 hours (80% reduction), 
Panactin - IL1-β/LTA+ 0.04 DF supernatant of 8325-4 12 hours (10 %). hBD2OE + 0.04 
DF supernatant of 8325-412 hours (40% reduction). The protection was achieved when 
HaCaT cells monolayers was pre-stimulated with IL1-β/LTA (100 ng/mL/ 5µg/mL) and 
hBD2 expressed HaCaT cells were exposed to 8µg/mL of V8 and 0.04 DF supernatant of 







Figure 5.8 Stimulated & hBD2 overexpressing HaCaT cells exposed to V8 
and 8325-4 12h.  
 Lysates were collected and W.B analysis was performed by using claudin-1 
primary antibody and Panactin was used as a standardised loading control. (a) Unexposed 
normal HaCaT cells lysate collected after 12 hours (NH-12 hours; n=4), Normal HaCaT 
cells exposed to V8-8 µg/mL 12 hours (NH+V8-8µg/mL12 hours; n=4), Normal HaCaT 
cells exposed to 8325-4 12 hours (NH+V8-8µg/mL12 hours; n=4), HaCaT cells 
stimulated with IL1-β/LTA and lysate collected after12 hours (IL1-β/LTA-12 hours; 
n=4), HaCaT cells stimulated with IL1-β/LTA exposed to V8-8 µg/mL 12 hours, lysate 
collected after12 hours (IL1-β/LTA + V8-8 µg/mL 12 hours; n=4). IL1-β/LTA stimulated 
HaCaT cells exposed to 8325-4 12 hours (IL1-β/LTA + 8325-4 12 hours; n=4). HBD2 






hours; n=4). hBD2 overexpressed HaCaT cells stable cell line exposed to V8-8 µg/mL 12 
hours, lysate collected after12 hours (hBD2OE + V8-8 µg/mL 12 hours; n=4). hBD2 
overexpressed HaCaT cells stable cell line exposed to 8325-4 12 hours (hBD2OE+8325-
4 12 hours; n=4). (b) Western Blot analysis was performed with lysate collected after 12 
hours and reduction in the Claudin protein band intensity was calculated by using Image J 
software. Data are shown reduction in the band intensity compare to standardised loading 
control Panactin. Data are representative of experiments n=4 and always performed in 
replicates (One way ANOVA). 
Tukey's Multiple Comparison Test 
 (Panactin-12 hours vs NH-12 hours P > 0.05) (Panactin-12 hour’s vs NH+V8-8mg/mL-
12 hours P < 0.01) (Panactin-12 hour’s vs NH+8325-4-12 hours P < 0.001) (Panactin-12 
hour’s vs IL1b/LTA-12 hours P > 0.05) (Panactin-12 hour’s vs IL1b/LTA+V8-8mg/mL-
12 hours P > 0.05) (Panactin-12 hour’s vs IL1b/LTA+8325-4-12 hours P > 0.05) 
(Panactin-12 hours vs hBD2OE-12 hours P>0.05) (Panactin-12 hours vs hBD2OE+V8-












 Atopic dermatitis patients are more prone to S. aureus infections, a phenotype that 
could be due to the down regulation of antibacterial defence (Gambichler et al., 2008).  
In normal conditions, keratinocytes express very low quantities of hBD2, but during 
infection, inflammation and wounding its expression is up-regulated and it accumulates 
in the lamellar bodies of the stratum granulosum layer of the epidermis (Gallo et al., 
2002).  Rie Ommori described how S. aureus and S. epidermidis secrete LTA, 
differentially, to induce subtypes of antimicrobial peptide (AMP) from human 
keratinocytes, through different receptors.  Therefore, it is possible that S. epidermidis 
secretes (Lipid S) short chain LTA which after binding to TLR2 up-regulate skin 
antibacterial defence mechanisms, which protects against S. aureus infections (Jones 
KJet al., 2005). It was mentioned before that TLR2 mutation modifies cytokine 
production and toll-like receptor expression, which may crucially modulate the 
pathogenesis of atopic dermatitis. More than 10% of patients with AD are heterozygous 
for TLR-2, R753Q single nucleotide polymorphism (SNP) (Mrabet-Dhabi et al., 2008). 
 A previous study by Ong et al. confirmed the presence of abundant LL37 and 
hBD2 in the superficial epidermis of all patients with psoriasis.  In contrast, significantly 
lesser amount of these peptides was present in acute and chronic lesions from patients 
with atopic dermatitis (Ong et al., 2002). LL37 having antimicrobial activity against 
bacteria, viruses, and fungi, is produced by epidermal keratinocytes, Reduced expression 
of antimicrobial peptides may cause recurrent infections in AD (Mallbris L et al., 2010). 






element (VDRE) occurs on the gene of LL-37 precursor cathelicidin. Oral vitamin D3 
increases cathelicidin expression in AD lesions, however vitamin D role in pathogenesis 
of AD is controversial (Hata TR., 2008) (Benson AA et al., 2012). Vitamin D3 
supplementation improves AD symptoms while vitamin D3 intake during infancy 
accelerates the development of AD (Back O et al., 2009). Studies have indicated that 
dysregulation of VDR may lead to exaggerated inflammatory responses, raising 
possibility that defect in vitamin D and VDR signaling transduction may be linked to 
bacterial infection and chronic inflammation (Sun J et al., 2010).  The bacteria secrete 
Capnine, a protein which may bind to and inactivate the VDR. A growing number of 
substances and species have been shown to down-regulate the activity of the VDR. It is 
shown that there is down-regulation of VDR receptor by mycobacterium tuberculosis 
(Xu Y et al., 2003). 
 The data described in chapter 4 suggested that HaCaT cells expressed a factor 
after being stimulated with Vitamin D3, HKSE and IL1-β/LTA, protected the monolayer 
from damage induced by the S. aureus-secreted proteases.  Based on our ELISA results, I 
found that hBD2 could be that protective factor, which released in response to Vitamin 
D3, HKSE and IL1-β/LTA stimulation. In order to check the antiprotease action of 
hBD2, we knocked it down with hBD2 siRNA. 
  In order to see the direct role of hBD2 as a protease inhibitor, we knocked it 
down with hBD2 siRNA and quantified our results by calculating percentage damage to 
the monolayer caused by the protease. Not surprisingly, cells that had not been stimulated 






We observed that hBD2-siRNA knock-down in HaCaT cells blocked the protection 
afforded by IL1-/LTA stimulation, whilst control-siRNA knock-down HaCaT cells 
cannot block the protection afforded by IL1-/LTA stimulation. To confirm increase 
secretion of hBD2 when stimulated with Vitamin D3, HKSE and IL1-β/LTA, we 
knocked down hBD2 in HaCaT cells with siRNA.  We quantified our results by 
calculating percentage damaged to the monolayer caused by the protease. Not 
surprisingly, cells that had not been stimulated to make hBD2 had a similar phenotype 
whether they knocked down by siRNA or not. We observed that DEFB4-siRNA knock-
down HaCaT cells blocked the protection afforded by IL1-/LTA stimulation, whilst 
control-siRNA knock-down HaCaT cells cannot block the projection afforded by IL1-
/LTA stimulation. In order to clearly assess the impact of hBD2 expression by HaCaT 
Cells, I assessed the responses of stable hBD2 over-expressing HaCaT cell lines.  Would 
they be protected from the S. aureus-secreted proteases? I found that, hBD2 over-
expressing HaCaT cell lines protected from the damaging effect of V8 proteases.  
 In order to clearly assess the impact of hBD2 expression by HaCaT cells, I 
assessed the responses of stable hBD2 overexpressing HaCaT cell lines.  Would they be 
protected from the S. aureus-secreted proteases? We found that, hBD2 overexpressing 
HaCaT cell lines protected from the damaging effect of V8 at concentrations of 4-µg/mL.  
After our hBD2 knockdown and hBD2 overexpression models worked very well, I tried 
to see the effect of synthetic hBD2 peptides. It was found that synthetic peptides work as 






5.4 Conclusion- hBD2 knockdown cells were unable to protect the monolayer, 
whilst cells overexpressing hBD2 were able to protect the HaCaT cell monolayers from 
the proteases in the supernatant, or recombinant V8 (serine) proteases.  Synthetic hBD2 
could also act as exogenously applied protective factor. The mechanism of anti-protease 
action of hBD2 remains unclear, further study need to find out the chemical interaction of 
hBD2 with S.aureus protease for the protection of HaCaT cell monolayer either it work 















6-Protease inhibitor action of hBD2: Characterised by enzyme kinetic 
assay.  
 6.1 Introduction  
 HaCaT cells transfected with hBD2 siRNA were unable to protect from the 
destructive potential of S.aureus proteases, while hBD2 over-expressing HaCaT cells 
were protected from the S.aureus proteases. This observation raised the possibility that 
hBD2 inhibits V8 protease by having anti-protease action. The anti-protease effect of 
hBD2 was tested by protecting HaCaT cell monolayers against S. aureus secreted 
proteases in the supernatant of strain 8325-4, RN6390 and with recombinant V8. It needs 
to test the antiprotease action of hBD2 in the kinetic reaction where direct interaction of 
hBD2 with S.aureus proteases either neat or present in the supernatant can be measured. 
 Here is a brief description about the mechanistic insight about the control of 
S.aureus secreted proteases. As described in the first chapter, S.aureus pathogenicity 
depends on the combined action of extracellular toxins, proteases and cell surface 
proteins. Modulation of virulence expression and synthesis is largely controlled by two 
global regulatory elements, accessory gene regulator (Agr) and staphylococcal accessory 
regulator (Sar). Although the production of extracellular proteases varied among clinical 
isolates of S.aureus and their protease production in vitro was primarily determined by 
the level of S.aureus accessory regulator A (SarA) expression, which acts as a repressor 
(Anna Karlsson et al., 2002). This was supported by inactivation of SarA in three 






protease genes, while overexpression of sarA in a protease-positive strain completely 
inhibited protease production (Arvidson, S et al., 2001). The alternate transcription 
factor sigma B is known to affect the expression of several genes encoding virulence 
factors and stress-response proteins, and seems to counterbalance the influence of the agr 
system on the expression of virulence factors. The activity of SigB peeks early during the 
stationary phase of growth (Senn MM et al., 2005). The Agr system and SigB are known 
to be interconnected (Bischoff M et al., 2001). (Palma, M., and A. L. Cheung. 2001).  
Much of my research aimed at defining the pathogenesis of S.aureus which had been 
done with a limited number of strains, most notably the 8325-4 derivative RN6390. 
Several lines of evidence indicate that this strain is unique by comparison to clinical 
isolates of S. aureus (Cassat JE et al., 2005) (Novick R.P et al., 2000).   
  The disturbance of the balance between protease and protease inhibitor could be 
associated with barrier defects in AD. Another study stated the importance of protease 
and protease inhibitor balance associated with barrier defect. Cheng stated that 
individuals with AD had decreased expression of cystatin A, which had been found in 
their epidermal lesions.  Reduced inhibition of both endogenous and exogenous cysteine 
proteases can be associated with barrier defects (Cheng et al., 2009).   
 A brief description about enzymes and their kinetics is discussed here before 
starting enzyme kinetics methodology. The enzymes act as catalysts which are not 
consumed in the reactions. The enzyme produces product at an initial rate that is 
approximately linear for a short period after that the start of the reaction. As the reaction 






initial and maximum rate, enzyme assay are typically carried out while the reaction has 
progressed only a few percent towards total completion. The length of the initial rate 
period depends on the assay conditions and can range from milliseconds to hours. Most 
enzyme studies concentrate on this initial, linear part of enzyme reactions. However it is 
also possible to measure the complete reaction curve and fit this data to a non-linear rate 
equation. This way of measuring enzyme reaction is called progress -curve analysis 
(Duggleby RG et al., 1995). 
 S. aureus secreted proteases act as  catalysts which are not consumed in the 
reactions. The rate of the reaction catalysed by S. aureus protease (V8) can be measured 
by change in the concentration of either substrate or products. The rate of the reaction (v) 
increases with increasing substrate concentration (S), until proteases become saturated 
with substrate and the rate of the reaction reaches to Vmax (maximum rate) (Danson et 
al., 2002).  A protease inhibitor by definition is a molecule which binds to protease and 
decreases its activity.  The binding of an inhibitor can stop a substrate from entering into 
the protease active site and/or hinder the protease from catalysing its reaction. The 
binding of inhibitor with the active site of the protease is either reversible or irreversible 
(Rawlings ND et al., 2004)  
 Enzyme kinetics was performed by using fluorescence substrate, Z-Phe-Arg-7-
amido-4-methyl coumarin.  It is generally assumed that serine proteases hydrolysed N-
acetyl-amino acid esters and amides through a three-step mechanism involving an 
acylenzyme intermediate (ES) in addition to the classic Michaelis complex (ES), as given 








 The k1 is an equilibrium constant and K2, k3 are the rate constant of the acylation and 
deacylation steps. This mechanism can be elucidated by kinetic study by using small 
synthetic fluorescence substrate. Which allow rapid and precise measurement of S.aureus 
protease activity? The interaction between protease and substrate can cause hydrolysis of 
the fluorescence substrate, Z-Phe-Arg-7-amido-4-methyl coumarin, by the protease and 
was measured with a spectrophotometer.  It is possible to undertake kinetic studies which 
might give some information about the mechanism of the S.aureus protease-catalysed 
hydrolysis. 
Objective 
1-To test the hydrolysis of synthetic substrate with V8 protease kinetic reactions were 
performed. 2- The enzyme kinetic reactions were performed to explore the proposed, 










6.2 Results  
Most of the work discussed in the previous chapters performed in-vitro on HaCaT cells 
monolayer and data was collected where hBD2 indirectly protect the monolayer from 
S.aureus proteases having anti-protease action. In this chapter direct interaction of 
recombinant and synthetic hBD2 with S.aureus proteases either in the supernatant or neat 
V8 was observed in kinetic reaction. In the kinetic assays hydrolysis of the substrate was 
optimised in a reaction with neat V8 or proteases present in the supernatant. The 
fluorescence substrate, Z-Phe-Arg-7-amido-4-methyl-coumarin, was hydrolysed by 
S.aureus serine protease during the kinetic reaction and increase in the fluorescence 
intensity was measured with spectrophotometer. To optimize the enzyme substrate 
reaction different concentration of substrate were used to achieve a sigmoidal curve. 
Initially a linear curve was obtained with low substrate concentration. The rate of the 
reaction (v) increases with increasing substrate concentration (S), until proteases become 
saturated with substrate and the rate of the reaction reach Vmax (maximum rate). The 
rate of the reaction was calculated by using following formula ΔP/Δt=v  (explain the 











6.2.1 - Inhibition of the proteases present in the RN supernatant with 
synthetic hBD2 in a kinetic assay 
 Protease inhibition activity of proteases present in the RN6390 (derivative of 
8325-4 strain) supernatant used with a dilution factor 0.04 (4 µL/100 µL) of the reaction 
volume here tested. Synthetic hBD2 was added at a concentration of 10 µg/mL and 
recombinant hBD2 at 1 µg/mL. Synthetic hBD2 was used to reduce substrate hydrolysis 
by proteases present in the RN6390 supernatant, which resulted in the reduction of 
fluorescence emission.  Substrate hydrolysis by S. aureus proteases in the supernatant and 
their inhibition with 10 µg/mL synthetic  and 1 µg/mL  recombinant hBD2 was also 
measured by spectrofluorometry by using the following formula ΔP/Δt=v (Fig 6.1 a). The 
percentage inhibition of the proteases in the RN6390 supernatant was calculated by 
comparing it with enzyme substrate progressive curve, which is considered as 100 % 
acceleration with no inhibition.  The ShBD2 has (37 %) reduction of enzyme substrate 
progressive curve of the protease present in the RN6390 supernatant in the kinetic assay 
relative to RN6390 which has no inhibition with 100% acceleration. The rhBD2 with 
concentration of 1 µg/mL attain 33 % inhibition reference to control RN6390 with 100% 
acceleration and no inhibition (Fig 6.1 b). The rate of the reaction (v) increases with 
increasing substrate concentration (S), until proteases become saturated with substrate 









Figure 6.1 Synthetic and r hBD2 action against RN6390 supernatant.  
 Enzyme kinetic assay was performed (a) 0.04 DF supernatant of RN6390 was 
used in a kinetic assay with 10 µg/mL synthetic hBD2 (ShBD2) and 1µg/mL of 
recombinant hBD2 (rhBD2). The change in the relative fluorescent intensity was assayed 
spectrofluorometrically by using  following formula ΔP/Δt=v. (b) Data are shown 
percentage inhibition of the protease in the RN6390 supernatant with 10 µg/mL ShBD2 
and 1µg/mL with r hBD2 in reference to control with no inhibition and have 100 % 
acceleration. Data is representative of n=4 experiments perform with replicates (one way 
ANOVA).  
Tukey's Multiple Comparison Test; (RN6390vsRN6390+ rhBD2-1µg/mL P < 0.001) 
(RN6390vs RN+ShBD2-10µg/mL P < 0.001) (RN6390+rhBD2-1mg/mL vs RN+Sbd2-






6.2.2 - Optimised V8 inhibition with recombinant and synthetic hBD2 
 Having shown  (ShBD2) inhibits V8 protease present in the supernatant of 
RN6390, I then set out an experiment to look at inhibition of neat V8 protease with the 
following different forms of  hBD2,  reduced cysteine amino acid swap with serine hBD2 
(C-S hBD2) and scrambled peptide (SCB). Scrambled peptides are a basic, broadly useful 
type of negative control peptide, useful for testing sequence specificity of the 
experimental peptide. Since the amino-acid content of control and experimental peptides 
are identical, which could keep the bulk properties of both control and experimental 
peptides similar?  V8 Protease inhibition by 1 µg/mL recombinant hBD2 (rhBD2), 
5µg/mL synthetic cysteine-swap-serine hBD2 (C-ShBD2), and scrambled synthetic 
peptide (SCB), was assayed spectrofluorometrically. Where recombinant ? and synthetic 
hBD2 peptides were used to reduce substrate hydrolysis by V8 protease, which result in 
the reduction of fluorescence emission.  5µg/mL S. aureus V8 was pre-incubated for 15 
minutes at 37°C with reaction buffer, then the substrate was added.  Before measuring 
fluorescence emission, recombinant and synthetic hBD2 was added separately at 
concentrations of 500 ng/mL and 5µg/mL, respectively. Hydrolysis of the substrate was 
reduced by synthetic hBD2, which resulted in the reduction of fluorescence emission.  
The rate of substrate hydrolysis with V8 protease and their inhibition with 5 µg/mL of 
synthetic hBD2 was measured by spectrofluorometry by using the following formula 
ΔP/Δt=v. The rate of the reaction was increased by adding substrate until it reached to the 
maximum velocity of Vmax where I got a hyperbola curve which is considered as a 100 






hydrolysis of the substrate by V8 protease), 5 µg/mL of  synthetic peptides have 
following % age of inhibition, ShBD2 23%, C-S hBD2 18% and SCB peptide 8%  
respectively  relative to 5µg/mL S. aureus V8 with 100 % acceleration and no inhibition 



















Figure 6.2:  kinetic assay with synthetic hBD2 at lower concentrations 
 The enzyme kinetic assay was perform to see the effect on V8- substrate 
acceleration rate with recombinant and synthetic hBD2 peptides (a) The interaction of V8 
proteases at concentration 5 µg/mL with 500 ng/mL of recombinant hBD2, 5 µg/mL 
synthetic hBD2, 5 µg/mL of C-S hBD2 and 5 µg/mL of SCB peptide was assayed 
spectrofluorometrically by using following formula ΔP/Δt=v (Fig 6.2 a). Data is shown 
percentage inhibition of the V8 proteases used as control with 500 ng/mL recombinant 
hBD2, 5µg/mL synthetic hBD2, 5µg/mL Cysteine replace with serine (C-S) hBD2cause 
and 5µg/mL SCB peptide. Data is representative of n=4 experiments perform with 
replicate (one way ANOVA)   
Tukey's Multiple Comparison Test (V8-5 µg/mL vs V8+rhBD2-500 ng/mL P > 0.05) 
(V8-5 µg/mL vs V8+shBD2-5 µg/mL P < 0.01) (V8-5 µg/mL vs V8+C-S hBD2-5 µg/mL 






6.2.3 V8 inhibition increased with higher concentrations of synthetic hBD2 
  
 Protease inhibition activity of synthetic, cysteine-swap-serine hBD2, and 
scrambled peptide, at a concentration of 10µg/mL each, was assayed 
spectrofluorometrically by measuring inhibition of substrate hydrolysis and reduction in 
the emission of fluorescent intensity by S. aureus V8 protease.  S. aureus V8 at a 
concentration of 5µg/mL was pre-incubated with reaction buffer for 15 minutes at 37°C, 
then fluorescent substrate, Z-Phe-Arg-7-amido-4-methylcoumarin, was added.  Before 
measuring the emission of fluorescence, inhibitors were added at the following 
concentrations: 1µg/mL recombinant and 10µg/mL synthetic, cysteine-swap-serine and 
scrambled synthetic hBD2.  The V8 neat protease with concentration of 5µg/mL 
interaction with substrate achieve 100 % acceleration which is considered as a control 
with no inhibition (Fig 6.3 a). The rhBD2 has 15 % inhibition, synthetic hBD2 (ShBD2, 
C-S hBD2 and SCB) peptide produced inhibition  respectively 23%, 18% , and  8%  
relative to 5µg/mL V8 + substrate reaction with 100 % acceleration, no inhibition (Fig 












Figure 6.3 V8 kinetic reaction with higher concentrations of Synthetic & 
rhBD2. 
 The kinetic assay was perform to see the effect of increasing concentration of 
recombinant and synthetic hBD2 peptides  (a) The interaction of  V8 proteases at 
concentration  5 µg/mL with 1 µg/mL of recombinant hBD2, 10 µg/mL synthetic hBD2, 
10 µg/mL of C-S hBD2 and 10 µg/mL of SCB peptide was assayed 
spectrofluorometrically. Whilst relative fluorescent intensity was measured by using the 
following formula ΔP/Δt=v. (b) Percentage inhibition of  substrate hydrolysis with 
1µg/mL of recombinant hBD2, 10µg/mL synthetic hBD2, 10µg/mL with C-S hBD2 and 
10µg/mL with SCB peptide. Data is shown as mean fold change (+/- SD) over no 
inhibitor. Data are representative of n=3 experiments perform with replicate (one way 
ANOVA). Tukey's Multiple Comparison Test (V8-5mg/mL vs V8+rhBD2-1mg/mL P 
< 0.001) (V8-5mg/mL vs V8+shBD2-10mg/mL P < 0.001) (V8-5mg/mL vs V8+C-S 






6.3 Discussion-Human serine proteases perform several physiological and cellular 
functions ranging from degradation and digestive processes to protein processing and 
tissue remodelling. They share a high degree of amino acid sequence identity in particular 
they share the histidine-aspartate-serine that is necessary for catalytic activity. Hachem 
demonstrate the importance of serine protease and their inhibitor balance for normal 
permeability barrier homeostasis (Hachem, J.-P et al., 2006). The presence of a broad 
range of protease inhibitors in the epidermis could control increase in protease activity 
due to homeostatic or inflammatory conditions (Armstrong, P.B., 2006). The epidermal 
protease inhibitors plays role in the maintenance of skin barrier by regulating disturbance 
of innate immunity caused by external proteases, expressed by several bacterium 
(Potempa.J et al., 2009). The barrier disruption caused by increase serine protease 
activity could be block by topical serine protease inhibitor application. The protease/ 
protease inhibitor balance disrupt the natural cycle of cornification (formation of 
cornified envelop) and desquamation (shedding of the stratum corneum).   The barrier 
abnormalities due to dysfunction of endogenous protease inhibitors were also studied in 
animals and rodents.  A murine model study described a transgenic mouse carrying a null 
mutation in the gene encoding either cystatin M or cystatin E, died shortly after birth due 
to severe barrier abnormalities (Zeeuwen PL et al., 2002).  
  The antiprotease action of hBD2 against S.aureus secreted proteases was 
observed in the kinetic assay where it prevented the cleavage of substrate by S.aureus 
proteases. The hBD2 protected HaCaT cell monolayer from the destructive potential of 






protease inhibitors, including LEKTI, elafin, SLPI, are believed to control the epidermal 
serine proteases signaling cascade that can lead to desquamation, or in some cases to 
inflammation. The relevance of these findings for human disease is underscored by the 
identification of mutations leading to truncated LEKTI forms in humans with Netherton 
syndrome. Therefore, fine-tuning of serine protease activity could be an important 
pharmacological tool in the control of several dermatological diseases (Leyvraz, C., 
2005). The antiprotease action of hBD2 correlated with SLPI and Elafin which belongs to 
the Whey acidic protein (WAP) family. The similarity of hBD2 to the members of Whey 
acidic protein (WAP) family SLPI and Elafin by possessing conserved whey, four 
disulphide core domain (WFDC). The Whey acidic protein (WAP) family have dual-
action, working as an antimicrobial agent and having the ability to inhibit cysteine 
proteases (Moreau, T et al., 2008). The interaction between protease and substrate was 
described where hydrolysis of the fluorescence substrate Z-Phe-Arg-7-amido-4-
methylcoumarin with S.aureus secreted proteases increase in the fluorescence intensity 
measured with spectrophotometer.  
  The enzyme kinetics assay was performed to quantify the antiprotease action of 
recombinant and synthetic hBD2 peptides against S. aureus-secreted proteases. The 
antiprorease effect of recombinant and synthetic hBD2 was observed against both 
S.aureus proteases present in the supernatant and recombinant proteases.  I learned from 
kinetic assay that ShBD2 acts non-specifically against the protease present in the RN6390 
supernatant and V8 protease. Increasing the concentration of synthetic ShBD2 peptide 






proteases which are the external proteases, hBD2 may have another adaptive function to 
control the rising level of endogenous protease i.e. (metryptase) activity due to 
homeostatic or inflammatory conditions. Sustained serine proteases activity by prolonged 
increase in pH leads to degradation of lipid processing enzymes and profound alterations 
of barrier function and stratum corneum integrity (Hachem, J.P. et al. 2005) 
The mechanism of antimicrobial action of hBD2 is well-known. It is due to 
cationic charges, which make electrostatic interactions with the anionic charges on the 
microbial membrane, which results in dimerization and penetration of the microbial cell 
wall (Hoover DM et al., 2000). This dimerization is conserved in hBD2, which 
differentiates it from the other peptides. The hBD2 dimerization allows formation of a 
higher-order oligomerization of the protein as an octamer. This octamer represents the 
stable, native, quaternary structure of hBD2.  The uniform surface distribution of positive 
charge residues suggests that hBD2 disrupts the bacterial membrane via electrostatic 
interactions with the polar head groups of the membrane.  It is therefore likely that the 
octameric that form of hBD2 binds to bacterial membranes (Hoover DM., 2000). The 
chemical interaction of hBD2 with V8 S. aureus serine protease is still not clear. 
6.4 Conclusion-The enzyme kinetic study revealed that hBD2, in addition to its 
antimicrobial action, also protect HaCaT cell from damaging effect of S.aureus proteases.  
I speculate that hBD2, in addition to killing pathogens by invading their membrane, 
blocks the proteolysis effect of S. aureus-secreted proteases. It is quite premature to 
describe the mechanism of chemical interaction between hBD2 and proteases, which 






Chapter 7: Final discussion: 
Atopic dermatitis is a chronic inflammatory disease, 90% of AD patients are S. 
aureus carriers, having the bacteria present in their nasal and perineal areas. Previous 
studies have confirmed the significance of S.aureus proteases in the exacerbation of skin 
barrier function in atopic dermatitis (Shaw.L et al., 2004).  S. aureus exfoliative toxin 
(serine protease) is a virulence factor can damage the skin barrier by enzymatic activity 
having homology to V8 protease (Amagai et al., 2000).  
As we know tight junctions are dynamically interconnected to the actin 
cytoskeleton, adherent junctions and desmosomes.  There is a structural, as well as a 
functional; linkage between tight junctions and the actin filament cytoskeleton, via 
various proteins (Schneeberger et al., 2004). The fate of tight junctions was investigated 
by exposing HaCaT cell monolayer’s to supernatant collected from various S. aureus 
strains. 
The deleterious effect of serine and cysteine proteases were analyzed when the 
monolayer was exposed to recombinant V8 and staphopain B; however staphopain B was 
unable to damage the HaCaT cell monolayer even at higher concentration.  These data 
suggest that V8 is the most active protease secreted by S. aureus into the supernatant and 
present in the conditioned media used in these studies. It would say, V8 could be the 
master protease secreted by S. aureus involved in deterioration of the skin barrier in 
individuals with AD.  This observation is consistent with another study, demonstrating 






(Hirasawa et al., 2009.  It is not just the bacterial proteases capable of breaking barrier, 
common allergens such as house dust mite’s secreted serine and cysteine proteases can 
damage skin barrier (Chapman et al., 2007).  S.aureus may play a role in the chronicity 
and severity of AD through its release of super-antigenic exotoxin (Leung et al., 1993). 
In addition to their immunological effects these toxins may also directly damage the skin 
barrier.  
The TJ is the main sealing site of the paracellular pathway in epithelia and many 
endothelia. Tight junctions (TJ) are composed of transmembrane proteins including 
occludin, the family of claudins and tricellulin.  Claudin is known to comprise a 
multigene family, consisting of more than 20 members (Morita et al., 1999). The two 
extracellular loops of these proteins link to the extracellular loops from neighbouring 
cells and by this tighten the Paracellular pathway. Some of the TJ proteins instead of 
sealing paracellular pathway form paracellular ion channels. S.aureus secreted proteases 
that break down corneodesmosomes by a mechanism similar to that of KLK- (Kallikrein-
related epidermal serine proteases) peptidases (Miedzobrodzki et al., 2002). 
Morphological and physiological studies revealed that tight junctions are not a 
simple barrier.  Tight junctions are ion-and size-selective and their barrier function varies 
significantly in tightness, depending on the cell type and physiological requirement 
(Diamond JM et al., 1977).  A murine model study described how Claudin (CLDN-1) 
and E-cadherin knock-out mice can cause deficiency of tight junction proteins which 
characterised by a leaky barrier. The affected mice died soon after birth due to 






tight junction proteins for the maintenance of the skin barrier against outside-in entrance 
of the environmental allergens was examined. The effect of S. aureus-secreted proteases 
in the dissolution of the tight junction protein Claudin-1 and ZO-1 was studied and 
quantified. ZO family proteins are the cross–linkers which anchor TJ proteins to the actin 
cytoskeleton. Damage to the TJ may cause dissolution of the actin cytoskeleton, which 
can be seen by staining HaCaT cells with Phalloidin-FITC.  
 S.aureus V8 protease cause damage to the monolayer results in the loss of cells at 
that area therefore no cells means reduction in the CLDN-1 staining at the damaged area 
(Fig 5.5 b-c). I presume epidermal barrier in AD which correlate with HaCaT cell 
monolayer and damage to claudin-1 caused by S. aureus proteases can disrupt the cell-
cell interactions, of HaCaT cells monolayer. Tight junction’s barrier function varies 
significantly in tightness, depending on the cell type and physiological requirement 
(Diamond et al., 1977). (Furuse, M et al., 2002). Damage to Claudin-1 by S. aureus-
secreted proteases was quantified by Western Blot assay, where the reduction of Claudin 
band intensity was observed.  
The ion permeability of the paracellular pathway could be the pathogenesis of 
inflammatory or infectious diseases turned out to cause, or to be caused by, paracellular 
barrier defects (Amasheh, S et al., 2002). The Brandner previously described 
mechanism of regulating tight junctions against S. aureus-secreted proteases. (Brandner 
JM et al., 2009). They demonstrated that barriers for diverse ions and molecules of 
different size are formed in keratinocytes by TJs, and TJ proteins CLDN 1, CLDN 4, 






dispensable for this barrier, however CLDN 1 influences important component of the 
stratum corneum (SC) barrier. 
The skin epidermal barrier can be protected by stimulating with secretery LTA 
released by S. epidermidis and Vitamin D. Part of skin defense against S. aureus 
exoproteases can be maintained by S. epidermidis a skin commensal by releasing Lipid S’ 
secretary LTA, a cell wall component, into the medium during growth (Schroder et al., 
2003). The role played by skin commensal against the pathogen was observed when heat 
killed S.epidermidis (HKSE)-stimulated HaCaT cells were protected from the deleterious 
effect of the proteases present in the supernatant of S.aureus 8325-4 and V8 protease. 
While unstimulated HaCaT cells were not protected from the proteases present in the 
supernatant of S.aureus 8325-4 and V8 protease.   
Internal defense system of epidermis was also tested when HaCaT cells were 
stimulated with Vitamin D3 and then exposed with the proteases present in the 
supernatant of S.aureus 8325-4 and V8 protease. The Vitamin D3 stimulated HaCaT cells 
were protected from the effect of the proteases and upregulation of hBD2 was assessed 
by performing ELISA. Vitamin D3 is another external factor; stimulate epidermal 
defence by up regulating AMP. 1, 25 OH D3 regulates keratinocyte prolifiration, 
differentiation and the formation of intact epidermal barrier.  Alteration in local vitamin 
D3 concentration and or activation will likely affect normal cutaneous immune function, 
barrier function and inflammation (Bikle DD, et al, 2004). Data presented in chapter 4 
described how Vitamin D-stimulated HaCaT cells protected HaCaT cells monolayer from 






inflammation in individuals with AD was reduced with UVB radiation.  In normal 
conditions, keratinocytes express very low quantities of AMP, but during infection, 
inflammation and wounding its expression is up-regulated and AMPs accumulate in the 
lamellar bodies of the SG of the epidermis (Gallo et al., 2002). 
I then aimed to establish whether the presence of Vitamin D3 (which is protective 
in atopic dermatitis) could also have a protective effect. In these studies HaCaT cells 
monolayer protection with vitamin D3 was assessed by visualization of the monolayer 
and by measuring TEER.  I, observe TEER of the monolayer is inversely proportion to 
the TJ permeability. Hence, as TJ becomes less permeable, the TEER is increased. 
Conversely, as permeability goes up, TEER is reduced. The use of HaCaT cells 
monolayer offers the possibility of measuring TJ function in response to S. aureus 
proteases in a simple assay.  
 There was significant drop in the TEER reading in unstimulated monolayer when 
exposed to V8 protease for 24 hour (Fig 4.3 b). In contrast, 1, 25 OH Vitamin D3 -pre-
stimulated HaCaT monolayer’s, TEER was increased and there was no damage to the 
monolayer after 24 hours of V8 exposure (Fig 4.3 c). In order to test that hBD2 was the 
key protective factor released in response to Vitamin D3, HKSE and IL1-β/LTA 
stimulation, ELISA was performed. I found encouraging results with ELISA which stated 







As disruption of the monolayer by S.aureus proteases, can be prevented by 
blocking the interaction of protease with peptide, which become substrate for the 
proteases. I presume epidermal barrier in AD which correlate with HaCaT cell monolayer 
can also be protected from S.aureus proteases. The leekage of tight junctions 
permeability barrier was investigated by exposing HaCaT cell monolayers to supernatant 
collected from various S. aureus strains, and blocked their effect with prior treatment 
with synthetic hBD2 or exposing hBD2 stable cell line with protease. Damage to 
Claudin-1 by S. aureus-secreted proteases, and their protection by hBD2, was quantified 
by Western Blot assay.  Two different techniques were used to test the anti-protease 
effect of hBD2.   IL1-β/LTA externally stimulated HaCaT cells and internally hBD2 
over-expressing stable HaCaT cell line were exposed to recombinant V8 and protease 
present in the supernatant of 8325-4. The hBD2 over-expressing stable HaCaT cells line 
was compared by adding synthetic hBD2, before exposing them to V8 and proteases 
present in the supernatant. I found synthetic hBD2 and hBD2 over-express HaCaT cell 
line protect the monolayer against 4µg/mL of V8 but unable to protect 8µg/mL of V8. 
The indirect antiprotease action of hBD2 was observed when IL1-β/LTA and Vitamin D3 
stimulated HaCaT cells were protected from S.auerus secreted proteases. These 
observation suggest that hBD2, in addition to killing pathogens by invading their 
membranes, blocks the proteolytic effect of S. aureus-secreted proteases.   
 To assess, directly, the link between hBD2 expression and permeability barrier 
function, I restored permeability barrier homeostasis artificially, by growing HaCaT cells 






µg/mL of V8 protease for 24 hours. In order to prevent this alteration in permeability 
barrier I grew normal HaCaT cells in different wells. Normal HaCaT cells were pre-
treated with 4 µg/mL of synthetic hBD2 before exposed them with 4 and 8 µg/mL of V8 
protease.  
Next, 1 restored permeability barrier homeostasis, naturally, by growing hBD2 
over-expressing HaCaT cell-lines on the transwell. The hBD2 over-expressing HaCaT 
cell-lines monolayer exposed with 4 and 8 µg/mL of V8 protease for 24 hours. Artificial 
permeability barrier homeostasis was quantified by using FITC-alb fluorescence dye.  
FITC-alb dye transportation was facilitated across the gaps produced between the cells 
due to damage caused by 4 and 8 µg/mL of V8 protease. The FITC-labelled albumin 
model was preferred to elucidate the importance of skin barrier against outside-in 
entrance of the environmental allergens in AD. FITC-labelled albumin has been used as a 
substrate for the proteases and also has been used to detect sites of protein leakage in the 
lungs (K. Matter and M. S. Balda, 2003).  FITC-labelled albumin Penetration through 
the intercellular junction, correlate with leaky barrier in AD, which cause outside-in 
entrance of environmental allergens (Schneeberger et al., 2004). The rate of FITC-alb 
dye transportation across the disturbed barrier was quantitated by measuring increase in 
the fluorescence intensity with spectrophotometer after 8 hours (Fig 4.4 a).   
 As patients with Atopic dermatitis (AD) are more prone to S.aureus infections 
which could be due to low hBD2 copy number. A study was done by Gambichler. T in 
2008, which stated that most antimicrobial peptides (AMP’s) investigated in that study 






compared to control. However, a statistically significant difference in AMP mRNA 
expression between atopics and Psoriatic patients was only found for hBD2. (Gmbichler 
et al., 2008). In another study it stated that the DNA copy number of the beta defensin 
gene cluster on chromosome 8q23 was highly polymorphic within the healthy population.  
It is suggested that defective hBD2 induction in crohn disease (CD) patients could be due 
to low DEFB4 gene (hBD2) copy number. I aimed to investigate mRNA expression level 
of hBD2 in human keratinocyte cell line HaCaT cells and then compare it with 18S 
ribosomal RNA as a control. For this purpose QRT-PCR was performed to find about the 
expression levels of hBD2 in both stimulated and unstimulated cells. 18S rRNA is a 
component of the small eukaryotic ribosomal submit (40S) and structural RNA for the 
small component of ribosome’s and thus one of the basic components of all eukaryotic 
cells. The genes coding for 18S rRNA are referred to as 18S rDNA. Sequence data from 
this gene is widely used in molecular analysis to reconstruct the evolutionary history of 
organism. The 18S rRNA gene is one of the most frequently used genes in polygenetic 
studies and an important marker for random target PCR in environmental biodiversity 
screening.  In general rRNA gene sequences are easy to access due to highly conserved 
flanking regions allowing for the use of universal primers (Meyer A et al., 2010). Their 
repetitive arrangement within the genome provide excessive amount of template DNA for 
PCR, 18S gene is part of the ribosomal functional core. QRT-PCR was performed to find 
out that DEFB4 gene expression either in over-expressing stable cell line or cells 
stimulated with IL1-β/LTA. The QRT-PCR results showed upregulation of DEFB4 in 






DEFB4 mRNA expression level when normalised to 18s was 1000 fold with IL1-β and 
1200 fold with hBD2 over-expressing stable line, which was higher than the WT. 
 To confirm that protection is due to increase secretion of hBD2 when stimulated 
with Vitamin D3, HKSE and IL1-β/LTA, we knocked down hBD2 in HaCaT cells with 
siRNA.  We quantified our results by calculating percentage damaged to the monolayer 
caused by the protease. Not surprisingly, cells that had not been stimulated to make hBD2 
had a similar phenotype whether they expressed the siRNA or not. We observed that 
DEFB4-siRNA knock-down HaCaT cells blocked the protection afforded by IL1-β/LTA 
stimulation, whilst control-siRNA knock-down HaCaT cells cannot block the projection 
afforded by IL1-β/LTA stimulation. In order to clearly assess the impact of hBD2 
expression by HaCaT cells, I assessed the responses of stable hBD2 over-expressing 
HaCaT cell lines.  Would they be protected from the S. aureus-secreted proteases? I 
found that, hBD2 over-expressing HaCaT cell lines protected from the damaging effect 
of V8 proteases.  
 Hoover described that antimicrobial action of hBD2 is due to cationic 
charges which make electrostatic interactions with the anionic charges on the microbial 
membrane, results in dimerization and penetration of the microbial cell wall (Hoover 
DM et al., 2000).The direct interaction of the hBD2 with S.auerus secreted proteases was 
studied by enzyme kinetics. It was demonstrated that hBD2; in addition to its 
antimicrobial action have antiprotease action by having direct interaction with protease. 
The enzyme kinetics assay confirmed that increasing hBD2 concentration has more 






7.1 Conclusion   
 It was found that DEFB4 (hBD2) knock-out cells were unable to block S. aureus-
secreted proteases, whilst hBD2 over-expressing HaCaT cells were protected.  The anti-
protease effect of hBD2 was also tested by inducing hBD2, with IL1-β/LTA, Vitamin D3 
and HKSE Stimulated HaCaT cells, which protects them from S. aureus-secreted 
proteases. AMPs are known to be multi-factorial having a role as a mediator of 
inflammation effects on epithelial and inflammatory cells. AMP also has the ability to 
modulate inflammation and immunity by functioning as immunomodulators (Hunter et 
al., 2002). AMP has been demonstrated to kill gram+ve and gram-ve bacteria’s, 
enveloped viruses, fungi and even cancerous cells (Hoskin et al., 2008). The anti-
protease effect of hBD2 was also evaluated in the enzyme kinetics assay.  After 
observing all the quantitative results, we can propose a novel anti-protease effect of 
hBD2.  This study is the first to show that hBD2, in addition to killing pathogens by 
invading their membrane, blocks the proteolytic effect of S. aureus-secreted proteases. 
7.2 Future plans-After this study it needs to be determined the chemical mechanism of 
protease inhibition? Which could be either direct binding to the active site of the 
protease, or hydrogen bonding with the enzyme-substrate complex? With the received 
information, we aim for further optimization of the inhibitor in respect of activity, 
selectivity and toxicity.  Further study will focus on the effects of environmental and skin 
condition as well as different pH values. We have future plan to determine the (Ki) value 
of hBD2 for V8, and staphopain B. NMR-spectroscopic study, co-crystallization and 






7.3 General conclusion and future work 
7.3.1 Novel  finding 
  1- The hBD2 can protect HaCaT cell monolayer by the S.aureus secreted protease as an  
 inhibitors 
 2- Vitamin D protect the monolayer by expressing hBD2 
3- V8 is the most active protease secreted in the CM 
4- TJ protein Claudin-1 become a substrate for V8 protease 
5- The hBD2 over-express HaCaT cell stable lines can be established 
7.3.2 Strength and weaknesses 
The major strength of this work is that it has been done in skin cell line hence the results 
 of my study are highly relevant to skin biology. -The major weakness of this 
study is the lack of functional data in human skin. Ultimately  understanding how 
S.aureus proteases disturb epidermal barrier by breaking tight junction (TJ) protein. how 
hBD2 can protect the barrier by blocking S.aureus proteases by having antiproteases 
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4%(v/v) Paraformaldehyde A mixture of 1 phosphate buffer saline tablet and 8g 
paraformaldehyde (PFA) in 200 mL distilled water was 
stirred and heated for 20 minutes until the PFA was 
dissolved.  
1x phosphate buffer saline 
(PBS) 
 
(0.137M NaCl, 0.05 M NaH2PO, pH 7.4 
 
o.5 % (v/v) Triton-X 100 A mixture of 500 µL Triton X-100 and 100mL 1X TBS. 
Blocking solutions 
1% blocking solution: 
3% blocking solution: 
 
 50 µL sera and 0.05g bovine serum albumin (BSA) 
were added to 5mL 1X TBS 
150 µL sere and 0.1g bovine serum albumin were added 




7.7 B preparation of Western blotting acrylamide gel  
 
 4.5%Gel 6% 9% 12% 15% 16.5% 
Protoflow 
acrylamide gel 
1.5 mL 2 mL 3 mL 4 mL 5 mL 5.5 mL 
2M-Tris-pH 
8.8 
2 mL 2 mL 2 mL 2 mL 2 mL 2 mL 
H2O 6.5 mL 6 mL 5 mL 4 mL 3 mL 2.5 mL 
10%SDS 150µL 150µL 150µL 150µL 150µL 150µL 
TEMED 15 µL 15 µL 15 µL 15 µL 15 µL 15 µL 
10% APS 150µL 150µL 150µL 150µL 150µL 150µL 
 
7.7 C preparing stacking gel 
 
Protoflow acrylamide gel 700 µL 
H20 600 µL 
0.5M Tris pH 6.8 600 µL 
H2O 3mL 
10% SDS 50 µL 
TEMED 5 µL 






7.7 D Western blotting solutions 
 
 
Western blotting solutions Preparation 
- APS 10% 1g Ammonium per sulphate in 10 mL of 
distilled water 
Blocking Buffer  5% (w/v) dried skim milk in 
PBS+0.05%Tween 20 
Running Buffer 1.5M PH 8.8 90.75 g Tris in 500 mL of distilled water 
adjust the pH 8.8 with HCL 
SDS 10% W/V 100g of Sodium Dodecyl Sulphate in 1000 
mL of distilled water 
Stacking Buffer 0.5 M, PH 6.8 6g Tris in 100g distilled water adjust the 
PH at 6.8 with HCL 
Tank buffer 10x 72g glycine 50 mL of SDS complete to 500 




24.2 g Tris and 84 g NaCl adjust the PH to 
7.6 with HCL complete to 1L with distilled 
water 
Transfer Buffer 1X 
 
3.03 g Tris HCL 
14.4 g glycine 
200 mL methenal 
1mL SDS complete to  with 1L of distilled 
water 
 
7.7 E Measurement of Trans-Epithelial Electrical Resistance (TEER) 
(Millipore) 
1 Electrodes were sterilized in 70% ethanol for 15 mint and then kept in the medium 
used to culture the cells 
2 Keep the shorter tip of electrodes in the culture plate insert in such a way that it 
should not contact cells grown on the membrane.  
3 The longer tip should be placed in the outer well and it should just touch the 
bottom of the outer well.  
4 To get stable and reproducible results, the electrodes are held steady and at a 90° 
angle to the plate insert. 
5 First measure the resistance across the blank insert with no cells
6 Each insert was measured at 3 different sites and the mean values were calculated. 
Unit area = cm2             
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